
<html lang="en"     class="pb-page"  data-request-id="a41dc3e3-16a4-4e1f-94c2-282b9f117a81"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2015.58.issue-20;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.5b00987;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)" /></meta><meta name="dc.Creator" content="Zack G.  Zachariassen" /></meta><meta name="dc.Creator" content="Stefanie  Karlshøj" /></meta><meta name="dc.Creator" content="Bengt Erik  Haug" /></meta><meta name="dc.Creator" content="Mette M.  Rosenkilde" /></meta><meta name="dc.Creator" content="Jon  Våbenø" /></meta><meta name="dc.Description" content="We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted..." /></meta><meta name="Description" content="We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 2, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00987" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00987" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00987" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00987" /></link>
        
    
    

<title>Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00987" /></meta><meta property="og:title" content="Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0010.jpeg" /></meta><meta property="og:description" content="We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of 1 were dependent on the transmembrane residues His113, Asp171, Asp262, and His281 and also suggested the involvement of Tyr45 and Gln200 (potency) and Tyr116 and Glu288 (affinity). Molecular docking of 1 to an X-ray structure of CXCR4 showed that the l-Arg guanidino group of 1 forms polar interactions with His113 and Asp171 and the (pyridin-2-ylmethyl)amino moiety is anchored by Asp262 and His281, whereas the naphthalene ring is tightly packed in a hydrophobic subpocket formed by the aromatic side chains of Trp94, Tyr45, and Tyr116. The detailed picture of ligand–receptor interactions provided here will assist in structure-based design and further development of small-molecule peptidomimetic CXCR4 antagonists." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00987"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00987">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00987&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00987&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00987&amp;href=/doi/10.1021/acs.jmedchem.5b00987" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8141-8153</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00984" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01037" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zack+G.++Zachariassen">Zack G. Zachariassen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefanie++Karlsh%C3%B8j">Stefanie Karlshøj</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bengt+Erik++Haug">Bengt Erik Haug</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mette+M.++Rosenkilde">Mette M. Rosenkilde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jon++V%C3%A5ben%C3%B8">Jon Våbenø</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Breivika, NO-9037 Tromsø, Norway</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">§</span> <span class="aff-text">Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Department of Chemistry and Centre for Pharmacy, University of Bergen, Allégaten 41, NO-5007 Bergen, Norway</span></div><div class="corresp-info"><strong>*</strong>(J.V.) Phone: +47 77 62 09 09. E-mail: <a href="/cdn-cgi/l/email-protection#3c565352124a5d5e5952537c495548125253"><span class="__cf_email__" data-cfemail="c4aeabaaeab2a5a6a1aaab84b1adb0eaaaab">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00987&amp;href=/doi/10.1021%2Facs.jmedchem.5b00987" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8141–8153</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 23, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 June 2015</li><li><span class="item_label"><b>Published</b> online</span>2 October 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 October 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00987" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00987</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8141%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZack%2BG.%2BZachariassen%252C%2BStefanie%2BKarlsh%25C3%25B8j%252C%2BBengt%2BErik%2BHaug%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D20%26contentID%3Dacs.jmedchem.5b00987%26title%3DProbing%2Bthe%2BMolecular%2BInteractions%2Bbetween%2BCXC%2BChemokine%2BReceptor%2B4%2B%2528CXCR4%2529%2Band%2Ban%2BArginine-Based%2BTripeptidomimetic%2BAntagonist%2B%2528KRH-1636%2529%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8153%26publicationDate%3DOctober%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00987"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1446</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00987" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zack&quot;,&quot;last_name&quot;:&quot;G. Zachariassen&quot;},{&quot;first_name&quot;:&quot;Stefanie&quot;,&quot;last_name&quot;:&quot;Karlshøj&quot;},{&quot;first_name&quot;:&quot;Bengt&quot;,&quot;last_name&quot;:&quot;Erik Haug&quot;},{&quot;first_name&quot;:&quot;Mette&quot;,&quot;last_name&quot;:&quot;M. Rosenkilde&quot;},{&quot;first_name&quot;:&quot;Jon&quot;,&quot;last_name&quot;:&quot;Våbenø&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8141-8153&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00987&quot;},&quot;abstract&quot;:&quot;We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (1). A limited SAR study based on the three functionalities of 1 was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of 1 were dependent on the transmembrane residues His113, Asp171, Asp262, and His281 and also suggested the involvement of Tyr45 and Gln200 (potency) and Tyr116 and Glu288 (affinity). Molecular docking of 1 to an X-ray structure of CXCR4 showed that the l-Arg guanidino group of 1 forms polar interactions with His113 and Asp171 and the (pyridin-2-ylmethyl)amino moiety is anchored by Asp262 and His281, whereas the naphthalene ring is tightly packed in a hydrophobic subpocket formed by the aromatic side chains of Trp94, Tyr45, and Tyr116. The detailed picture of ligand–receptor interactions provided here will assist in structure-based design and further development of small-molecule peptidomimetic CXCR4 antag&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00987&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00987" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00987&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00987" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00987&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00987" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00987&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00987&amp;href=/doi/10.1021/acs.jmedchem.5b00987" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00987" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00987" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00987%26sid%3Dliteratum%253Aachs%26pmid%3D26397724%26genre%3Darticle%26aulast%3DZachariassen%26date%3D2015%26atitle%3DProbing%2Bthe%2BMolecular%2BInteractions%2Bbetween%2BCXC%2BChemokine%2BReceptor%2B4%2B%2528CXCR4%2529%2Band%2Ban%2BArginine-Based%2BTripeptidomimetic%2BAntagonist%2B%2528KRH-1636%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D20%26spage%3D8141%26epage%3D8153%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/jmcmar.2015.58.issue-20/20151022/jmcmar.2015.58.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We here report an experimentally verified binding mode for the known tripeptidomimetic CXCR4 antagonist KRH-1636 (<b>1</b>). A limited SAR study based on the three functionalities of <b>1</b> was first conducted, followed by site-directed mutagenesis studies. The receptor mapping showed that both the potency and affinity of <b>1</b> were dependent on the transmembrane residues His<sup>113</sup>, Asp<sup>171</sup>, Asp<sup>262</sup>, and His<sup>281</sup> and also suggested the involvement of Tyr<sup>45</sup> and Gln<sup>200</sup> (potency) and Tyr<sup>116</sup> and Glu<sup>288</sup> (affinity). Molecular docking of <b>1</b> to an X-ray structure of CXCR4 showed that the <span class="smallcaps smallerCapital">l</span>-Arg guanidino group of <b>1</b> forms polar interactions with His<sup>113</sup> and Asp<sup>171</sup> and the (pyridin-2-ylmethyl)amino moiety is anchored by Asp<sup>262</sup> and His<sup>281</sup>, whereas the naphthalene ring is tightly packed in a hydrophobic subpocket formed by the aromatic side chains of Trp<sup>94</sup>, Tyr<sup>45</sup>, and Tyr<sup>116</sup>. The detailed picture of ligand–receptor interactions provided here will assist in structure-based design and further development of small-molecule peptidomimetic CXCR4 antagonists.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemokines are small (8–14 kDa) proteins from the cytokine superfamily that exert their biological effects through interaction with GPCRs.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The involvement and physiological role of the chemokine ligand–receptor system extends from control of chemotaxis (directional migration of leukocytes)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and hematopoiesis<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> to embryonic development, angiogenesis, and cancer metastasis.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> The human CXC chemokine receptor 4 (CXCR4) is activated by CXC chemokine ligand 12 (CXCL12), which is a 68-residue polypeptide.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> CXCL12–CXCR4 interaction is involved in the development of the hematopoietic, nervous, and gastrointestinal systems<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and plays an essential role in immune defense and inflammation.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> In addition to these physiological roles, CXCR4 is the coreceptor for cellular entry of T-tropic HIV strains;<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> thus, inhibition of CXCR4 has emerged as a promising strategy for anti-HIV therapy. CXCR4 has also been shown to play an important role in angiogenesis, metastasis, and stem cell mobilization.<a onclick="showRef(event, 'ref2 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref4">(2, 4)</a> Consequently, development of CXCR4 antagonists for therapeutic applications remains an important goal.</div><div class="NLM_p">Significant advances in the development of novel CXCR4 antagonists have been made, and several different classes of CXCR4 antagonists, both peptides and nonpeptides, have been reported.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> So far, the hematopoietic stem cell mobilizing agent plerixafor (AMD3100, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> is the only CXCR4 antagonist that has reached the market.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Due to its high positive charge at physiological pH, AMD3100 exhibits poor oral bioavailability and is therefore administered by subcutaneous injection.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected CXCR4 antagonists: (A) bicyclam AMD3100; (B) cyclopentapeptide FC131; (C) prototype arginine-based tripeptidomimetic <b>1</b>; (D) 16-mer peptide <b>2</b>; (E) isothiourea derivative <b>3</b>; (F) tetrahydroquinoline derivative <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Extensive studies by Fujii and co-workers on polyphemusin II-derived peptide CXCR4 antagonists culminated in the discovery of the potent cyclopentapeptide antagonist FC131 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Successive SAR studies of FC131 have since shown that the Arg<sup>1</sup>-Arg<sup>2</sup>-2-Nal<sup>3</sup> tripeptide fragment of the cyclopentapeptide serves as an essential recognition motif for peptide-based CXCR4 antagonists,<a onclick="showRef(event, 'ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23 ref24">(20-24)</a> providing impetus for the development of tripeptidomimetic ligands that block CXCR4. Indeed, a series of tripeptide-like CXCR4 antagonists containing a central arginine residue has been reported by Kureha Chemical Industries<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> with the potent tripeptidomimetic <b>1</b> (KRH-1636, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C)<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> as a prototype compound. These small-molecule peptidomimetics represent a particularly interesting class of CXCR4 antagonists due to their potentially improved pharmacokinetic properties compared to their peptide counterparts.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> On the basis of structural comparison of low-energy conformations of <b>1</b> with a 3D-pharmacophore model for the cyclopentapeptide CXCR4 antagonists, <b>1</b> has been suggested to mimic the Arg<sup>1</sup>-Arg<sup>2</sup>-2-Nal<sup>3</sup> fragment of FC131.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, it has not been shown experimentally that the two ligands bind to CXCR4 in the same way.</div><div class="NLM_p last">The first X-ray structures of CXCR4 were reported in 2010 and are cocrystallized complexes containing the 16-mer peptide antagonist <b>2</b> (CVX15, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D) and the small-molecule antagonist <b>3</b> (IT1t, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Very recently, an X-ray structure of a covalent complex between CXCR4 and the viral chemokine vMIP-II was also released.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> The CXCR4:<b>2</b> complex provided the first detailed insight into binding of a peptide antagonist to CXCR4, and on the basis of this structure we have recently reported an experimentally verified binding mode for the cyclopentapeptide FC131 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Prior to the publication of the X-ray structures of CXCR4, extensive receptor mapping studies were performed for the AMD compound series, which resulted in the identification of plausible binding modes for the bicyclam AMD3100,<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36-38)</a> its monocyclam analogues,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> and the noncyclam <b>4</b> (AMD11070, <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>F).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> However, whereas the molecular pharmacology of the prototype small-molecule peptide and nonpeptide CXCR4 antagonists has been extensively characterized, experimental binding mode studies for the more drug-like tripeptidomimetic CXCR4 antagonists have not been reported. Thus, to facilitate rational design of novel peptidomimetic CXCR4 antagonists, we here report the binding mode of the known tripeptidomimetic CXCR4 antagonist <b>1</b> using a combination of SAR studies, receptor mapping by site-directed mutagenesis, and molecular docking.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> SAR Study</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i4" class="anchor-spacer"></div><h4 class="article-section__title" id="_i4"> Design</h4><div class="NLM_p">The lead compound <b>1</b> was developed from a hit compound identified through screening of a chemical library,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> and although recent patent literature discloses compounds related to <b>1</b>,<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> no SAR data have been reported for this compound class. To confirm the importance of the functionalities in <b>1</b> that could be assumed to represent pharmacophoric groups, we first carried out a limited SAR study focusing on the two positively charged groups (R<sup>1</sup> and R<sup>2</sup>) and the aromatic group (R<sup>3</sup>) (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). To probe the R<sup>1</sup> position, the pyridine ring was replaced with a phenyl ring (<b>5</b>), the pyridin-2-ylmethyl substituent was removed to give the primary amine (<b>6</b>), and the charged (pyridin-2-ylmethyl)amino moiety was removed altogether (<b>7</b>). The importance of the charged guanidino group (R<sup>2</sup>) was investigated by replacing it with a urea group (<b>8</b>), whereas the aromatic position (R<sup>3</sup>) was probed by removal of the naphthalene unit (<b>9</b>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of compounds <b>1</b> and <b>5</b>–<b>9</b>. The modified groups (R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>) in the lead compound <b>1</b> are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Chemistry</h4><div class="NLM_p">Compounds <b>1</b> and <b>5</b>–<b>9</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) were all prepared by adopting a procedure previously reported for the synthesis of <b>1</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For compound <b>1</b>, the right-hand side was prepared by N-alkylation of Boc-protected pyridin-2-ylmethanamine (<b>10</b>) with methyl 4-(bromomethyl)benzoate followed by hydrolysis of the methyl ester to give carboxylic acid <b>11</b>. The left-hand side was assembled by coupling of Fmoc-<span class="smallcaps smallerCapital">l</span>-Arg(Pbf)-OH with (<i>S</i>)-1-(naphthalen-1-yl)ethanamine using PyBOP as the coupling reagent, followed by Fmoc deprotection with diethylamine in DMF to afford amine <b>12</b>. Coupling of the two halves (<b>11</b> and <b>12</b>) was facilitated by EDCI/HOBt, and subsequent removal of the Boc and Pbf protecting groups by treatment with a TFA cocktail gave <b>1</b>. For the preparation of <b>6</b> and <b>7</b>, the left-hand side (<b>12</b>) was coupled with <i>N</i>-Boc 4-(aminomethyl)benzoic acid and 4-methylbenzoic acid, respectively. Analogue <b>5</b> was prepared by N-alkylation of <b>6</b> with benzyl bromide using K<sub>2</sub>CO<sub>3</sub> as base and DMF as solvent. The R<sup>2</sup> analogue <b>8</b> was prepared using Fmoc-protected citrulline as the starting material, whereas the R<sup>3</sup> analogue <b>9</b> was prepared by use of ethanamine in the first coupling step (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NaH, DMF, 0 °C; (ii) methyl 4-(bromomethyl)benzoate, DMF, 0 °C to room temperature; (b) 1 M NaOH/THF/MeOH (1:1:1); (c) (<i>S</i>)-1-(naphthalen-1-yl)ethanamine, PyBOP, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to room temperature; (d) Et<sub>2</sub>HN, DMF; (e) <b>11</b>, EDCI, HOBt, DMF; (f) TFA/TIS/H<sub>2</sub>O (95:2.5:2.5).</p></p></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Biology and SAR</h4><div class="NLM_p">The antagonistic potency of compounds <b>1</b> and <b>5</b>–<b>9</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was assessed in a functional assay measuring the inhibition of CXCL12-induced activation of human CXCR4, transiently expressed in COS-7 cells. The known lead compound <b>1</b> was originally reported by Ichiyama et al. to efficiently inhibit binding of [<sup>125</sup>I]CXCL12 (IC<sub>50</sub> = 0.013 μM),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and our own functional data validates <b>1</b> as a potent CXCR4 antagonist (EC<sub>50</sub> = 0.50 μM, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) with respect to the endogenous ligand CXCL12. The phenyl analogue <b>5</b> (EC<sub>50</sub> = 8.5 μM) displayed a 17-fold lower potency than <b>1</b>, demonstrating an important role of the pyridine nitrogen in <b>1</b>. The potency of the primary amine <b>6</b> (EC<sub>50</sub> = 12 μM) was 24-fold lower than that for <b>1</b>, representing the overall contribution from the pyridin-2-ylmethyl substituent to the antagonistic potency, whereas the loss of potency for compound <b>7</b> (EC<sub>50</sub> > 100 μM) confirms the positively charged amino group in R<sup>1</sup> as an essential pharmacophoric element. Compound <b>8</b>, containing a neutral urea group that partly retains the H-bonding properties of the original guanidino group, failed to show antagonistic potency (EC<sub>50</sub> > 100 μM), demonstrating the importance of the positive charge in R<sup>2</sup> position. Similarly, the loss of potency for the R<sup>3</sup> analogue <b>9</b> (EC<sub>50</sub> > 100 μM) confirms an important role for the naphthyl group.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Antagonistic Potency of 1 and 5–9 on Human CXCR4</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">log EC<sub>50</sub> ± SEM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">–6.30 ± 0.07</td><td class="colsep0 rowsep0" align="left">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">–5.12 ± 0.08</td><td class="colsep0 rowsep0" align="left">8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">–4.93 ± 0.08</td><td class="colsep0 rowsep0" align="left">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">> –4</td><td class="colsep0 rowsep0" align="left"> > 100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">> –4</td><td class="colsep0 rowsep0" align="left"> > 100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">> –4</td><td class="colsep0 rowsep0" align="left"> > 100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values represent the mean of at least three independent experiments performed in duplicates.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Known compound.</p></div></div></div><div class="NLM_p">Earlier attempts to improve the pharmacokinetic profile of the bicyclam CXCR4 antagonists, that is, AMD3100 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A), led to the discovery of the monocyclam AMD3465 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>),<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> which was shown to be 22-fold more potent than its precursor AMD3100<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and contains the same (pyridin-2-ylmethyl)amino moiety as <b>1</b>. The importance of this group for the antagonistic activity of AMD3465 has been investigated previously using the analogues <b>13</b> (AMD3529) and <b>14</b> (AMD3389) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> which are structural counterparts of the KRH analogues <b>5</b> and <b>7</b> in the present study (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). In line with the present findings for <b>5</b> and <b>7</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), <b>13</b> and <b>14</b> were shown to display significantly lower potencies for CXCR4 than AMD3465 as determined by a functional assay inhibiting CXCL12-induced receptor activation.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and reported potencies of the monocyclam AMD3465 and the two analogues <b>13</b> and <b>14</b>,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> also showing the structural analogy of these monocyclams with the R<sup>1</sup> substituent in compounds <b>1</b>, <b>5</b>, and <b>7</b> in the present study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With regard to the central Arg residue in <b>1</b> (R<sup>2</sup>), it has been suggested that this position could correlate to Arg<sup>2</sup> in the cyclopentapeptide antagonist FC131 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> SAR studies of the cyclopentapeptides have shown that the Arg<sup>2</sup> position is very sensitive to modifications<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a> and that replacement of the guanidino group with a urea group (Cit<sup>2</sup>) leads to complete loss of antagonistic potency,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which is in agreement with the present data for the KRH analogue <b>8</b>.</div><div class="NLM_p last">Collectively, the findings from this initial SAR study confirmed that the secondary amine, the guanidino group, and the aromatic naphthyl group are essential for the antagonistic potency of <b>1</b>, whereas the pyridine ring in the R<sup>1</sup> position contributes to increased potency.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Identification of Binding Site for 1: Receptor Mutagenesis</h3><div class="NLM_p">Next, we carried out mutagenesis studies to map key binding interactions between <b>1</b> and CXCR4 using a library of 25 CXCR4 mutants (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Most of the mutations were located in the transmembrane helices (TMs), but some were also introduced in extracellular loop 2 (ECL2) that connects TM4 and TM5. In most cases, the mutations included replacement with Ala; however, certain acidic Asp residues were alternatively substituted with the structurally similar and uncharged Asn residue. Selective substitutions with Trp were also done to introduce more bulk. We have recently utilized the same receptor library to map the binding of the cyclopentapeptide CXCR4 antagonist FC131, where we reported the surface expression (using ELISA) and functional response to CXCL12 of WT-CXCR4 and all mutant receptors<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (the same data are provided in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Although there was some variation in surface expression and ability to be activated by CXCL12, the receptors in the mutant library were considered suitable for mapping of the binding site, as previously discussed.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency of Lead Compound 1 and the R<sup>1</sup> Analogues 5 and 6 on WT-CXCR4 and 25 Mutant Receptors, Measured as Inhibition of CXCL12-Induced Activation in COS-7 Cells Transiently Co-transfected with CXCR4 Receptor Mutants and Chimeric G Protein G<sub>qi4myr</sub> (Functional Assay)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0009.gif" alt="" id="gr50" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Data for CXCL12 activation are from ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">The position of each residue is given on the basis of the generic numbering system proposed by Baldwin and modified by Schwartz, followed by the Ballesteros/Weinstein numbering system.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last"><i>F</i><sub>mut</sub> is the ratio of the mutant and WT-CXCR4 potencies. Red, <i>F</i><sub>mut</sub> > 25; orange, <i>F</i><sub>mut</sub> from 10 to 25; yellow, <i>F</i><sub>mut</sub> from 5 to 10; green, <i>F</i><sub>mut</sub> < 0.5. EC<sub>50</sub> values >100 μM are underlined and also colored red. ***, <i>P</i> < 0.001; **, <i>P</i> < 0.01; *, <i>P</i> < 0.05.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">The number of independent experiments is shown in parentheses (<i>n</i>).</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">These mutant receptors were also tested in binding assay (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</p></div></div><div></div></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Inhibition of CXCL12-Induced Activation of CXCR4</h4><div class="NLM_p">We first assessed the antagonistic potency of <b>1</b> on the entire CXCR4 mutant library (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The H113A, D262N, and H281A mutations were found to have the largest impact (>25-fold reduction) on the antagonistic potency of <b>1</b> relative to WT-CXCR4 (the positions of residues based on the generic numbering system proposed by Baldwin<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and modified by Schwartz<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> followed by the Ballesteros/Weinstein numbering system<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> are given in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The potency of <b>1</b> was also reduced (by 5–25-fold) by mutations of Tyr<sup>45</sup> (Y45A), Asp<sup>171</sup> (D171N), Gln<sup>200</sup> (Q200A and Q200W), Trp<sup>252</sup> (W252A), Ile<sup>259</sup> (I259A), and Ile<sup>284</sup> (I284A). In contrast, the W94A, D97A, T117A, and F189A mutants led to <i>increased</i> potency (>2-fold).</div><div class="NLM_p">As the mutagenesis data for <b>1</b> alone did not provide information about which parts of the ligand interact with the different parts of the receptor, the R<sup>1</sup> analogues <b>5</b> and <b>6</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), which showed decent activity on WT-CXCR4 (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), were also included in the mutagenesis study to further probe the molecular interactions of the R<sup>1</sup> side chain with CXCR4. The collective functional data analysis for <b>1</b>, <b>5</b>, and <b>6</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) showed that the mutations in TM1 (Y45A), TM2 (W94A, D97A), TM3 (H113A, T117A), TM4 (D171N), and ECL2 affected the three ligands in a similar manner. However, several mutations in TMs 5–7 affected the three ligands in a distinctive manner. Specifically, the H281A mutation in TM7 was the mutation with the largest effect on the potency of <b>1</b> (61-fold reduction), but affected analogue <b>5</b> to a much lesser extent (6-fold). Thus, the overall trend identified in the phosphatidylinositol (PI) turnover experiments for <b>1</b>, <b>5</b>, and <b>6</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) suggests that the structurally modified R<sup>1</sup> group contacts TMs 5–7; this trend is further illustrated in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–C) Bar-graphs representations of fold reduction in potency (<i>F</i><sub>mut</sub>) for compounds <b>1</b>, <b>5</b>, and <b>6</b> for each mutant with respect to WT-CXCR4 (functional data, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Gray bars, mutants in TMs 1–4 and ECL2; black bars, mutants in TMs 5–7. (D–F) Residues identified to be important for the potency of compounds <b>1</b>, <b>5</b>, and <b>6</b> (functional data, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), shown in a helical wheel diagram of CXCR4. Red background color, >25-fold decrease; orange, 10–25-fold decrease; yellow, 5–10-fold decrease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The absolute majority of the mutations had no or little effect on the potency of CXCL12 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), demonstrating that most of the mutants were functional. However, the W94A, D97A, and D187A mutations reduced the agonistic potency of CXCL12 by 8–14 -fold (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Furthermore, the Y116A and E288A mutants were not activated by CXCL12 despite expression levels of 69 and 77%, respectively (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>); consequently, no data on the antagonistic action of <b>1</b>, <b>5</b>, and <b>6</b> on these mutants are available. In line with the findings in the present study, the D97A, D187A, and E288A mutations have previously been found to affect both the binding and signaling of CXCL12.<a onclick="showRef(event, 'ref37 ref45 ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref37 ref45 ref46 ref47 ref48 ref49">(37, 45-49)</a> Moreover, Trp<sup>94</sup> and Tyr<sup>116</sup>, together with the three aforementioned residues, have been implicated as part of “site two” in the “two-site model” for binding of CXCL12 to CXCR4.<a onclick="showRef(event, 'ref33 ref45 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref33 ref45 ref50 ref51">(33, 45, 50, 51)</a> Additionally, the direct interaction of Tyr<sup>116</sup> with agonists has been suggested in the activation of GPCRs.<a onclick="showRef(event, 'ref34 ref52'); return false;" href="javascript:void(0);" class="ref ref34 ref52">(34, 52)</a> Thus, for these residues there are certain limitations in using CXCL12 as a probe.</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Displacement of Radiolabeled Monoclonal Antibody (<sup>125</sup>I-12G5)</h4><div class="NLM_p">To address the issue of reduced activity of CXCL12 in certain mutants (W94A, D97A, Y116A, D187A, and E288A), a competitive binding assay using the radiolabeled monoclonal antibody 12G5 (<sup>125</sup>I-12G5) was employed to probe ligand affinity (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). A good correlation between anti-HIV potency and binding affinity measured as displacement of <sup>125</sup>I-12G5 has previously been demonstrated for the bicyclam antagonists,<a onclick="showRef(event, 'ref36 ref38 ref53'); return false;" href="javascript:void(0);" class="ref ref36 ref38 ref53">(36, 38, 53)</a> which represents an additional advantage of using 12G5 as radioligand. In addition to the five mutants mentioned above, the binding experiments were extended to also include four of the mutants that were identified as important for the potency of <b>1</b> in the functional assay (H113A, D171N, D262N, and H281A). All nine mutants had affinities for 12G5 similar to that of the WT receptor (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), meaning that the mutations did not significantly affect receptor folding.</div><div class="NLM_p">Compared to the strong antagonistic potency (EC<sub>50</sub> = 0.50 μM) measured in the functional assay (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A), <b>1</b> displayed lower affinity to WT-CXCR4 (IC<sub>50</sub> = 8.0 μM) measured against <sup>125</sup>I-12G5 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B), suggesting that this compound binds allosterically with respect to 12G5. This finding clearly illustrates the differences between displacing <sup>125</sup>I-12G5 (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) and inhibiting the action of CXCL12 (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The two R<sup>1</sup> analogues <b>5</b> and <b>6</b> did not completely displace 12G5 (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B), which also indicates an allosteric binding mode, and were therefore excluded from further binding experiments. The affinity of <b>1</b> determined against <sup>125</sup>I-12G5 was strongly (from 8 to >12-fold) negatively affected by the TM3 mutant H113A, the TM4 mutant D171N, the TM5 mutant D262N, and the TM7 mutants H281A and E288A (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Moreover, <b>1</b> could not displace 12G5 from the Y116A mutant. Overall, the binding data show that His<sup>113</sup>, Tyr<sup>116</sup>, and Asp<sup>171</sup> at the interface between TM3 and TM4 and Asp<sup>262</sup>, His<sup>281</sup>, and Glu<sup>288</sup> at the interface between TM6 and TM7 in the main binding pocket are important for the displacement of 12G5 by <b>1</b>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Ability of lead compound <b>1</b> and analogues <b>5</b> and <b>6</b> to inhibit CXCL12-induced activation of WT-CXCR4 and (B) to displace <sup>125</sup>I-12G5 from WT-CXCR4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To summarize, the functional studies (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and the binding studies (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>) show that Tyr<sup>45</sup> (TM1), His<sup>113</sup> and Tyr<sup>116</sup> (TM3), Asp<sup>171</sup> (TM4), Gln<sup>200</sup> (TM5), Asp<sup>262</sup> (TM6), and His<sup>281</sup> and Glu<sup>288</sup> (TM7) are important for the function and/or binding of <b>1</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Affinity of 1 for WT-CXCR4 and Nine Mutant Receptors Measured as Displacement of <sup>125</sup>I-Labeled Antibody 12G5 in Transiently Transfected COS-7 Cells (Competition Binding Assay)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">receptor</th><th class="rowsep1 colsep0" colspan="5" align="center" char="±">12G5<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="6" align="center">compd <b>1</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">helix</th><th class="colsep0 rowsep0" align="center">position<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">mutation</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (log ± SEM)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>mut</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>B</i><sub>max</sub> ± SEM (fmol/10<sup>5</sup> cells)</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>P</i><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a><i>B</i><sub>max</sub></th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> ± SEM (log)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>mut</sub></th><th class="colsep0 rowsep0" align="center"><i>P</i></th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="left">WT</td><td class="colsep0 rowsep0" align="char" char="±">–8.3 ± 0.13</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char="±">0.096 ± 0.018</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">–5.1 ± 0.116</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM-2</td><td class="colsep0 rowsep0" align="left">II: 20/2.60</td><td class="colsep0 rowsep0" align="left">W94A</td><td class="colsep0 rowsep0" align="char" char="±">–8.7 ± 0.15</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="char" char="±">0.053 ± 0.022</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">–5.8 ± 0.217</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="center">**</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">II: 23/2.63</td><td class="colsep0 rowsep0" align="left">D97A</td><td class="colsep0 rowsep0" align="char" char="±">–8.0 ± 0.12</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char="±">0.086 ± 0.013</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">–5.1 ± 0.129</td><td class="colsep0 rowsep0" align="char" char=".">8.5</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM-3</td><td class="colsep0 rowsep0" align="left">III: 05/3.29</td><td class="colsep0 rowsep0" align="left">H113A</td><td class="colsep0 rowsep0" align="char" char="±">–8.6 ± 0.15</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char="±">0.037 ± 0.006</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="center">*</td><td class="colsep0 rowsep0" align="char" char="±">> –4</td><td class="colsep0 rowsep0" align="char" char="."> > 100</td><td class="colsep0 rowsep0" align="char" char="."> > 12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">III: 08/3.32</td><td class="colsep0 rowsep0" align="left">Y116A</td><td class="colsep0 rowsep0" align="char" char="±">–8.1 ± 0.08</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="±">0.036 ± 0.016</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" colspan="3" align="left" char="±">no displacement</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM-4</td><td class="colsep0 rowsep0" align="left">IV: 20/4.60</td><td class="colsep0 rowsep0" align="left">D171N</td><td class="colsep0 rowsep0" align="char" char="±">–8.7 ± 0.18</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td><td class="colsep0 rowsep0" align="char" char="±">0.034 ± 0.017</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="center">*</td><td class="colsep0 rowsep0" align="char" char="±">–4.2 ± 0.112</td><td class="colsep0 rowsep0" align="char" char=".">67</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="center">***</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ECL-2</td><td class="colsep0 rowsep0" align="left">Cys+1</td><td class="colsep0 rowsep0" align="left">D187A</td><td class="colsep0 rowsep0" align="char" char="±">–7.8 ± 0.04</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char="±">0.161 ± 0.012</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">–4.6 ± 0.097</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM-6</td><td class="colsep0 rowsep0" align="left">VI: 23/6.58</td><td class="colsep0 rowsep0" align="left">D262N</td><td class="colsep0 rowsep0" align="char" char="±">–8.4 ± 0.15</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char="±">0.101 ± 0.020</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="±">> –4</td><td class="colsep0 rowsep0" align="char" char="."> > 100</td><td class="colsep0 rowsep0" align="char" char="."> > 12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TM-7</td><td class="colsep0 rowsep0" align="left">VII: −02/7.32</td><td class="colsep0 rowsep0" align="left">H281A</td><td class="colsep0 rowsep0" align="char" char="±">–8.6 ± 0.15</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">0.52</td><td class="colsep0 rowsep0" align="char" char="±">0.028 ± 0.008</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="center">*</td><td class="colsep0 rowsep0" align="char" char="±">–4.2 ± 0.13</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="center">***</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">VII: 06/7.39</td><td class="colsep0 rowsep0" align="left">E288A</td><td class="colsep0 rowsep0" align="char" char="±">–8.7 ± 0.16</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td><td class="colsep0 rowsep0" align="char" char="±">0.035 ± 0.011</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="center">*</td><td class="colsep0 rowsep0" align="char" char="±">> –4</td><td class="colsep0 rowsep0" align="char" char="."> > 100</td><td class="colsep0 rowsep0" align="char" char="."> > 12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data for 12G5 binding are from ref <a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">35</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>F</i><sub>mut</sub> is the ratio of the mutant and WT-CXCR4 affinities.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">The number of independent experiments is shown in parentheses (<i>n</i>).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">***, <i>P</i> < 0.001; **, <i>P</i> < 0.01; *, <i>P</i> < 0.05.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">The position of each residue is given on the basis of the generic numbering system proposed by Baldwin and modified by Schwartz, followed by the Ballesteros/Weinstein numbering system.</p></div></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Molecular Docking and Derived Binding Model</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Binding Model: Key Interactions</h4><div class="NLM_p last">To rationalize the experimental data, <b>1</b> was docked to the X-ray structure of CXCR4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0">3OE0</a>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> using Schrödinger’s induced-fit docking protocol,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> which models the conformational changes induced by ligand binding. To avoid generation of irrelevant poses, a H-bond constraint was set on His<sup>113</sup> (N<sup>δ1</sup>), which was shown to be highly important for both the affinity and potency of <b>1</b>. Visual inspection of the 15 generated ligand–receptor complexes resulted in the identification of a pose that was in agreement with the experimental data. In our proposed binding model (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), the (pyridin-2-ylmethyl)amino moiety (R<sup>1</sup> side chain) of <b>1</b> is oriented toward the TM6 and TM7 region and the R<sup>1</sup> side chain adopts a bent conformation around the secondary amino group, where the pyridine and phenyl rings lie in almost parallel planes. His<sup>281</sup> in TM7 forms an aromatic π–π stacking interaction with the pyridine ring, and Asp<sup>262</sup> in TM6 is involved in a bidentate interaction with the charged secondary amine in the R<sup>1</sup> side chain of <b>1</b>. The guanidino group of Arg (R<sup>2</sup> position) forms polar interactions with His<sup>113</sup> and Thr<sup>117</sup> (TM3) and Asp<sup>171</sup> (TM4). The aromatic naphthyl ring (R<sup>3</sup> position) is embedded in a hydrophobic pocket formed by the aromatic side chains of Tyr<sup>45</sup> and Trp<sup>94</sup> and further stabilized by the Tyr<sup>116</sup> side chain located directly below Trp<sup>94</sup>. Interestingly, previous studies indicate that the three aromatic residues Tyr<sup>45</sup>, Trp<sup>94</sup>, and Tyr<sup>116</sup> of CXCR4, which are also found in the CCR5 chemokine receptor as Tyr<sup>37</sup>, Trp<sup>86</sup>, and Tyr<sup>108</sup>, respectively, might form a hydrophobic pocket that is involved in the binding of small-molecule inhibitors.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> Thus, mutations of the aforementioned three residues could destabilize the hydrophobic subpocket that interacts with the naphthyl ring of <b>1</b>. Furthermore, the observation that Tyr<sup>116</sup> is involved in a direct interaction with Glu<sup>288</sup> (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf" class="ext-link">Supporting Information</a> Figure S1) implies that the Y116A mutation can affect the overall geometry of the main binding crevice, specifically the orientations of TM3 and TM7. Thus, the Y116A mutation may indirectly affect the potential interactions between the ligand and His<sup>113</sup>, Thr<sup>117</sup>, His<sup>281</sup>, and Glu<sup>288</sup>.</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Binding Model: Indirect Effects</h4><div class="NLM_p">The docking pose for <b>1</b> also reveals the involvement of Glu<sup>288</sup>, which is a key residue as shown in the binding assay (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). A Glu residue at this position (VII: 06/7.39) is highly conserved among chemokine receptors and acts as an anchor point for several small molecule ligands.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Glu<sup>288</sup> in CXCR4 has been consistently implicated in binding modes of several different classes of CXCR4 antagonists, that is, AMD3100, AMD3465, <b>4</b>, FC131, and also the CXCR4 cocrystallized ligands <b>2</b> and <b>3</b>,<a onclick="showRef(event, 'ref33 ref35 ref37 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref33 ref35 ref37 ref39 ref40">(33, 35, 37, 39, 40)</a> either through direct or water-mediated interactions with the ligand. Similarly, our binding model shows a water-mediated interaction between Glu<sup>288</sup> and the ligand backbone (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effects of the H113A and D171N mutations on the inhibition of CXCL12-induced PI turnover by <b>1</b>. (B) Proposed binding model for <b>1</b>, showing the key interacting residues in CXCR4. The ligand is shown in orange sticks, the receptor in gray-white sticks and ribbons, and the water molecule as a red sphere; H-bonds are shown in magenta and π–π interactions in green. (C) Effects of the H281A and D262N mutations on the inhibition of CXCL12-induced PI turnover by <b>1</b>. (D) 2D representation of the docking pose for <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substitution of Gln<sup>200</sup> with Ala and Trp (Q200A and Q200W) caused 7- and 21-fold reductions in potency of <b>1</b> with respect to WT-CXCR4; the involvement of this residue was also seen in previous binding mode studies of the monocyclam antagonist AMD3465.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In our binding model for <b>1</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), an intrareceptor H-bond between Gln<sup>200</sup> and Asp<sup>262</sup> was identified, suggesting that substitution of Gln<sup>200</sup> can affect the interaction between Asp<sup>262</sup> and the ligand.</div><div class="NLM_p">The model further shows an interaction between the guanidino group of Arg<sup>188</sup> and the ligand backbone (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), which was also previously identified in the binding modes of the peptide antagonists FC131 and <b>2</b>.<a onclick="showRef(event, 'ref23 ref33 ref58'); return false;" href="javascript:void(0);" class="ref ref23 ref33 ref58">(23, 33, 58)</a> However, the R188A mutation did not have any effect on the antagonistic potency of <b>1</b> or the two analogues (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>); interestingly, the R188A mutant was also reported to have no effect on the potency of FC131.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> A possible explanation is that both <b>1</b> and FC131 are doubly positively charged, which results in electrostatic repulsion by Arg<sup>188</sup>. Substitution of Arg<sup>188</sup> with Ala (R188A) therefore results in two opposing effects: an unfavorable removal of the H-bond interaction with the ligand and a favorable removal of the electrostatic repulsion. Thus, it can be hypothesized that the net result is no overall effect of the R188A mutation on <b>1</b> and FC131.</div><div class="NLM_p">Whereas the effect of most mutations (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) can be explained by the binding model, it is not possible to rationalize each one. For example, the W94A and D97A mutations both led to increased potencies for all three analogues (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Earlier studies have suggested the involvement of these residues in the second binding step (“site two”) for the endogenous ligand CXCL12,<a onclick="showRef(event, 'ref33 ref45'); return false;" href="javascript:void(0);" class="ref ref33 ref45">(33, 45)</a> and the present mutagenesis data showed a reduced ability (13–14-fold) of CXCL12 to induce signaling for the W94A and D97A mutants. Moreover, the X-ray structure of CXCR4 suggests that Asp<sup>97</sup> constitutes a gate-entry position that controls ligand access to the major binding pocket;<a onclick="showRef(event, 'ref33 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref35">(33, 35)</a> thus, a preinteraction with Asp<sup>97</sup> is implicated in the passage of the ligands to the TM receptor region. Taken together, the existing data supported by our mutagenesis suggest that the TM2 residues (Trp<sup>94</sup> and Asp<sup>97</sup>) have a less distinctive involvement in the binding of these ligands to the receptor. First, mutation of Trp<sup>94</sup> and Asp<sup>97</sup> will weaken the binding of CXCL12, thereby increasing the antagonistic potency of the three analogues as reflected in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Second, the potential pre-interaction with Asp<sup>97</sup> is removed in the D97A mutant, which allows easier access of the ligands to the TM binding pocket. Third, the involvement of the Trp<sup>94</sup> in the hydrophobic pocket surrounding the naphthalene ring (R<sup>3</sup> position) in <b>1</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>) suggests that removal of the bulky side chain of Trp (W94A mutant) allows a more energetically favorable position of the naphthyl group in the binding pocket.</div><div class="NLM_p">Conversely, mutation of hydrophobic residues in TM6 and TM7 reduced the potency of <b>1</b> (W252A, I259A, and I284A) and <b>6</b> (W252A and I284A). However, residues Trp<sup>252</sup>, Ile<sup>259</sup>, and Ile<sup>284</sup> are not directly involved in ligand binding, meaning that the observed effects of the mutations most likely are secondary, that is, implemented through local or global changes in TM6 and TM7.</div><div class="NLM_p last">Despite the lower WT potency of <b>6</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), the effects of mutants Y45A and D171N were more pronounced for this analogue. Our SAR data showed that gradual removal of the R<sup>1</sup> group led to reduced potency, whereas receptor mapping (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) suggested that the R<sup>1</sup> group contacts TMs 5–7. It could be reasoned that the weakened interaction of <b>6</b> with TMs 5–7 (R<sup>1</sup> group interaction) makes the remaining interactions more important, which would explain the stronger dependence on Tyr<sup>45</sup> (R<sup>3</sup> group interaction) and Asp<sup>171</sup> (R<sup>2</sup> group interaction) for <b>6</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Comparison with Experimentally Determined Binding Modes for Other Small-Molecule CXCR4 Antagonists</h3><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Isothiourea Derivatives</h4><div class="NLM_p last">Thoma et al. have reported a series of small-molecule isothiourea derivatives that selectively block CXCL12 and HIV gp120 binding to CXCR4.<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59, 60)</a> The X-ray structures of CXCR4 in complex with the most potent compound <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>E)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> later showed that <b>3</b> exhibits a unique binding mode by occupying the so-called “minor binding pocket” between TMs 1, 2, 3, and 7,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> that is, without interacting with TMs 4–6. Consequently, the binding mode of <b>3</b> differs from other reported binding modes of CXCR4 antagonists (see below) and is distinct from the present binding mode for <b>1</b>.</div></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Peptide Antagonists</h4><div class="NLM_p">Prior to the publication of the X-ray structure of CXCR4, computational binding mode studies had been performed for the cyclopentapeptide CXCR4 antagonist FC131<a onclick="showRef(event, 'ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref62 ref63">(62, 63)</a> and <b>1</b><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> based on molecular docking to homology models of CXCR4 that were built on the crystal structure of bovine rhodopsin. These studies were purely theoretical, that is, not based on any experimentally verified ligand–receptor interactions. Moreover, when the X-ray structure of CXCR4<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was revealed in 2010, it showed that bovine rhodopsin was a poor template for CXCR4,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> questioning the validity of the previously proposed binding models for the small-molecule peptide-based antagonists.</div><div class="NLM_p">However, we have recently proposed an experimentally verified binding mode for FC131 based on ligand modifications, receptor mutagenesis, and molecular docking to the X-ray structure of CXCR4.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The binding model for FC131 was generally consistent with the binding mode for the Arg<sup>1</sup>-Arg<sup>2</sup>-1-Nal<sup>3</sup> fragment of the 16-mer peptide antagonist <b>2</b> in complex with CXCR4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0">3OE0</a>);<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> that is, the Arg<sup>1</sup> side chain in FC131 projected toward ECL2 of the receptor to interact with Asp<sup>187</sup>, and the Arg<sup>2</sup> guanidino group interacted with His<sup>113</sup>, Thr<sup>117</sup>, and Asp<sup>171</sup> in TMs 3–4, whereas the aromatic 2-Nal<sup>3</sup> side chain was accommodated in a hydrophobic pocket around TM5.</div><div class="NLM_p last">Thus, the Arg<sup>2</sup> guanidino group in FC131 and the guanidino group (R<sup>2</sup> position) in <b>1</b> both interact with His<sup>113</sup>, Thr<sup>117</sup>, and Asp<sup>171</sup> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>); structural comparison of the reported binding mode for FC131<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the present binding mode for <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf" class="ext-link">Supporting Information</a> Figure S2) also shows that the <span class="smallcaps smallerCapital">l</span>-Arg<sup>2</sup> side chain of FC131 overlaps relatively well with the central arginine residue of <b>1</b>. However, the orientation of the naphthyl groups in FC131 and <b>1</b> are different; the 2-naphthyl group in FC131 is oriented toward TM5, whereas the 1-naphthyl group in <b>1</b> is facing TM2.</div></div><div id="sec2_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> AMD Compound Series</h4><div class="NLM_p">On the basis of site-directed mutagenesis studies of CXCR4 and binding site transfer to CXCR3, the critical CXCR4 receptor residues for binding of the bicyclam AMD3100 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) have been shown to be Asp<sup>171</sup>, Asp<sup>262</sup>, and Glu<sup>288</sup>.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> From the fact that AMD3100 and <b>1</b> inhibit binding of the same set of monoclonal antibodies, directed against the extracellular loops of CXCR4, it has been suggested that they have similar binding sites and molecular mode of action.<a onclick="showRef(event, 'ref28 ref65'); return false;" href="javascript:void(0);" class="ref ref28 ref65">(28, 65)</a> As Asp<sup>171</sup>, Asp<sup>262</sup>, and indirectly Glu<sup>288</sup> are also involved in the binding of <b>1</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>), the present study confirms that these two compounds bind to the same receptor region.</div><div class="NLM_p">In addition to the key interactions seen for AMD3100, the monocyclam analogue AMD3465 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) has been shown to interact with His<sup>113</sup> in TM3 and with His<sup>281</sup> in TM7,<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> which were also identified as important for <b>1</b> in the present study. The reduced potency observed for <b>1</b> in the D262N and H281A mutants is of particular interest as the same mutations were shown to have selective importance for the receptor interactions of AMD3465,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> which contains the same (pyridin-2-ylmethyl)amino moiety as <b>1</b>. Thus, in addition to the key interactions with His<sup>113</sup> and Asp<sup>171</sup> (R<sup>2</sup> guanidino group) and Asp<sup>262</sup> (R<sup>1</sup> amino group), the present study suggests that the pyridine ring in the R<sup>1</sup> side chain of <b>1</b> picks up an additional interaction with His<sup>281</sup> in TM7, in the same way as AMD3465.</div><div class="NLM_p last">The interaction pattern for the non-cyclam <b>4</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>F) is more unclear, but it has been suggested that it binds in a similar fashion as AMD3100 and AMD3465; however, Asp<sup>97</sup> and Asp<sup>171</sup> appeared to have a unique importance for the binding of this analogue.<a onclick="showRef(event, 'ref40 ref66'); return false;" href="javascript:void(0);" class="ref ref40 ref66">(40, 66)</a></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The present study describes the binding of the prototype tripeptidomimetic antagonist <b>1</b> to CXCR4 on the basis of SAR studies, receptor mapping, and molecular docking. This ternary approach resulted in the identification of a binding model for <b>1</b> in which the secondary amino group is anchored by interaction with Asp<sup>262</sup> in TM6, with the distal pyridine ring further involved in a π–π stacking interaction with His<sup>281</sup> in TM7; the Arg-guanidino group engages in polar interactions mainly with His<sup>113</sup> in TM3 and Asp<sup>171</sup> in TM4, whereas the naphthyl group is tightly packed in a hydrophobic subpocket formed by residues Trp<sup>94</sup>, Tyr<sup>45</sup>, and Tyr<sup>116</sup>. Our findings contradict earlier suggestions that <b>1</b> mimics the binding of the Arg<sup>1</sup>-Arg<sup>1</sup>-2-Nal<sup>3</sup> fragment in the cyclopentapeptide antagonist FC131. Instead, we propose a “hybrid” binding mode for <b>1</b>, where the guanidino group of the central arginine residue (R<sup>2</sup> side chain) overlaps with the binding mode of the Arg<sup>2</sup> residue in the peptide antagonist FC131 and <b>2</b>, whereas the (pyridin-2-ylmethyl)amino moiety (R<sup>1</sup> side chain) overlaps with the binding mode for the same moiety in the monocyclam AMD3465. This experimentally verified binding model for <b>1</b> provides important insight for future structure-based design of small-molecule CXCR4 antagonists.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div id="sec4_1_0" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General</h4><div class="NLM_p last">All reagents and solvents were purchased from Sigma-Aldrich and used as received. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a 400 MHz Varian spectrometer. Chemical shifts are expressed in parts per million relative to methanol (<sup>1</sup>H 3.31 ppm, <sup>13</sup>C 49.0 ppm). Coupling constants are given in hertz (Hz). Mass spectra were recorded on a Micromass Quattro LC (Micromass, Manchester, UK), and high-resolution mass spectra were recorded on an LTQ Orbitrap XL (Thermo Scientific, Bremen, Germany) using positive-mode ESI. Preparative RP-HPLC was performed on a Waters 600 Semi Prep System equipped with an XBridge C<sub>18</sub> column (250 mm × 19 mm, 10 μm particle size) using a 15 mL/min flow rate or on a Waters 2695 system equipped with an XBridge C<sub>18</sub> column (250 mm × 10 mm, 5 μm particle size) using a 10 mL/min flow rate with mixtures of acetonitrile and water (both containing 0.1% TFA) as the eluent in both cases. Analytical RP-HPLC was performed on a Waters 2695 system equipped with an XBridge C<sub>18</sub> column (250 mm × 4.6 mm, 5 μm particle size) using a 1 mL/min flow rate with detection at 214 and 254 nm facilitated by a PDA detector (210–310 nm). In some cases, analyses were performed on a Waters ACQUITY UHPLC H-Class equipped with a Waters ACQUITY UHPLC BEH C<sub>18</sub> column (1 × 150 mm, 1.75 μm particle size) with a 0.120 mL/min flow rate. All compounds undergoing biological evaluation were found to be of >95% purity as judged by analytical RP-HPLC with PDA detection (210–310 nm).</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> N-((S)-5-Guanidino-1-(((S)-1-(naphthalen-1-yl)ethyl)amino)-1-oxopentan-2-yl)-4-(((pyridin-2-ylmethyl)amino)methyl)benzamide (<b>1</b>)</h4><div class="NLM_p last">The title compound was prepared following an earlier reported procedure.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Purification by RP-HPLC afforded after lyophilization the title compound as a white fluffy material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 8.3, 1H), 7.96 (d, <i>J</i> = 8.0, 2H), 7.91–7.85 (m, 2H), 7.81 (d, <i>J</i> = 8.2, 1H), 7.64 (d, <i>J</i> = 8.0, 2H), 7.60–7.37 (m, 7H), 5.94–5.82 (m, 1H), 4.62 (app t, <i>J</i> = 8.0, 1H), 4.41 (s, 2H), 4.39 (s, 2H), 3.19–3.05 (m, 2H), 1.94–1.74 (m, 2H), 1.66 (d, <i>J</i> = 6.9, 3H), 1.64–1.50 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 172.7, 169.2, 158.5, 152.3, 150.6, 140.1, 138.8, 136.3, 136.1, 135.4, 132.2, 131.2, 129.9, 129.3, 129.0, 127.2, 126.7, 126.4, 125.1, 124.1, 124.1, 123.7, 54.9, 51.5, 51.3, 46.2, 41.9, 30.5, 26.4, 21.2; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>32</sub>H<sub>38</sub>N<sub>7</sub>O<sub>2</sub> 552.3081, found 552.3081. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(Aminomethyl)-N-((S)-5-guanidino-1-(((S)-1-(naphthalen-1-yl)ethyl)amino)-1-oxopentan-2-yl)benzamide (<b>6</b>)</h4><div class="NLM_p last">The title compound was prepared by adopting a literature procedure<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in which <i>N</i>-Boc 4-(methylamino)benzoic acid was used instead of <b>11</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Purification by RP-HPLC afforded after lyophilization the title compound as a white fluffy material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.89 (d, <i>J</i> = 8.3, 1H), 7.72 (d, <i>J</i> = 8.3, 2H), 7.66 (app t, <i>J</i> = 8.2, 1H), 7.58 (d, <i>J</i> = 8.2, 1H), 7.41–7.23 (m, 6H), 5.69–5.60 (m, 1H), 4.41 (app dd, <i>J</i> = 8.3, 6.0, 1H), 3.98 (s, 2H), 3.00–2.82 (m, 2H), 1.76–1.55 (m, 2H), 1.52–1.45 (m, 1H), 1.44 (d, <i>J</i> = 6.9, 3H), 1.40–1.30 (m, 1H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 172.7, 169.1, 158.3, 139.9, 138.0, 135.6, 135.2, 132.0, 129.8, 129.7, 129.1, 128.9, 127.1, 126.6, 126.2, 123.9, 123.5, 54.8, 46.0, 43.6, 41.7, 30.3, 26.3, 21.1; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>33</sub>N<sub>6</sub>O<sub>2</sub> 461.2660, found 461.2664. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-((Benzylamino)methyl)-N-((S)-5-guanidino-1-(((S)-1-(naphthalen-1-yl)ethyl)amino)-1-oxopentan-2-yl)benzamide (<b>5</b>)</h4><div class="NLM_p last">A solution of <b>6</b> (crude product following TFA mediated deprotection, 0.09 mmol) in DMF (2.0 mL) was cooled to 0 °C, and K<sub>2</sub>CO<sub>3</sub> (24 mg, 0.18 mmol) was added. To this suspension was added slowly benzyl bromide (10 μL, 0.09 mmol), and the reaction mixture was allowed to stir at room temperature for 24 h. Water (1 mL) was added, and the mixture was extracted with diethyl ether (10 mL) and washed with water (2 × 5 mL) and a saturated solution of NaCl (10 mL). The organic layer was dried over anhydrous MgSO<sub>4</sub> and filtered, and the solvents were removed under reduced pressure. The crude product was purified using RP-HPLC followed by lyophilization to give the title compound as a fluffy white material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 8.2, 1H), 7.95 (d, <i>J</i> = 8.2, 2H), 7.90 (d, <i>J</i> = 7.8, 1H), 7.81 (d, <i>J</i> = 8.2, 1H), 7.60 (t, <i>J</i> = 7.6, 3H), 7.57–7.45 (m, 8H), 5.95–5.82 (m, 1H), 4.62 (app dd, <i>J</i> = 7.9, 6.3, 1H), 4.33 (s, 2H), 4.28 (s, 2H), 3.21–3.06 (m, 2H), 1.97–1.73 (m, 2H), 1.66 (d, <i>J</i> = 6.9, 3H), 1.64–1.48 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) 173.0, 169.5, 158.7, 140.3, 136.5, 136.3, 135.7, 132.5, 132.4, 131.4, 131.3, 131.0, 130.6, 130.1, 129.6, 129.3, 127.5, 127.0, 126.6, 124.3, 123.9, 55.2, 52.5, 51.7, 46.5, 42.1, 30.7; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>33</sub>H<sub>39</sub>N<sub>6</sub>O<sub>2</sub> 551.3129, found 551.3131. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> N-((S)-5-Guanidino-1-(((S)-1-(naphthalen-1-yl)ethyl)amino)-1-oxopentan-2-yl)-4-methylbenzamide (<b>7</b>)</h4><div class="NLM_p last">The title compound was prepared by adopting a literature procedure<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in which 4-methylbenzoic acid was used instead of <b>11</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Purification by RP-HPLC afforded after lyophilization the title compound as a white fluffy material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 8.3, 1H), 7.90 (d, <i>J</i> = 7.7, 1H), 7.81 (d, <i>J</i> = 8.2, 1H), 7.76 (d, <i>J</i> = 8.2, 2H), 7.60–7.45 (m, 4H), 7.30 (d, <i>J</i> = 8.2, 2H), 5.88 (m, 1H), 4.70–4.59 (m, 1H), 3.20–3.04 (m, 2H), 2.41 (s, 3H), 1.93–1.72 (m, 2H), 1.66 (d, <i>J</i> = 6.9, 3H), 1.64–1.48 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) 171.5, 168.9, 157.0, 143.1, 138.7, 133.8, 130.5, 129.8, 129.4, 128.9, 128.0, 127.2, 126.3, 125.8, 125.4, 122.6, 122.4, 53.2, 45.5, 40.4, 29.6, 24.5, 21.4, 21.1; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> 446.2551, found 446.2550. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> N-((S)-1-(((S)-1-(Naphthalen-1-yl)ethyl)amino)-1-oxo-5-ureidopentan-2-yl)-4-(((pyridin-2-ylmethyl)amino)methyl)benzamide (<b>8</b>)</h4><div class="NLM_p last">The title compound was prepared by adopting a literature procedure<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in which Fmoc-Cit-OH was used instead of Fmoc-Arg(Pbf)-OH. Purification by RP-HPLC afforded after lyophilization the title compound as a white fluffy material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.38 (d, <i>J</i> = 4.3, 1H), 7.81 (d, <i>J</i> = 8.3, 1H), 7.67 (d, <i>J</i> = 8.3, 2H), 7.63–7.57 (m, 2H), 7.51 (d, <i>J</i> = 8.2, 1H), 7.32 (m, 3H), 7.27–7.13 (m, 5H), 5.56 (app q, <i>J</i> = 6.8, 1H), 4.37 (app dd, <i>J</i> = 8.7, 5.6, 1H), 4.12 (s, 2H), 4.09 (s, 2H), 2.89–2.73 (m, 2H), 1.65–1.43 (m, 2H), 1.36 (d, <i>J</i> = 6.9, 3H), 1.34–1.16 (m, 2H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 173.3, 169.3, 162.3, 152.1, 150.4, 140.2, 139.1, 136.3, 135.9, 135.4, 132.1, 131.2, 129.9, 129.4, 129.0, 127.3, 126.7, 126.4, 125.2, 124.4, 124.1, 123.6, 55.2, 51.5, 51.2, 46.3, 40.4, 30.5, 27.7, 21.4; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>32</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> 553.2922, found 553.2921. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (S)-N-(1-(Ethylamino)-5-guanidino-1-oxopentan-2-yl)-4-(((pyridin-2-ylmethyl)amino)methyl)benzamide (<b>9</b>)</h4><div class="NLM_p last">The title compound was prepared by adopting a literature procedure<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> in which ethanamine was used instead of (<i>S</i>)-1-(naphthalene-1-yl)ethanamine. Purification by RP-HPLC afforded after lyophilization the title compound as a white fluffy material. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.66 (d, <i>J</i> = 4.8, 1H), 7.97 (d, <i>J</i> = 8.2, 2H), 7.87 (td, <i>J</i> = 7.7, 1.7, 1H), 7.64 (d, <i>J</i> = 8.2, 2H), 7.46–7.39 (m, 2H), 4.55 (dd, <i>J</i> = 8.6, 5.9, 1H), 4.40 (s, 2H), 4.39 (s, 2H), 3.29–3.19 (m, 4H), 1.97–1.61 (m, 4H), 1.14 (t, <i>J</i> = 7.3, 3H); <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ 173.6, 169.3, 158.8, 152.3, 150.7, 138.8, 136.3, 136.1, 131.2, 129.4, 125.1, 124.2, 55.0, 51.5, 51.3, 42.0, 35.4, 30.4, 26.5, 14.8; HRMS (ESI) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub> 426.2612, found 426.2611. The purity of the title compound was found to be >99% using analytical RP-HPLC (diode array detection, 210–310 nm).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Biology</h3><div id="sec4_2_0" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Materials</h4><div class="NLM_p last">The human CXCR4 receptor cDNA was kindly provided by Tim Wells (GSK, UK). The human chemokine CXCL12 was purchased from Peprotech (Rocky Hill, NJ, USA). The monoclonal antibody 12G5 was kindly provided by Jim Hoxie (University of Pennsylvania, Philadelphia, PA, USA), and the promiscuous chimeric G protein Gα<sub>Δ6qi4myr</sub> (abbreviated Gα<sub>qi4myr</sub>) was kindly provided by Evi Kostenis (University of Bonn, Germany).<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Myo[<sup>3</sup>H]inositol (PT6-271), scintillation proximity assay (SPA) beads, and Bolton–Hunter reagent for 12G5 iodination (in-house procedure)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were purchased from PerkinElmer (Boston, MA, USA). Primer-cDNAs for mutagenesis were purchased from TAG Copenhagen (Copenhagen, Denmark), and AG1-X8 anion exchange resin was from Bio-Rad (Hercules, CA, USA). Stock solutions of the ligand antagonists were prepared in different mixtures of DMSO/water, and dilutions were made in water. For dilutions of CXCL12, a buffer with 1 mM acetic acid + 0.1% BSA was used.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Site-Directed Mutagenesis</h3><div class="NLM_p last">Point mutations were introduced in the receptor by the polymerase chain reaction overlap extension technique<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> or the QuikChange technique (Agilent Technologies, Santa Clara, CA, USA), using WT-CXCR4 as a template. All reactions were carried out using <i>Pfu</i> polymerase (Stratagene, Santa Clara, CA, USA) under conditions recommended by the manufacturer. The mutations were cloned into the eukaryotic expression vector pcDNA3.1+ (Invitrogen, UK), and were verified by restriction endonuclease digestion and DNA sequencing (Eurofins MWG Operon, Germany).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Transfections and Tissue Culture</h3><div class="NLM_p last">COS-7 cells were grown at 10% CO<sub>2</sub> and 37 °C in Dulbecco’s modified Eagle’s medium with glutamax (Invitrogen, Loughborough, UK) adjusted with 10% fetal bovine serum, 180 units/mL penicillin, and 45 μg/mL penicillin/streptomycin (PenStrep). Transfection of the COS-7 cells was performed by the calcium phosphate precipitation method.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Phosphatidylinositol (PI) Turnover Assays</h3><div class="NLM_p">Transfection of COS-7 cells was carried out according to the above-mentioned procedure. Briefly, 6 × 10<sup>6</sup> cells were transfected with 20 μg of receptor cDNA along with 30 μg of the promiscuous chimeric G protein, Gα<sub>qi4myr</sub>, which turns the Gα<sub>i</sub>-coupled signal, the most common pathway for endogenous chemokine receptors, into the Gα<sub>q</sub> pathway (phospholipase C activation measured as IP<sub>3</sub> turnover). Two alternative methods, which were found to give the same result, were used:</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Anion-Exchange Separation of Phosphoinositides</h4><div class="NLM_p last">In the classic IP<sub>3</sub> assay, which includes an anion-exchange chromatography step, 1 day after transfection COS-7 cells (1.5 × 10<sup>5</sup> cells/well) were incubated for 24 h with 2 μCi of myo[<sup>3</sup>H]inositol in 0.3 mL of growth medium per well in a 24-well plate. The next day, the cells were washed twice in PBS and were incubated (90 min) in 0.2 mL of Hank’s balanced salt solution (Invitrogen) supplemented with 10 mM LiCl at 37 °C in the presence of various concentrations of the tested compounds. Cells were then extracted by the addition of 1 mL of 10 mM formic acid to each well followed by incubation on ice for 30–60 min. The generated [<sup>3</sup>H]inositol phosphates were purified on an AG 1-X8 anion -exchange resin. Following the addition of multipurpose liquid scintillation cocktail (Gold Star, TrisKem-International, Bruz, France), γ-radiation was counted in a Beckman Coulter counter LS6500.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Scintillation Proximity Assay</h4><div class="NLM_p last">The day after transfection, COS-7 cells (35 000 cells/well) were incubated for 24 h with 0.5 μCi/mL myo[<sup>3</sup>H]inositol in 100 μL of growth medium per well in a 96-well plate. The following day, cells were treated as mentioned in the classic assay with volumes adjusted as follows: 100 μL of reaction solution with LiCl and 50 μL of ice-cold formic acid. Next, the generated [<sup>3</sup>H]inositol phosphates were quantified by radioactivity measurement; in brief, 20 μL of the formic acid cell extracts was transferred to a white 96-well plate, and 80 μL of 1:8 diluted YSi poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated beads (SPA-beads, PerkinElmer) was added. Plates were sealed, agitated at maximum speed for at least 30 min, and centrifuged (5 min at 1500 rpm) before γ-radiation was counted in a Packard Top Count NXT counter. In both assays, determinations were made in duplicates.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Binding Experiments</h3><div class="NLM_p last">COS-7 cells (6 ×10<sup>6</sup>) were transfected with 40 μg of receptor cDNA and transferred to culture plates. The number of cells seeded per well was determined by the apparent expression efficiency of the receptors and was aimed at obtaining 5–10% specific binding of the added radioactive ligand. Two days after transfection, cells were assayed by competition binding for 3 h at 4 °C using 10–15 pM <sup>125</sup>I-12G5 plus unlabeled ligand in 0.2 mL of 50 mM Hepes buffer, pH 7.4, supplemented with 1 mM CaCl<sub>2</sub>, 5 mM MgCl<sub>2</sub>, and 0.5% (w/v) bovine serum albumin. Following incubation, cells were washed quickly two times in 4 °C binding buffer supplemented with 0.5 M NaCl (and on ice). Cells were lysed by the addition of 0.5 mL of carbamide solution (18% acetic acid, 8 M urea, 2% v/v P-40), and radioactivity was counted in a Beckman Coulter counter LS6500. Nonspecific binding was determined in the presence of 0.1 μM unlabeled 12G5. Determinations were made in duplicates.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Cell Surface Expression Measurement (ELISA)</h3><div class="NLM_p last">COS-7 cells were transfected with FLAG-tagged receptor DNA in 96-well plates (6 × 10<sup>3</sup> cells/well). Following the transfection (48 h), cells were washed three times in Tris-buffered saline (TBS), fixed in 3.7% formaldehyde for 15 min at room temperature, washed, and incubated in blocking solution (TBS with 2% BSA) for 30 min. Cells were incubated for 2 h with anti-FLAG (M1) antibody (Sigma-Adrich) at 2 μg/mL in TBS with 1 mM CaCl<sub>2</sub> and 1% BSA. After three washes with TBS/CaCl<sub>2</sub>/BSA, the cells were incubated with goat anti-mouse horseradish peroxidase (HRP)-conjugated antibody at 0.8 μg/mL (Thermo Fisher Scientific) for 1 h. After three washes, the immunoreactivity was revealed by the addition of TMB Plus substrate (Kem-En-Tec, Taastrup, Denmark), and the reaction was stopped with 0.2 M H<sub>2</sub>SO<sub>4</sub>. Absorbance was measured at 450 nm on a Wallac plate reader (PerkinElmer).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Statistical Calculations</h3><div class="NLM_p last">The apparent EC<sub>50</sub> and IC<sub>50</sub> values were determined by nonlinear regression using GraphPad Prism 4 software (GraphPad Software, San Diego, CA, USA). <i>P</i> values were calculated using unpaired two-tailed <i>t</i> tests with 95% confidence intervals. The data analysis was performed as recently described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Computational Modeling Procedure</h3><div class="NLM_p">All molecular modeling calculations were performed using the Schrödinger software suite 2012.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Default settings were used, if not specified otherwise. The crystal structure of CXCR4 in complex with <b>2</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0">3OE0</a>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was first prepared and optimized with the Protein Preparation Wizard workflow<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> using the same procedure as previously described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The automatically assigned tautomeric and protonation states (pH 7.4) for ionizable residues were kept, except for Asp<sup>262</sup>, which was manually assigned a negative charge (predicted to be neutral). The ligand (<b>1</b>) was docked to the prepared receptor structure using the induced-fit workflow<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> with a docking box of (26 Å)<sup>3</sup> centered on Asp<sup>187</sup>. The ligand was built with two positive charges (the guanidino group and the amino group), and the “penalize nonplanar conformation” option was chosen for amide bonds.</div><div class="NLM_p last">In the first step (Glide docking: flexible ligand, rigid receptor), 50 poses were generated using a softened van der Waals potential (scaling 0.5) for both receptor and ligand. In the second step (Prime refinement: rigid ligand, flexible receptor), receptor residues within a radius of 5.0 Å from the ligand were optimized for the 50 initial poses. In the final step (Glide redocking: flexible ligand, rigid receptor), the ligand was redocked into the optimized binding site using the extra-precision (XP) scoring function, and the top 20 poses within an energy window of 30 kcal/mol were kept. In the absence of constraints, a number of irrelevant poses were generated, and a H-bond constraint (applied in both docking steps) was therefore assigned to the N<sup>δ1</sup> atom of His<sup>113</sup>, which resulted in the identification of the binding mode for <b>1</b> that is shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00987">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00987" class="ext-link">10.1021/acs.jmedchem.5b00987</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Characterization data (<sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC/UPLC chromatograms) for <b>1</b> and <b>5</b>–<b>9</b> and additional 3D figures from computational modeling (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf">jm5b00987_si_001.pdf (2.18 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00987" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jon Våbenø</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway,
Breivika, NO-9037 Tromsø, Norway</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#68020706461e090a0d0607281d011c460607"><span class="__cf_email__" data-cfemail="204a4f4e0e564142454e4f605549540e4e4f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zack G. Zachariassen</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway,
Breivika, NO-9037 Tromsø, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanie Karlshøj</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Molecular Pharmacology, Department of Neuroscience and Pharmacology,
Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bengt Erik Haug</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Centre for Pharmacy, University
of Bergen, Allégaten
41, NO-5007 Bergen, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mette M. Rosenkilde</span> - <span class="hlFld-Affiliation affiliation">Laboratory
for Molecular Pharmacology, Department of Neuroscience and Pharmacology,
Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen, Denmark</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1425e3559-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support for this project was obtained from UiT The Arctic University of Norway (to Z.G.Z. and J.V.), from the University of Bergen (to B.E.H.), and from the Danish Council for Independent Research/Medical Sciences, the Novo Nordisk Foundation, the Lundbeck Foundation, and the European Community Sixth Framework program (INNOCHEM: Grant LSHBCT-2005-518167) (to S.K. and M.M.R). We thank Inger Smith Simonsen, Randi Thøgersen, and Maibritt Sigvardt Baggesen for outstanding technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">2-Nal</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">l</span>-3-(2-naphthyl)alanine</p></td></tr><tr><td class="NLM_term">CXCL12</td><td class="NLM_def"><p class="first last">CXC chemokine ligand 12</p></td></tr><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">CXC chemokine receptor 4</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">ECL</td><td class="NLM_def"><p class="first last">extracellular loop</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last"><i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>′-ethylcarbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">Pbf</td><td class="NLM_def"><p class="first last">2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-sulfonyl</p></td></tr><tr><td class="NLM_term">PI</td><td class="NLM_def"><p class="first last">phosphatidylinositol</p></td></tr><tr><td class="NLM_term">PyBOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">TIS</td><td class="NLM_def"><p class="first last">triisopropylsilane</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Murphy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charo, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horuk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C. A.</span><span> </span><span class="NLM_article-title">International union of pharmacology. XXII. Nomenclature for chemokine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=145-176&author=P.+M.+Murphyauthor=M.+Baggioliniauthor=I.+F.+Charoauthor=C.+A.+H%C3%A9bertauthor=R.+Horukauthor=K.+Matsushimaauthor=L.+H.+Millerauthor=J.+J.+Oppenheimauthor=C.+A.+Power&title=International+union+of+pharmacology.+XXII.+Nomenclature+for+chemokine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26aulast%3DBaggiolini%26aufirst%3DM.%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DH%25C3%25A9bert%26aufirst%3DC.%2BA.%26aulast%3DHoruk%26aufirst%3DR.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DL.%2BH.%26aulast%3DOppenheim%26aufirst%3DJ.%2BJ.%26aulast%3DPower%26aufirst%3DC.%2BA.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520XXII.%2520Nomenclature%2520for%2520chemokine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D145%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Laing, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secombes, C. J.</span><span> </span><span class="NLM_article-title">Chemokines</span> <span class="citation_source-journal">Dev. Comp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1016/j.dci.2003.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.dci.2003.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2004&pages=443-460&author=K.+J.+Laingauthor=C.+J.+Secombes&title=Chemokines&doi=10.1016%2Fj.dci.2003.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.dci.2003.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dci.2003.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DLaing%26aufirst%3DK.%2BJ.%26aulast%3DSecombes%26aufirst%3DC.%2BJ.%26atitle%3DChemokines%26jtitle%3DDev.%2520Comp.%2520Immunol.%26date%3D2004%26volume%3D28%26spage%3D443%26epage%3D460%26doi%3D10.1016%2Fj.dci.2003.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Sugiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span> </span><span class="NLM_article-title">Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1016/j.immuni.2006.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.immuni.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=17174120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=977-988&author=T.+Sugiyamaauthor=H.+Koharaauthor=M.+Nodaauthor=T.+Nagasawa&title=Maintenance+of+the+hematopoietic+stem+cell+pool+by+CXCL12-CXCR4+chemokine+signaling+in+bone+marrow+stromal+cell+niches&doi=10.1016%2Fj.immuni.2006.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches</span></div><div class="casAuthors">Sugiyama, Tatsuki; Kohara, Hiroshi; Noda, Mamiko; Nagasawa, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">977-988</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In the bone marrow, the special microenvironment niches nurture a pool of hematopoietic stem cells (HSCs).  Many HSCs reside near the vasculature, but the mol. regulatory mechanism of niches for HSC maintenance remains unclear.  Here the authors showed that the induced deletion of CXCR4, a receptor for CXC chemokine ligand (CXCL) 12 in adult mice, resulted in severe redn. of HSC nos. and increased sensitivity to myelotoxic injury, although it did not impair expansion of the more mature progenitors.  Most HSCs were found in contact with the cells expressing high amts. of CXCL12, which the authors have called CXCL12-abundant reticular (CAR) cells.  CAR cells surrounded sinusoidal endothelial cells or were located near the endosteum.  CXCL12-CXCR4 signaling plays an essential role in maintaining the quiescent HSC pool, and CAR cells appear to be a key component of HSC niches, including both vascular and endosteal niches in adult bone marrow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-fmlTq8fMPbVg90H21EOLACvtfcHk0lj6RzfZjiPNLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFehsg%253D%253D&md5=61fbe88427e33601f8d3b72a7d94253f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DKohara%26aufirst%3DH.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DNagasawa%26aufirst%3DT.%26atitle%3DMaintenance%2520of%2520the%2520hematopoietic%2520stem%2520cell%2520pool%2520by%2520CXCL12-CXCR4%2520chemokine%2520signaling%2520in%2520bone%2520marrow%2520stromal%2520cell%2520niches%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D977%26epage%3D988%26doi%3D10.1016%2Fj.immuni.2006.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ward, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwick, J.</span><span> </span><span class="NLM_article-title">Chemokines: understanding their role in T-lymphocyte biology</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1042/bj3330457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1042%2Fbj3330457" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1998&pages=457-470&author=S.+G.+Wardauthor=J.+Westwick&title=Chemokines%3A+understanding+their+role+in+T-lymphocyte+biology&doi=10.1042%2Fbj3330457"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1042%2Fbj3330457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3330457%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BG.%26aulast%3DWestwick%26aufirst%3DJ.%26atitle%3DChemokines%253A%2520understanding%2520their%2520role%2520in%2520T-lymphocyte%2520biology%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D333%26spage%3D457%26epage%3D470%26doi%3D10.1042%2Fbj3330457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Horuk, R.</span><span> </span><span class="NLM_article-title">Chemokine receptors</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1016/S1359-6101(01)00014-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1359-6101%2801%2900014-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=11544102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFChtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=313-335&author=R.+Horuk&title=Chemokine+receptors&doi=10.1016%2FS1359-6101%2801%2900014-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors</span></div><div class="casAuthors">Horuk, R.</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">313-335</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Although chemokines were originally defined as host defense proteins it is now clear that their repertoire of functions extend well beyond this role.  For example chemokines such as MGSA have growth regulatory properties while members of the CXC chemokine family can be mediators or inhibitors of angiogenesis and may be important targets for oncol.  Recent work shows that the chemokine receptor CXCR4 and its cognate ligand SDF play important roles in the development of the immune, circulatory, and central nervous systems.  In addn., chemokine receptors play an important role in the pathogenesis of the AIDS virus, HIV-1.  Taken together, these findings expand the biol. importance of chemokines from that of simple immune modulators to a much broader biol. role than was at first appreciated and these and other properties of the chemokine receptor family are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5yVUY1wRsbVg90H21EOLACvtfcHk0lj6RzfZjiPNLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFChtLw%253D&md5=b828ebf6fcb99f9884b802d4cc5112fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1359-6101%2801%2900014-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6101%252801%252900014-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DChemokine%2520receptors%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2001%26volume%3D12%26spage%3D313%26epage%3D335%26doi%3D10.1016%2FS1359-6101%2801%2900014-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bleul, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span><span class="refDoi"> DOI: 10.1038/382829a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F382829a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=1996&pages=829-833&author=C.+C.+Bleulauthor=M.+Farzanauthor=H.+Choeauthor=C.+Parolinauthor=I.+Clark-Lewisauthor=J.+Sodroskiauthor=T.+A.+Springer&title=The+lymphocyte+chemoattractant+SDF-1+is+a+ligand+for+LESTR%2Ffusin+and+blocks+HIV-1+entry&doi=10.1038%2F382829a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F382829a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F382829a0%26sid%3Dliteratum%253Aachs%26aulast%3DBleul%26aufirst%3DC.%2BC.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DParolin%26aufirst%3DC.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DThe%2520lymphocyte%2520chemoattractant%2520SDF-1%2520is%2520a%2520ligand%2520for%2520LESTR%252Ffusin%2520and%2520blocks%2520HIV-1%2520entry%26jtitle%3DNature%26date%3D1996%26volume%3D382%26spage%3D829%26epage%3D833%26doi%3D10.1038%2F382829a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Oberlin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelerie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virelizier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenzana-Seisdedos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legler, D.</span><span> </span><span class="NLM_article-title">The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1038/382833a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F382833a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=1996&pages=833-835&author=E.+Oberlinauthor=A.+Amaraauthor=F.+Bachelerieauthor=C.+Bessiaauthor=J.+Virelizierauthor=F.+Arenzana-Seisdedosauthor=O.+Schwartzauthor=J.+Heardauthor=I.+Clark-Lewisauthor=D.+Legler&title=The+CXC+chemokine+SDF-1+is+the+ligand+for+LESTR%2Ffusin+and+prevents+infection+by+T-cell-line-adapted+HIV-1&doi=10.1038%2F382833a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F382833a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F382833a0%26sid%3Dliteratum%253Aachs%26aulast%3DOberlin%26aufirst%3DE.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DBachelerie%26aufirst%3DF.%26aulast%3DBessia%26aufirst%3DC.%26aulast%3DVirelizier%26aufirst%3DJ.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3DHeard%26aufirst%3DJ.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DLegler%26aufirst%3DD.%26atitle%3DThe%2520CXC%2520chemokine%2520SDF-1%2520is%2520the%2520ligand%2520for%2520LESTR%252Ffusin%2520and%2520prevents%2520infection%2520by%2520T-cell-line-adapted%2520HIV-1%26jtitle%3DNature%26date%3D1996%26volume%3D382%26spage%3D833%26epage%3D835%26doi%3D10.1038%2F382833a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghesani, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">9448</span><span class="NLM_x">–</span> <span class="NLM_lpage">9453</span><span class="refDoi"> DOI: 10.1073/pnas.95.16.9448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.95.16.9448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=9689100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=9448-9453&author=Q.+Maauthor=D.+Jonesauthor=P.+R.+Borghesaniauthor=R.+A.+Segalauthor=T.+Nagasawaauthor=T.+Kishimotoauthor=R.+T.+Bronsonauthor=T.+A.+Springer&title=Impaired+B-lymphopoiesis%2C+myelopoiesis%2C+and+derailed+cerebellar+neuron+migration+in+CXCR4-+and+SDF-1-deficient+mice&doi=10.1073%2Fpnas.95.16.9448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span></div><div class="casAuthors">Ma, Qing; Jones, Dan; Borghesani, Paul R.; Segal, Rosalind A.; Nagasawa, Takashi; Kishimoto, Tadamitsu; Bronson, Roderick T.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9448-9453</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor 1, SDF-1, is an important regulator of leukocyte and hematopoietic precursor migration and pre-B cell proliferation.  The receptor for SDF-1, CXCR4, also functions as a coreceptor for T-tropic HIV-1 entry.  The authors find that mice deficient for CXCR4 die perinatally and display profound defects in the hematopoietic and nervous systems.  CXCR4-deficient mice have severely reduced B-lymphopoiesis, reduced myelopoiesis in fetal liver, and a virtual absence of myelopoiesis in bone marrow.  However, T-lymphopoiesis is unaffected.  Furthermore, the cerebellum develops abnormally with an irregular external granule cell layer, ectopically located Purkinje cells, and numerous chromophilic cell clumps of abnormally migrated granule cells within the cerebellar anlage.  Identical defects are obsd. in mice lacking SDF-1, suggesting a monogamous relation between CXCR4 and SDF-1.  This receptor-ligand selectivity is unusual among chemokines and their receptors, as is the function in migration of nonhematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ag_HDqKuUrVg90H21EOLACvtfcHk0li76os3Tzm2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D&md5=8a71d69046ba28782c4cffdef33b77ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.16.9448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.16.9448%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DBorghesani%26aufirst%3DP.%2BR.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DImpaired%2520B-lymphopoiesis%252C%2520myelopoiesis%252C%2520and%2520derailed%2520cerebellar%2520neuron%2520migration%2520in%2520CXCR4-%2520and%2520SDF-1-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D9448%26epage%3D9453%26doi%3D10.1073%2Fpnas.95.16.9448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tachibana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, S.-i.</span><span> </span><span class="NLM_article-title">The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1038/31261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F31261" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=591-594&author=K.+Tachibanaauthor=S.+Hirotaauthor=H.+Iizasaauthor=H.+Yoshidaauthor=K.+Kawabataauthor=Y.+Kataokaauthor=Y.+Kitamuraauthor=K.+Matsushimaauthor=N.+Yoshidaauthor=S.-i.+Nishikawa&title=The+chemokine+receptor+CXCR4+is+essential+for+vascularization+of+the+gastrointestinal+tract&doi=10.1038%2F31261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F31261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31261%26sid%3Dliteratum%253Aachs%26aulast%3DTachibana%26aufirst%3DK.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIizasa%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DNishikawa%26aufirst%3DS.-i.%26atitle%3DThe%2520chemokine%2520receptor%2520CXCR4%2520is%2520essential%2520for%2520vascularization%2520of%2520the%2520gastrointestinal%2520tract%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D591%26epage%3D594%26doi%3D10.1038%2F31261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Busillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benovic, J. L.</span><span> </span><span class="NLM_article-title">Regulation of CXCR4 signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2006.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bbamem.2006.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=17169327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=952-963&author=J.+M.+Busilloauthor=J.+L.+Benovic&title=Regulation+of+CXCR4+signaling&doi=10.1016%2Fj.bbamem.2006.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of CXCR4 signaling</span></div><div class="casAuthors">Busillo, John M.; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1768</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">952-963</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The chemokine receptor CXCR4 belongs to the large superfamily of G protein-coupled receptors, and is directly involved in a no. of biol. processes including organogenesis, hematopoiesis, and immune response.  Recent evidence has highlighted the role of CXCR4 in a variety of diseases including HIV, cancer, and WHIM syndrome.  Importantly, the involvement of CXCR4 in cancer metastasis and WHIM syndrome appears to be due to dysregulation of the receptor leading to enhanced signaling.  Herein we review what is currently known regarding the regulation of CXCR4 and how dysregulation contributes to disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlc7mFuaCt8LVg90H21EOLACvtfcHk0li76os3Tzm2PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLY%253D&md5=95bf1618df71400975d9543c391b6ac7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DBusillo%26aufirst%3DJ.%2BM.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DRegulation%2520of%2520CXCR4%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2007%26volume%3D1768%26spage%3D952%26epage%3D963%26doi%3D10.1016%2Fj.bbamem.2006.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">Molecular cloning and structure of a pre-B-cell growth-stimulating factor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span><span class="refDoi"> DOI: 10.1073/pnas.91.6.2305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.91.6.2305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2305-2309&author=T.+Nagasawaauthor=H.+Kikutaniauthor=T.+Kishimoto&title=Molecular+cloning+and+structure+of+a+pre-B-cell+growth-stimulating+factor&doi=10.1073%2Fpnas.91.6.2305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.6.2305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.6.2305%26sid%3Dliteratum%253Aachs%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKikutani%26aufirst%3DH.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DMolecular%2520cloning%2520and%2520structure%2520of%2520a%2520pre-B-cell%2520growth-stimulating%2520factor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D2305%26epage%3D2309%26doi%3D10.1073%2Fpnas.91.6.2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, E. A.</span><span> </span><span class="NLM_article-title">HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">872</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1126/science.272.5263.872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.272.5263.872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=8629022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK28XivFajsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=872-877&author=Y.+Fengauthor=C.+C.+Broderauthor=P.+E.+Kennedyauthor=E.+A.+Berger&title=HIV-1+entry+cofactor%3A+functional+cDNA+cloning+of+a+seven-transmembrane%2C+G+protein-coupled+receptor&doi=10.1126%2Fscience.272.5263.872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor</span></div><div class="casAuthors">Feng, Yu; Broder, Christopher C.; Kennedy, Paul E.; Berger, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5263</span>),
    <span class="NLM_cas:pages">872-877</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A cofactor for HIV-1 (human immunodeficiency virus-type 1) fusion and entry was identified with the use of a novel functional complementary DNA (cDNA) cloning strategy.  This protein, designated "fusin," is a putative G protein-coupled receptor with seven transmembrane segments.  Recombinant fusin enabled CD4-expressing nonhuman cell types to support HIV-1 Env-mediated cell fusion and HIV-1 infection.  Antibodies to fusin blocked cell fusion and infection with normal CD4-pos. human target cells.  Fusin mRNA levels correlated with HIV-1 permissiveness in diverse human cell types.  Fusin acted preferentially for T cell line-tropic isolates, in comparison to its activity with macrophage-tropic HIV-1 isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3gJxnzdhzo7Vg90H21EOLACvtfcHk0liawtU_FXjKKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFajsLc%253D&md5=4a23c79f5fee5cadb979430fc1f550b3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5263.872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5263.872%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DBroder%26aufirst%3DC.%2BC.%26aulast%3DKennedy%26aufirst%3DP.%2BE.%26aulast%3DBerger%26aufirst%3DE.%2BA.%26atitle%3DHIV-1%2520entry%2520cofactor%253A%2520functional%2520cDNA%2520cloning%2520of%2520a%2520seven-transmembrane%252C%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D872%26epage%3D877%26doi%3D10.1126%2Fscience.272.5263.872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Berson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doranz, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirik, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span> </span><span class="NLM_article-title">A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">6288</span><span class="NLM_x">–</span> <span class="NLM_lpage">6295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=8709256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1996&pages=6288-6295&author=J.+F.+Bersonauthor=D.+Longauthor=B.+J.+Doranzauthor=J.+Ruckerauthor=F.+R.+Jirikauthor=R.+W.+Doms&title=A+seven-transmembrane+domain+receptor+involved+in+fusion+and+entry+of+T-cell-tropic+human+immunodeficiency+virus+type+1+strains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains</span></div><div class="casAuthors">Berson, Joanne F.; Long, Deborah; Doranz, Benjamin J.; Rucker, Joseph; Jirik, Frank R.; Doms, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6288-6295</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Entry of human immunodeficiency virus type 1 (HIV-1) into cells requires binding to CD4 and fusion with a cellular membrane.  Fusion does not occur in most nonhuman cells even when they express human CD4, indicating that one or more human accessory factors are required for virus infection.  Recently, a seven-transmembrane domain protein has been shown to serve as an accessory factor for T-cell-tropic (T-tropic) HIV-1 isolates (Y. Feng, et al., 1996).  Here we show that expression of this glycoprotein, termed fusin, in murine, feline, simian, and quail cell lines, in conjunction with human CD4, rendered these cells fully permissive for HIV-1 envelope glycoprotein (Env)-mediated membrane fusion.  Expression of CD4 or fusin alone did not permit fusion.  In addn., introduction of fusin and CD4 into a human cell line, U87MG, that is resistant to HIV-1-induced syncytium formation and to infection by HIV-1 when expressing CD4 alone made this cell line permissive for Env-mediated cell-cell fusion.  Fusion was obsd. only with T-tropic Env proteins.  Macrophage-tropic (M-tropic) Env proteins from the SF162, ADA, and Ba-L HIV-1 strains did not fuse with cells expressing fusin and CD4, suggesting that M-tropic viruses utilize an accessory mol. other than fusin.  Finally, coexpression of fusin and CD4 made both a murine and feline cell line susceptible to virus infection by T-tropic, but not M-tropic, HIV-1 strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsR_9vTNV9TbVg90H21EOLACvtfcHk0liawtU_FXjKKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGgsLs%253D&md5=052e1d5ea522ab5cfe527ff8aeda1112</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerson%26aufirst%3DJ.%2BF.%26aulast%3DLong%26aufirst%3DD.%26aulast%3DDoranz%26aufirst%3DB.%2BJ.%26aulast%3DRucker%26aufirst%3DJ.%26aulast%3DJirik%26aufirst%3DF.%2BR.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DA%2520seven-transmembrane%2520domain%2520receptor%2520involved%2520in%2520fusion%2520and%2520entry%2520of%2520T-cell-tropic%2520human%2520immunodeficiency%2520virus%2520type%25201%2520strains%26jtitle%3DJ.%2520Virol.%26date%3D1996%26volume%3D70%26spage%3D6288%26epage%3D6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1021/jm200568c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200568c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=977-994&author=W.+T.+Choiauthor=S.+Duggineniauthor=Y.+Xuauthor=Z.+Huangauthor=J.+An&title=Drug+discovery+research+targeting+the+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm200568c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)</span></div><div class="casAuthors">Choi, Won-Tak; Duggineni, Srinivas; Xu, Yan; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">977-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The CXC chemokine receptor 4 (CXCR4) is an attractive target for therapeutic intervention because of its involvement in the pathogenesis of a wide range of infectious, inflammatory, and other diseases.  There has been intensive biol., chem., and pharmaceutical research to understand the mol. mechanisms of chemokine-receptor interactions and the modulation of chemokine-receptor functions.  The ultimate goal is to translate these discoveries into novel treatment strategies for clin. applications.  This review describes and discusses some of the recent advances in medicinal chem. and drug discovery that involve CXCR4, which is implicated in human immunodeficiency virus (HIV)-1 infection, normal hematopoietic and neural stem cell migration, cancer-stromal cell interaction, solid tumors, and inflammation and autoimmune diseases such as rheumatoid arthritis and allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvqHX-IPaxrVg90H21EOLACvtfcHk0liawtU_FXjKKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF&md5=c996a29f564ca4197139f4802dcbe061</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm200568c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200568c%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520research%2520targeting%2520the%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D977%26epage%3D994%26doi%3D10.1021%2Fjm200568c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Scholten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maussang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of chemokine receptor function</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01551.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fj.1476-5381.2011.01551.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=21699506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1617-1643&author=D.+Scholtenauthor=M.+Canalsauthor=D.+Maussangauthor=L.+Roumenauthor=M.+Smitauthor=M.+Wijtmansauthor=C.+de+Graafauthor=H.+Vischerauthor=R.+Leurs&title=Pharmacological+modulation+of+chemokine+receptor+function&doi=10.1111%2Fj.1476-5381.2011.01551.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of chemokine receptor function</span></div><div class="casAuthors">Scholten, D. J.; Canals, M.; Maussang, D.; Roumen, L.; Smit, M. J.; Wijtmans, M.; de Graaf, C.; Vischer, H. F.; Leurs, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1617-1643</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G protein-coupled chemokine receptors and their peptidergic ligands are interesting therapeutic targets due to their involvement in various immune-related diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, chronic obstructive pulmonary disease, HIV-1 infection, and cancer.  To tackle these diseases, a lot of effort was focused on discovery and development of small-mol. chemokine receptor antagonists.  This was rewarded by the market approval of 2 novel chemokine receptor inhibitors, AMD3100 (CXCR4) and Maraviroc (CCR5) for stem cell mobilization and treatment of HIV-1 infection resp.  The recent GPCR crystal structures together with mutagenesis and pharmacol. studies have aided in understanding how small-mol. ligands interact with chemokine receptors.  Many of these ligands display behavior deviating from simple competition and do not interact with the chemokine binding site, providing evidence for an allosteric mode of action.  This review aims to give an overview of the evidence supporting modulation of this intriguing receptor family by a range of ligands, including small mols., peptides and antibodies.  Moreover, the computer-assisted modeling of chemokine receptor-ligand interactions is discussed in view of GPCR crystal structures.  Finally, the implications of concepts such as functional selectivity and chemokine receptor dimerization are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NeldtD0vf7Vg90H21EOLACvtfcHk0lglbn7vCQ0uQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVKqtbY%253D&md5=481acf0786ab696ab1fc7eadc09c3aa8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01551.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01551.x%26sid%3Dliteratum%253Aachs%26aulast%3DScholten%26aufirst%3DD.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DMaussang%26aufirst%3DD.%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DSmit%26aufirst%3DM.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DVischer%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DPharmacological%2520modulation%2520of%2520chemokine%2520receptor%2520function%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1617%26epage%3D1643%26doi%3D10.1111%2Fj.1476-5381.2011.01551.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Singh, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauthe, S. K.</span><span> </span><span class="NLM_article-title">Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004–2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1517/13543776.2011.542412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1517%2F13543776.2011.542412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=21219250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=227-269&author=I.+P.+Singhauthor=S.+K.+Chauthe&title=Small+molecule+HIV+entry+inhibitors%3A+Part+I.+Chemokine+receptor+antagonists%3A+2004%E2%80%932010&doi=10.1517%2F13543776.2011.542412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004 - 2010</span></div><div class="casAuthors">Singh, Inder Pal; Chauthe, Siddheshwar K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-269</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HIV/AIDS is one of the most devastating diseases in the world affecting > 40 million people worldwide.  Morbidity and mortality from AIDS are significantly reduced due to the advent of highly active antiretroviral therapy (HAART).  Long-term toxicity, emergence of drug resistant HIV strains and drug-drug interactions limit the effectiveness of HAART therapy.  Chemokine receptor antagonists can provide drugs with lesser side effects and enhanced anti-HIV activity.  Maraviroc, a chemokine co-receptor 5 (CCR5) antagonist from Pfizer, is already in clin. use.  This review covers patents and patent applications for small mol. CCR5 and CXC chemokine receptor 4 (CXCR4) antagonists published between 2004 and 2010 and related literature with a focus on recent developments based on lead generation and lead modification.  The reader will gain information about the development of small mol. CCR5 and CXCR4 antagonists from the major pharmaceutical and biopharmaceutical companies.  Several small lead mols. (CCR5 and CXCR4 antagonists) have been modified over this period for enhanced therapeutic activity and to obtain drug-like properties.  CCR5 antagonists such as TBK-652 and TBK-220 from Tobira Therapeutics, and vicriviroc from Schering Plough showed a lot of promise in the developmental stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN7_q_L4BFF7Vg90H21EOLACvtfcHk0lglbn7vCQ0uQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentLo%253D&md5=e22a0175d7b87b2ae6d7d63b41aeadfd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.542412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.542412%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DI.%2BP.%26aulast%3DChauthe%26aufirst%3DS.%2BK.%26atitle%3DSmall%2520molecule%2520HIV%2520entry%2520inhibitors%253A%2520Part%2520I.%2520Chemokine%2520receptor%2520antagonists%253A%25202004%25E2%2580%25932010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D227%26epage%3D269%26doi%3D10.1517%2F13543776.2011.542412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picker, D.</span><span> </span><span class="NLM_article-title">Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">5286</span><span class="NLM_x">–</span> <span class="NLM_lpage">5290</span><span class="refDoi"> DOI: 10.1073/pnas.89.12.5286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.89.12.5286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1608936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK38XkvVaqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=5286-5290&author=E.+De+Clercqauthor=N.+Yamamotoauthor=R.+Pauwelsauthor=M.+Babaauthor=D.+Scholsauthor=H.+Nakashimaauthor=J.+Balzariniauthor=Z.+Debyserauthor=B.+A.+Murrerauthor=D.+Schwartzauthor=D.+Thorntonauthor=G.+Bridgerauthor=S.+Frickerauthor=G.+Hensonauthor=M.+Abramsauthor=D.+Picker&title=Potent+and+selective+inhibition+of+human+immunodeficiency+virus+%28HIV%29-1+and+HIV-2+replication+by+a+class+of+bicyclams+interacting+with+a+viral+uncoating+event&doi=10.1073%2Fpnas.89.12.5286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of cicyclams interacting with a viral uncoating event</span></div><div class="casAuthors">De Clercq, Erik; Yamamoto, Naohiko; Pauwels, Rudi; Baba, Masanori; Schols, Dominique; Nakashima, Hideki; Balzarini, Jan; Debyser, Zeger; Murrer, Barry A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5286-90</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A series of bicyclams have been shown to be potent and selective inhibitors of human immunodeficiency virus (HIV).  The compds. are inhibitory to the replication of various HIV-1 and HIV-2 strains in various human T-cell systems, including peripheral blood lymphocytes, at 0.14-1.4 μM, without being toxic to the host cells at 2.2 mM.  The bicyclam JM2763 (I) is active against 3'-azido-3'-deoxythymidine (zidovudine; AZT)-resistant HIV-1 strains and acts additively with AZT.  Mechanism of action studies revealed that the bicyclams (i.e., I) interact with an early event of the retrovirus replicative cycle, which could be tentatively identified as a viral uncoating event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkZ-WLPGwyLVg90H21EOLACvtfcHk0lglbn7vCQ0uQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVaqtro%253D&md5=67db6384097fedeb73572d8f7628be34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.12.5286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.12.5286%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DMurrer%26aufirst%3DB.%2BA.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DThornton%26aufirst%3DD.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DFricker%26aufirst%3DS.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DAbrams%26aufirst%3DM.%26aulast%3DPicker%26aufirst%3DD.%26atitle%3DPotent%2520and%2520selective%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520and%2520HIV-2%2520replication%2520by%2520a%2520class%2520of%2520bicyclams%2520interacting%2520with%2520a%2520viral%2520uncoating%2520event%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D5286%26epage%3D5290%26doi%3D10.1073%2Fpnas.89.12.5286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.pharmthera.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20826182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=509-518&author=E.+De+Clercq&title=Recent+advances+on+the+use+of+the+CXCR4+antagonist+plerixafor+%28AMD3100%2C+Mozobil%29+and+potential+of+other+CXCR4+antagonists+as+stem+cell+mobilizers&doi=10.1016%2Fj.pharmthera.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">509-518</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  AMD3100 was originally discovered as an anti-HIV agent effective in inhibiting the replication of HIV in vitro at nanomolar concns.  We found it to be a potent and selective antagonist of CXCR4, the receptor for the chemokine SDF-1 (now called CXCL12).  AMD3100 was then developed, and marketed, as a stem cell mobilizer, and renamed plerixafor (Mozobil).  The path to the discovery of Mozobil as a stem cell mobilizer was described in Biochem.  Pharmacol. 77: 1655-1664 (2009).  Here I review the recent advances that have consolidated the role of plerixafor in mobilizing hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) from the bone marrow into the blood circulation.  Plerixafor acts synergistically with granulocyte colony-stimulating factor (G-CSF), and its usefulness has been proven particularly for the mobilization of HSCs and HPCs for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).  Plerixafor also has great potential for the treatment of hematol. malignancies other than NHL and MM, and non-hematol. malignancies, and, eventually, several other diseases depending on the CXCL12-CXCR4 interaction.  Various AMD3100 analogs have been described (i.e. AMD11070, AMD3465, KRH-3955, T-140, and 4F-benzoyl-TN14003), primarily as potential anti-HIV agents.  They are all strong CXCR4 antagonists.  Their role in stem cell mobilization remains to be assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNBMywfEvpbVg90H21EOLACvtfcHk0lhx0F1QdGYsLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7zO&md5=cb344c4a5966627126ec462e271e3d9e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DRecent%2520advances%2520on%2520the%2520use%2520of%2520the%2520CXCR4%2520antagonist%2520plerixafor%2520%2528AMD3100%252C%2520Mozobil%2529%2520and%2520potential%2520of%2520other%2520CXCR4%2520antagonists%2520as%2520stem%2520cell%2520mobilizers%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D128%26spage%3D509%26epage%3D518%26doi%3D10.1016%2Fj.pharmthera.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terakubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span> </span><span class="NLM_article-title">Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3253</span><span class="refDoi"> DOI: 10.1002/anie.200351024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fanie.200351024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtF2rtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3251-3253&author=N.+Fujiiauthor=S.+Oishiauthor=K.+Hiramatsuauthor=T.+Arakiauthor=S.+Uedaauthor=H.+Tamamuraauthor=A.+Otakaauthor=S.+Kusanoauthor=S.+Terakuboauthor=H.+Nakashimaauthor=J.+A.+Broachauthor=J.+O.+Trentauthor=Z.+X.+Wangauthor=S.+C.+Peiper&title=Molecular-size+reduction+of+a+potent+CXCR4-chemokine+antagonist+using+orthogonal+combination+of+conformation-+and+sequence-based+libraries&doi=10.1002%2Fanie.200351024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries</span></div><div class="casAuthors">Fujii, Nobutaka; Oishi, Shinya; Hiramatsu, Kenichi; Araki, Takanobu; Ueda, Satoshi; Tamamura, Hirokazu; Otaka, Akira; Kusano, Shuichi; Terakubo, Shigemi; Nakashima, Hideki; Broach, James A.; Trent, John O.; Wang, Zi-xuan; Peiper, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3251-3253</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report a new strategy for the downsizing of bioactive peptides using 2 orthogonal small libraries o cyclic peptides, which allowed us to identify a novel CXCR4 antagonist equipotent to the parent peptide.  By combination of two orthogonal "conformation-based" and "sequence-based" libraries, the cyclic pentapeptide cyclo-(-L-Nal1-Gly2-D-Tyr3-L-Arg4-L-Arg5-) (Nal=L-3-(2-naphthyl)alanine), which exhibited strong CXCR4 antagonism (IC50=4 nM) comparable to that of a 14-residue lead compd., T140, was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonplDn8xbOq7Vg90H21EOLACvtfcHk0lhx0F1QdGYsLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtF2rtb4%253D&md5=4f284b00b93935628be8c3d29eb52c79</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351024%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DTerakubo%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DBroach%26aufirst%3DJ.%2BA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26atitle%3DMolecular-size%2520reduction%2520of%2520a%2520potent%2520CXCR4-chemokine%2520antagonist%2520using%2520orthogonal%2520combination%2520of%2520conformation-%2520and%2520sequence-based%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D3251%26epage%3D3253%26doi%3D10.1002%2Fanie.200351024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span><span class="refDoi"> DOI: 10.1039/b513145f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1039%2Fb513145f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=4392-4394&author=H.+Tamamuraauthor=A.+Esakaauthor=T.+Ogawaauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=J.+O.+Trentauthor=H.+Tsutsumiauthor=H.+Masunoauthor=H.+Nakashima&title=Structure%E2%80%93activity+relationship+studies+on+CXCR4+antagonists+having+cyclic+pentapeptide+scaffolds&doi=10.1039%2Fb513145f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fb513145f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb513145f%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DTsutsumi%26aufirst%3DH.%26aulast%3DMasuno%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520on%2520CXCR4%2520antagonists%2520having%2520cyclic%2520pentapeptide%2520scaffolds%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D4392%26epage%3D4394%26doi%3D10.1039%2Fb513145f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3280</span><span class="NLM_x">–</span> <span class="NLM_lpage">3289</span><span class="refDoi"> DOI: 10.1021/jm050009h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050009h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3280-3289&author=H.+Tamamuraauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=S.+Oishiauthor=A.+Esakaauthor=J.+O.+Trentauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=S.+C.+Peiperauthor=A.+Otakaauthor=N.+Fujii&title=Identification+of+novel+low+molecular+weight+CXCR4+antagonists+by+structural+tuning+of+cyclic+tetrapeptide+scaffolds&doi=10.1021%2Fjm050009h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm050009h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050009h%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520novel%2520low%2520molecular%2520weight%2520CXCR4%2520antagonists%2520by%2520structural%2520tuning%2520of%2520cyclic%2520tetrapeptide%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3280%26epage%3D3289%26doi%3D10.1021%2Fjm050009h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1021/jm0607350</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607350" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=192-198&author=S.+Uedaauthor=S.+Oishiauthor=Z.+X.+Wangauthor=T.+Arakiauthor=H.+Tamamuraauthor=J.+Cluzeauauthor=H.+Ohnoauthor=S.+Kusanoauthor=H.+Nakashimaauthor=J.+O.+Trentauthor=S.+C.+Peiperauthor=N.+Fujii&title=Structure-activity+relationships+of+cyclic+peptide-based+chemokine+receptor+CXCR4+antagonists%3A+disclosing+the+importance+of+side-chain+and+backbone+functionalities&doi=10.1021%2Fjm0607350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0607350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607350%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationships%2520of%2520cyclic%2520peptide-based%2520chemokine%2520receptor%2520CXCR4%2520antagonists%253A%2520disclosing%2520the%2520importance%2520of%2520side-chain%2520and%2520backbone%2520functionalities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D192%26epage%3D198%26doi%3D10.1021%2Fjm0607350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksteen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Rational design of conformationally constrained cyclopentapeptide antagonists for CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10291</span><span class="refDoi"> DOI: 10.1021/jm300926y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300926y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10287-10291&author=J.+Mungalparaauthor=S.+Thieleauthor=%C3%98.+Eriksenauthor=J.+Eksteenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Rational+design+of+conformationally+constrained+cyclopentapeptide+antagonists+for+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm300926y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm300926y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300926y%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3D%25C3%2598.%26aulast%3DEksteen%26aufirst%3DJ.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%2520conformationally%2520constrained%2520cyclopentapeptide%2520antagonists%2520for%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10287%26epage%3D10291%26doi%3D10.1021%2Fjm300926y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8202</span><span class="NLM_x">–</span> <span class="NLM_lpage">8208</span><span class="refDoi"> DOI: 10.1039/c3ob41941j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1039%2Fc3ob41941j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=8202-8208&author=J.+Mungalparaauthor=Z.+G.+Zachariassenauthor=S.+Thieleauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Structure-activity+relationship+studies+of+the+aromatic+positions+in+cyclopentapeptide+CXCR4+antagonists&doi=10.1039%2Fc3ob41941j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41941j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41941j%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520the%2520aromatic%2520positions%2520in%2520cyclopentapeptide%2520CXCR4%2520antagonists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D8202%26epage%3D8208%26doi%3D10.1039%2Fc3ob41941j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Yamazaki, T.; Saitou, A.; Ono, M.; Yokoyama, S.; Bannai, K.; Hirose, K.; Yanaka, M.</span><span> </span><span class="NLM_article-title">Preparation of amino acid amide derivatives as antagonists of chemokine CXCR4 receptor</span>. WO2003029218A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Yamazaki&author=A.+Saitou&author=M.+Ono&author=S.+Yokoyama&author=K.+Bannai&author=K.+Hirose&author=M.+Yanaka&title=Preparation+of+amino+acid+amide+derivatives+as+antagonists+of+chemokine+CXCR4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520amino%2520acid%2520amide%2520derivatives%2520as%2520antagonists%2520of%2520chemokine%2520CXCR4%2520receptor%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yamazaki, T.; Kikumoto, S.; Ono, M.; Saitou, A.; Takahashi, H.; Kumakura, S.; Hirose, K.; Yanaka, M.; Takemura, Y.; Suzuki, S.; Matsui, R.</span><span> </span><span class="NLM_article-title">Preparation of bis(heterocyclylmethyl)amine compounds as chemokine receptor CXCR4 antagonists</span>. WO2004024697A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Yamazaki&author=S.+Kikumoto&author=M.+Ono&author=A.+Saitou&author=H.+Takahashi&author=S.+Kumakura&author=K.+Hirose&author=M.+Yanaka&author=Y.+Takemura&author=S.+Suzuki&author=R.+Matsui&title=Preparation+of+bis%28heterocyclylmethyl%29amine+compounds+as+chemokine+receptor+CXCR4+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520bis%2528heterocyclylmethyl%2529amine%2520compounds%2520as%2520chemokine%2520receptor%2520CXCR4%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1128/AAC.01727-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FAAC.01727-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2940-2948&author=T.+Murakamiauthor=S.+Kumakuraauthor=T.+Yamazakiauthor=R.+Tanakaauthor=M.+Hamatakeauthor=K.+Okumaauthor=W.+Huangauthor=J.+Tomaauthor=J.+Komanoauthor=M.+Yanaka&title=The+novel+CXCR4+antagonist+KRH-3955+is+an+orally+bioavailable+and+extremely+potent+inhibitor+of+human+immunodeficiency+virus+type+1+infection%3A+comparative+studies+with+AMD3100&doi=10.1128%2FAAC.01727-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.01727-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01727-08%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DToma%26aufirst%3DJ.%26aulast%3DKomano%26aufirst%3DJ.%26aulast%3DYanaka%26aufirst%3DM.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520KRH-3955%2520is%2520an%2520orally%2520bioavailable%2520and%2520extremely%2520potent%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%253A%2520comparative%2520studies%2520with%2520AMD3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D2940%26epage%3D2948%26doi%3D10.1128%2FAAC.01727-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ichiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama-Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano-Kurosaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4190</span><span class="refDoi"> DOI: 10.1073/pnas.0630420100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.0630420100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4185-4190&author=K.+Ichiyamaauthor=S.+Yokoyama-Kumakuraauthor=Y.+Tanakaauthor=R.+Tanakaauthor=K.+Hiroseauthor=K.+Bannaiauthor=T.+Edamatsuauthor=M.+Yanakaauthor=Y.+Niitaniauthor=N.+Miyano-Kurosakiauthor=H.+Takakuauthor=Y.+Koyanagiauthor=N.+Yamamoto&title=A+duodenally+absorbable+CXC+chemokine+receptor+4+antagonist%2C+KRH-1636%2C+exhibits+a+potent+and+selective+anti-HIV-1+activity&doi=10.1073%2Fpnas.0630420100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630420100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630420100%26sid%3Dliteratum%253Aachs%26aulast%3DIchiyama%26aufirst%3DK.%26aulast%3DYokoyama-Kumakura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DBannai%26aufirst%3DK.%26aulast%3DEdamatsu%26aufirst%3DT.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DNiitani%26aufirst%3DY.%26aulast%3DMiyano-Kurosaki%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520duodenally%2520absorbable%2520CXC%2520chemokine%2520receptor%25204%2520antagonist%252C%2520KRH-1636%252C%2520exhibits%2520a%2520potent%2520and%2520selective%2520anti-HIV-1%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4185%26epage%3D4190%26doi%3D10.1073%2Fpnas.0630420100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yanaka, M.; Yamazaki, T.; Bannai, K.; Hirose, K.</span><span> </span><span class="NLM_article-title">CXCR4-antagonistic drugs composed of nitrogen-containing compound</span>. US 0157818, August 12,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Yanaka&author=T.+Yamazaki&author=K.+Bannai&author=K.+Hirose&title=CXCR4-antagonistic+drugs+composed+of+nitrogen-containing+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYanaka%26aufirst%3DM.%26atitle%3DCXCR4-antagonistic%2520drugs%2520composed%2520of%2520nitrogen-containing%2520compound%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span> </span><span class="NLM_article-title">Small molecules anti-HIV therapeutics targeting CXCR4</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.2174/138161208783497714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F138161208783497714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=18289065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=385-404&author=N.+Neamatiauthor=F.+Grandeauthor=A.+Garofalo&title=Small+molecules+anti-HIV+therapeutics+targeting+CXCR4&doi=10.2174%2F138161208783497714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules anti-HIV therapeutics targeting CXCR4</span></div><div class="casAuthors">Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-404</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HIV cellular entry is a multistep process that requires the interaction of a viral envelope glycoprotein (gp120) and a host receptor (CD4) followed by binding to a co-receptor.  The CC-chemokine receptor 5 (CCR5) and CXC-chemokine receptor 4 (CXCR4) have been identified as the major HIV co-receptors and therefore are promising targets for the development of new anti-HIV drugs.  CXCR4 is also involved in several diseases such as angiogenesis, metabolic and neurol. disorders, rheumatoid arthritis and in different forms of metastatic cancer.  Herein, we present a review focusing on small mol. CXCR4 antagonists.  These compds. are divided into 11 classes that include cyclic penta- and tetrapeptides, diketopiperazine mimetics, bicyclams, non-bicyclams, tetrahydroquinolines, thiazolylisothiourea derivs., benzodiazepines, alkyl amine analogs and non-peptides derivs., dipicolylamine-zinc(II) complexes, ampelopsin and distamycin analogs.  The most advanced CXCR4 antagonists documented are bicyclam derivs., which are specific CXCR4 antagonists and exhibit potency in the nanomolar range.  Further development of selective CXCR4 antagonists continues to be crucial for the design of second generation of anti-HIV drugs.  We aim to provide a comprehensive summary of diverse structural templates that could be useful for optimization and discovery of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr748B8doAAOrVg90H21EOLACvtfcHk0ljDbf6oTXfkWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntr4%253D&md5=b6a409ddd76bfee59fcd407ca04f629e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F138161208783497714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783497714%26sid%3Dliteratum%253Aachs%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520anti-HIV%2520therapeutics%2520targeting%2520CXCR4%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D385%26epage%3D404%26doi%3D10.2174%2F138161208783497714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of CXCR4</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.7150/thno.5376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.7150%2Fthno.5376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=47-75&author=B.+Debnathauthor=S.+Xuauthor=F.+Grandeauthor=A.+Garofaloauthor=N.+Neamati&title=Small+molecule+inhibitors+of+CXCR4&doi=10.7150%2Fthno.5376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7150%2Fthno.5376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5376%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520CXCR4%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26spage%3D47%26epage%3D75%26doi%3D10.7150%2Fthno.5376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforovich, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/bip.20508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fbip.20508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=459-471&author=J.+V%C3%A5ben%C3%B8author=G.+V.+Nikiforovichauthor=G.+R.+Marshall&title=A+minimalistic+3D+pharmacophore+model+for+cyclopentapeptide+CXCR4+antagonists&doi=10.1002%2Fbip.20508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fbip.20508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20508%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DNikiforovich%26aufirst%3DG.%2BV.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DA%2520minimalistic%25203D%2520pharmacophore%2520model%2520for%2520cyclopentapeptide%2520CXCR4%2520antagonists%26jtitle%3DBiopolymers%26date%3D2006%26volume%3D84%26spage%3D459%26epage%3D471%26doi%3D10.1002%2Fbip.20508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+GPCR+with+small-molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0ljDbf6oTXfkWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520GPCR%2520with%2520small-molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0lgmBzLDTeA3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1111/bph.12842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fbph.12842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=25039237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=5313-5329&author=S.+Thieleauthor=J.+Mungalparaauthor=A.+Steenauthor=M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Determination+of+the+binding+mode+for+the+cyclopentapeptide+CXCR4+antagonist+FC131+using+a+dual+approach+of+ligand+modifications+and+receptor+mutagenesis&doi=10.1111%2Fbph.12842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span></div><div class="casAuthors">Thiele, S.; Mungalpara, J.; Steen, A.; Rosenkilde, M. M.; Vabeno, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5313-5329</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The cyclopentapeptide FC131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-)) is an antagonist at the CXC chemokine receptor CXCR4, which plays a role in human immunodeficiency virus infection, cancer and stem cell recruitment.  Binding modes for FC131 in CXCR4 have previously been suggested based on mol. docking guided by structure-activity relationship (SAR) data; however, none of these have been verified by in vitro expts.  Exptl. Approach : Heterologous 125I-12G5-competition binding and functional assays (inhibition of CXCL12-mediated activation) of FC131 and three analogs were performed on wild-type CXCR4 and 25 receptor mutants.  Computational modeling was used to rationalize the exptl. data.  Key Results : The Arg2 and 2-Nal3 side chains of FC131 interact with residues in TM-3 (His113, Asp171) and TM-5 (hydrophobic pocket) resp.  Arg1 forms charge-charge interactions with Asp187 in ECL-2, while D-Tyr5 points to the extracellular side of CXCR4.  Furthermore, the backbone of FC131 interacts with the chemokine receptor-conserved Glu288 via two water mols.  Intriguingly, Tyr116 and Glu288 form a H-bond in CXCR4 crystal structures and mutation of either residue to Ala abolishes CXCR4 activity.  Conclusions and Implications : Ligand modification, receptor mutagenesis and computational modeling approaches were used to identify the binding mode of FC131 in CXCR4, which was in agreement with binding modes suggested from previous SAR studies.  Furthermore, insights into the mechanism for CXCR4 activation by CXCL12 were gained.  The combined findings will facilitate future design of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTJVv4tLiRYrVg90H21EOLACvtfcHk0lgmBzLDTeA3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE&md5=de979e35933c1b6566e6b4b43034e875</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fbph.12842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12842%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DSteen%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DDetermination%2520of%2520the%2520binding%2520mode%2520for%2520the%2520cyclopentapeptide%2520CXCR4%2520antagonist%2520FC131%2520using%2520a%2520dual%2520approach%2520of%2520ligand%2520modifications%2520and%2520receptor%2520mutagenesis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D5313%26epage%3D5329%26doi%3D10.1111%2Fbph.12842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">14153</span><span class="NLM_x">–</span> <span class="NLM_lpage">14160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14153-14160&author=L.+O.+Gerlachauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+interactions+of+cyclam+and+bicyclam+non-peptide+antagonists+with+the+CXCR4+chemokine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520interactions%2520of%2520cyclam%2520and%2520bicyclam%2520non-peptide%2520antagonists%2520with%2520the%2520CXCR4%2520chemokine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14153%26epage%3D14160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3041</span><span class="refDoi"> DOI: 10.1074/jbc.M309546200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M309546200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=3033-3041&author=M.+M.+Rosenkildeauthor=L.+O.+Gerlachauthor=J.+S.+Jakobsenauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+mechanism+of+AMD3100+antagonism+in+the+CXCR4+receptor&doi=10.1074%2Fjbc.M309546200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309546200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309546200%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DJakobsen%26aufirst%3DJ.%2BS.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520AMD3100%2520antagonism%2520in%2520the%2520CXCR4%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D3033%26epage%3D3041%26doi%3D10.1074%2Fjbc.M309546200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00609-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS0014-5793%2803%2900609-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2003&pages=300-306&author=S.+Hatseauthor=K.+Princenauthor=K.+Vermeireauthor=L.+O.+Gerlachauthor=M.+M.+Rosenkildeauthor=T.+W.+Schwartzauthor=G.+Bridgerauthor=E.+De+Clercqauthor=D.+Schols&title=Mutations+at+the+CXCR4+interaction+sites+for+AMD3100+influence+anti-CXCR4+antibody+binding+and+HIV-1+entry&doi=10.1016%2FS0014-5793%2803%2900609-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900609-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900609-4%26sid%3Dliteratum%253Aachs%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DMutations%2520at%2520the%2520CXCR4%2520interaction%2520sites%2520for%2520AMD3100%2520influence%2520anti-CXCR4%2520antibody%2520binding%2520and%2520HIV-1%2520entry%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D546%26spage%3D300%26epage%3D306%26doi%3D10.1016%2FS0014-5793%2803%2900609-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">27354</span><span class="NLM_x">–</span> <span class="NLM_lpage">27365</span><span class="refDoi"> DOI: 10.1074/jbc.M704739200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M704739200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27354-27365&author=M.+M.+Rosenkildeauthor=L.+O.+Gerlachauthor=S.+Hatseauthor=R.+T.+Skerljauthor=D.+Scholsauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+mechanism+of+action+of+monocyclam+versus+bicyclam+non-peptide+antagonists+in+the+CXCR4+chemokine+receptor&doi=10.1074%2Fjbc.M704739200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704739200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704739200%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520action%2520of%2520monocyclam%2520versus%2520bicyclam%2520non-peptide%2520antagonists%2520in%2520the%2520CXCR4%2520chemokine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D27354%26epage%3D27365%26doi%3D10.1074%2Fjbc.M704739200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1124/mol.108.049775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1124%2Fmol.108.049775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1485-1495&author=R.+S.+Y.+Wongauthor=V.+Bodartauthor=M.+Metzauthor=J.+Labrecqueauthor=G.+Bridgerauthor=S.+P.+Fricker&title=Comparison+of+the+potential+multiple+binding+modes+of+bicyclam%2C+monocylam%2C+and+noncyclam+small-molecule+CXC+chemokine+receptor+4+inhibitors&doi=10.1124%2Fmol.108.049775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049775%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26aulast%3DBodart%26aufirst%3DV.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DComparison%2520of%2520the%2520potential%2520multiple%2520binding%2520modes%2520of%2520bicyclam%252C%2520monocylam%252C%2520and%2520noncyclam%2520small-molecule%2520CXC%2520chemokine%2520receptor%25204%2520inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1485%26epage%3D1495%26doi%3D10.1124%2Fmol.108.049775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clercq, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Abad, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.05.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bcp.2005.05.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=752-761&author=S.+Hatseauthor=K.+Princenauthor=E.+D.+Clercqauthor=M.+M.+Rosenkildeauthor=T.+W.+Schwartzauthor=P.+E.+Hernandez-Abadauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=D.+Schols&title=AMD3465%2C+a+monomacrocyclic+CXCR4+antagonist+and+potent+HIV+entry+inhibitor&doi=10.1016%2Fj.bcp.2005.05.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DClercq%26aufirst%3DE.%2BD.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DHernandez-Abad%26aufirst%3DP.%2BE.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DAMD3465%252C%2520a%2520monomacrocyclic%2520CXCR4%2520antagonist%2520and%2520potent%2520HIV%2520entry%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D752%26epage%3D761%26doi%3D10.1016%2Fj.bcp.2005.05.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Charles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronenborn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodawer, A.</span><span> </span><span class="NLM_article-title">Crystal structure of interleukin 8: symbiosis of NMR and crystallography</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1073/pnas.88.2.502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.88.2.502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1988949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFOhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=502-506&author=E.+T.+Baldwinauthor=I.+T.+Weberauthor=R.+St+Charlesauthor=J.+C.+Xuanauthor=E.+Appellaauthor=M.+Yamadaauthor=K.+Matsushimaauthor=B.+F.+Edwardsauthor=G.+M.+Cloreauthor=A.+M.+Gronenbornauthor=A.+Wlodawer&title=Crystal+structure+of+interleukin+8%3A+symbiosis+of+NMR+and+crystallography&doi=10.1073%2Fpnas.88.2.502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of interleukin 8:  symbiosis of NMR and crystallography</span></div><div class="casAuthors">Baldwin, Eric T.; Weber, Irene T.; St. Charles, Robert; Xuan, Jian Cheng; Appella, Ettore; Yamada, Masaki; Matsushima, Kouji; Edwards, Brian F. P.; Clore, G. Marius; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The crystal structure of a host defense system chemotactic factor, interleukin 8, was solved by mol. replacement using as a model the soln. structure derived from NMR expts.  The structure was refined with 2 Å x-ray data to an R factor of 0.187 (0.217 at 1.6 Å).  A comparison indicates some potential differences between the structure in soln. and in the cryst. state.  The anal. also predicts that residues 4-9 on the N terminus and the β-bend, which includes His-33, may be important for receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5c-Ty3aiibVg90H21EOLACvtfcHk0lgb5O7Ee9GdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFOhsA%253D%253D&md5=cf028d5e1efcf197e1b59984cb58cf53</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.2.502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.2.502%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DSt%2BCharles%26aufirst%3DR.%26aulast%3DXuan%26aufirst%3DJ.%2BC.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DEdwards%26aufirst%3DB.%2BF.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DGronenborn%26aufirst%3DA.%2BM.%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520interleukin%25208%253A%2520symbiosis%2520of%2520NMR%2520and%2520crystallography%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D502%26epage%3D506%26doi%3D10.1073%2Fpnas.88.2.502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Locating ligand-binding sites in 7TM receptors by protein engineering</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/0958-1669(94)90054-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2F0958-1669%2894%2990054-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=7765177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVSgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=434-444&author=T.+W.+Schwartz&title=Locating+ligand-binding+sites+in+7TM+receptors+by+protein+engineering&doi=10.1016%2F0958-1669%2894%2990054-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Locating ligand-binding sites in 7TM receptors by protein engineering</span></div><div class="casAuthors">Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">434-44</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    </div><div class="casAbstract">Over the past year, mutational anal. of peptide receptors has started to change our understanding of the interaction between G protein coupled receptors and their ligands, an area previously almost totally dominated by results from studies of monoamine receptors.  A picture is currently emerging, in which small ligands appear to bind in three (more or less) overlapping ligand-binding pockets in between the transmembrane segments.  In contrast, contact residues for peptide and protein ligands have mainly been found in exterior regions of peptide and protein receptors.  It is also becoming increasingly clear that agonists and antagonists may interact in vastly different manners, even though they are competitive ligands for a common receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosQm6mxsg1RbVg90H21EOLACvtfcHk0lgb5O7Ee9GdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVSgsb4%253D&md5=b7ca10b3197c991f2efcf5d367705065</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2894%2990054-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252894%252990054-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DLocating%2520ligand-binding%2520sites%2520in%25207TM%2520receptors%2520by%2520protein%2520engineering%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1994%26volume%3D5%26spage%3D434%26epage%3D444%26doi%3D10.1016%2F0958-1669%2894%2990054-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lgb5O7Ee9GdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Brelot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heveker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alizon, M.</span><span> </span><span class="NLM_article-title">Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">23736</span><span class="NLM_x">–</span> <span class="NLM_lpage">23744</span><span class="refDoi"> DOI: 10.1074/jbc.M000776200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M000776200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10825158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12murg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=23736-23744&author=A.+Brelotauthor=N.+Hevekerauthor=M.+Montesauthor=M.+Alizon&title=Identification+of+residues+of+CXCR4+critical+for+human+immunodeficiency+virus+coreceptor+and+chemokine+receptor+activities&doi=10.1074%2Fjbc.M000776200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities</span></div><div class="casAuthors">Brelot, Anne; Heveker, Nikolaus; Montes, Monica; Alizon, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">23736-23744</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CXCR4 is a G-coupled receptor for the stromal cell-derived factor (SDF-1) chemokine, and a CD4-assocd. human immunodeficiency virus type 1 (HIV-1) coreceptor.  These functions were studied in a panel of CXCR4 mutants bearing deletions in the NH2-terminal extracellular domain (NT) or substitutions in the NT, the extracellular loops (ECL), or the transmembrane domains (TMs).  The coreceptor activity of CXCR4 was markedly impaired by mutations of two Tyr residues in NT (Y7A/Y12A) or at a single Asp residue in ECL2 (D193A), ECL3 (D262A), or TMII (D97N).  These acidic residues could engage electrostatical interactions with basic residues of the HIV-1 envelope protein gp120, known to contribute to the selectivity for CXCR4.  The ability of CXCR4 mutants to bind SDF-1 and mediate cell signal was consistent with the two-site model of chemokine-receptor interaction.  Site I involved in SDF-1 binding but not signaling was located in NT with particular importance of Glu14 and/or Glu15 and Tyr21.  Residues required for both SDF-1 binding and signaling, and thus probably part of site II, were identified in ECL2 (Asp187), TMII (Asp97), and TMVII (Glu288).  The first residues (2-9) of NT also seem required for SDF-1 binding and signaling.  A deletion in the third intracellular loop abolished signaling, probably by disrupting the coupling with G proteins.  The identification of CXCR4 residues involved in the interaction with both SDF-1 and HIV-1 may account for the signaling activity of gp120 and has implications for the development of antiviral compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkduYACuzA2bVg90H21EOLACvtfcHk0lgb5O7Ee9GdBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12murg%253D&md5=e0b778ce19ed5a084a4d5711901f2cb0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M000776200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M000776200%26sid%3Dliteratum%253Aachs%26aulast%3DBrelot%26aufirst%3DA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DAlizon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520residues%2520of%2520CXCR4%2520critical%2520for%2520human%2520immunodeficiency%2520virus%2520coreceptor%2520and%2520chemokine%2520receptor%2520activities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D23736%26epage%3D23744%26doi%3D10.1074%2Fjbc.M000776200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Crump, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajarathnam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenzana-Seisdedos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virelizier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span> </span><span class="NLM_article-title">Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6996</span><span class="NLM_x">–</span> <span class="NLM_lpage">7007</span><span class="refDoi"> DOI: 10.1093/emboj/16.23.6996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1093%2Femboj%2F16.23.6996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=9384579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1cXisVChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=6996-7007&author=M.+P.+Crumpauthor=J.+H.+Gongauthor=P.+Loetscherauthor=K.+Rajarathnamauthor=A.+Amaraauthor=F.+Arenzana-Seisdedosauthor=J.+L.+Virelizierauthor=M.+Baggioliniauthor=B.+D.+Sykesauthor=I.+Clark-Lewis&title=Solution+structure+and+basis+for+functional+activity+of+stromal+cell-derived+factor-1%3B+dissociation+of+CXCR4+activation+from+binding+and+inhibition+of+HIV-1&doi=10.1093%2Femboj%2F16.23.6996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1</span></div><div class="casAuthors">Crump, Matthew P.; Gong, Jiang-Hong; Loetscher, Pius; Rajarathnam, Krishna; Amara, Ali; Arenzana-Seisdedos, Fernando; Virelizier, Jean-Louis; Baggiolini, Marco; Sykes, Brian D.; Clark-Lewis, Ian</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6996-7007</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was detd. by NMR spectroscopy.  SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution.  Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation.  Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists.  Residues 12-17 of the loop region, which the authors term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure.  The RFFESH formed a receptor binding site, which the authors propose to be an important initial docking site of SDF-1 with its receptor.  The ability of the SDF-1 analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for the virus in addn. to being the receptor for SDF-1, correlated with their affinity for CXCR4.  Activation of the receptor is not required for HIV-1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMsriBtMZq7Vg90H21EOLACvtfcHk0liBDUmtfXDzjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVChtw%253D%253D&md5=ccf51d9ca51561e4da2aab95d886be22</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.23.6996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.23.6996%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DM.%2BP.%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DLoetscher%26aufirst%3DP.%26aulast%3DRajarathnam%26aufirst%3DK.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DVirelizier%26aufirst%3DJ.%2BL.%26aulast%3DBaggiolini%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26aulast%3DClark-Lewis%26aufirst%3DI.%26atitle%3DSolution%2520structure%2520and%2520basis%2520for%2520functional%2520activity%2520of%2520stromal%2520cell-derived%2520factor-1%253B%2520dissociation%2520of%2520CXCR4%2520activation%2520from%2520binding%2520and%2520inhibition%2520of%2520HIV-1%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D6996%26epage%3D7007%26doi%3D10.1093%2Femboj%2F16.23.6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">42826</span><span class="NLM_x">–</span> <span class="NLM_lpage">42833</span><span class="refDoi"> DOI: 10.1074/jbc.M106582200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M106582200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42826-42833&author=N.+Zhouauthor=Z.+Luoauthor=J.+Luoauthor=D.+Liuauthor=J.+W.+Hallauthor=R.+J.+Pomerantzauthor=Z.+Huang&title=Structural+and+functional+characterization+of+human+CXCR4+as+a+chemokine+receptor+and+HIV-1+co-receptor+by+mutagenesis+and+molecular+modeling+studies&doi=10.1074%2Fjbc.M106582200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106582200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106582200%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DJ.%2BW.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DStructural%2520and%2520functional%2520characterization%2520of%2520human%2520CXCR4%2520as%2520a%2520chemokine%2520receptor%2520and%2520HIV-1%2520co-receptor%2520by%2520mutagenesis%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D42826%26epage%3D42833%26doi%3D10.1074%2Fjbc.M106582200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">15398</span><span class="NLM_x">–</span> <span class="NLM_lpage">15404</span><span class="refDoi"> DOI: 10.1128/JVI.79.24.15398-15404.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.79.24.15398-15404.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16306611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=15398-15404&author=W.+T.+Choiauthor=S.+Tianauthor=C.+Z.+Dongauthor=S.+Kumarauthor=D.+Liuauthor=N.+Madaniauthor=J.+Anauthor=J.+G.+Sodroskiauthor=Z.+Huang&title=Unique+ligand+binding+sites+on+CXCR4+probed+by+a+chemical+biology+approach%3A+implications+for+the+design+of+selective+human+immunodeficiency+virus+type+1+inhibitors&doi=10.1128%2FJVI.79.24.15398-15404.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Unique ligand binding sites on CXCR4 probed by a chemical biology approach: Implications for the design of selective human immunodeficiency virus type 1 inhibitors</span></div><div class="casAuthors">Choi, Won-Tak; Tian, Shaomin; Dong, Chang-Zhi; Kumar, Santosh; Liu, Dongxiang; Madani, Navid; An, Jing; Sodroski, Joseph G.; Huang, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15398-15404</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR4 plays an important role as the receptor for the normal physiol. function of stromal cell-derived factor 1α (SDF-1α) and the coreceptor for the entry of human immunodeficiency virus type 1 (HIV-1) into the cell.  Many residues throughout CXCR4 transmembrane (TM) and extracellular loop 2 domains are known to be specifically involved in interaction with HIV-1 gp120, as most of these sites did not play a role in either SDF-1α binding or signaling.  These results provided direct exptl. evidence for the distinct functional sites on CXCR4 for HIV-1 and the normal ligand SDF-1α.  To further understand the CXCR4-ligand interaction and to develop new CXCR4 inhibitors to block HIV-1 entry, a new family of unnatural chemokines, termed synthetically and modularly modified (SMM) chemokines, were recently generated from the native sequence of SDF-1α or viral macrophage inflammatory protein II (vMIP-II).  These SMM chemokines contain various de novo-designed sequence replacements and substitutions by D-amino acids and display more enhanced CXCR4 selectivity, binding affinities, and/or anti-HIV activities than natural chemokines.  Using these novel CXCR4-targeting SMM chemokines as receptor probes, ligand binding site mapping expts. were conducted on a panel of site-directed mutants of CXCR4.  This provides the first exptl. evidence demonstrating that SMM chemokines interact with many residues on CXCR4 TM and extracellular domains that are important for HIV-1 entry, but not SDF-1α binding or signaling.  The preferential overlapping in the CXCR4 binding residues of SMM chemokines with HIV-1 over SDF-1α illustrates a mechanism for the potent HIV-1 inhibition by these SMM chemokines.  The discovery of distinct functional sites or conformational states influenced by these receptor sites mediating different functions of the natural ligand vs. the viral or synthetic ligands has important implications for drug discovery, since the sites shared by SMM chemokines and HIV-1 but not by SDF-1α can be targeted for the development of selective HIV-1 inhibitors devoid of interference with normal SDF-1α function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IZtIiF1BpbVg90H21EOLACvtfcHk0liBDUmtfXDzjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOgtw%253D%253D&md5=057a8120327933fa77ab2461cbcdcde3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.24.15398-15404.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.24.15398-15404.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DC.%2BZ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DUnique%2520ligand%2520binding%2520sites%2520on%2520CXCR4%2520probed%2520by%2520a%2520chemical%2520biology%2520approach%253A%2520implications%2520for%2520the%2520design%2520of%2520selective%2520human%2520immunodeficiency%2520virus%2520type%25201%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D15398%26epage%3D15404%26doi%3D10.1128%2FJVI.79.24.15398-15404.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesavento, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">12667</span><span class="NLM_x">–</span> <span class="NLM_lpage">12673</span><span class="refDoi"> DOI: 10.1128/JVI.79.20.12667-12673.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.79.20.12667-12673.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16188969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=12667-12673&author=S.+Tianauthor=W.-T.+Choiauthor=D.+Liuauthor=J.+Pesaventoauthor=Y.+Wangauthor=J.+Anauthor=J.+G.+Sodroskiauthor=Z.+Huang&title=Distinct+functional+sites+for+human+immunodeficiency+virus+type+1+and+stromal+cell-derived+factor+1%CE%B1+on+CXCR4+transmembrane+helical+domains&doi=10.1128%2FJVI.79.20.12667-12673.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains</span></div><div class="casAuthors">Tian, Shaomin; Choi, Won-Tak; Liu, Dongxiang; Pesavento, James; Wang, Youli; An, Jing; Sodroski, Joseph G.; Huang, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12667-12673</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of the viral surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5.  The natural ligand of CXCR4 is stromal cell-derived factor 1α (SDF-1α).  Whereas the overlap between HIV-1 and SDF-1α functional sites on the extracellular domains of CXCR4 has been well documented, it has yet to be detd. whether there are sites in the transmembrane (TM) helixes of CXCR4 important for HIV-1 and/or SDF-1α functions, and if such sites do exist, whether they are overlapping or distinctive for the sep. functions of CXCR4.  For this study, by employing alanine-scanning mutagenesis, 125I-SDF-1α competition binding, Ca2+ mobilization, and cell-cell fusion assays, we found that the mutation of many CXCR4 TM residues, including Tyr45, His79, Asp97, Pro163, Trp252, Tyr255, Asp262, Glu288, His294, and Asn298, could selectively decrease HIV-1-mediated cell fusion but not the binding activity of SDF-1α.  Phe87 and Phe292, which were involved in SDF-1α binding, did not play a significant role in the coreceptor activity of CXCR4, further demonstrating the disconnection between physiol. and pathol. activities of CXCR4 TM domains.  Our data also show that four mutations of the second extracellular loop, D182A, D187A, F189A, and P191A, could reduce HIV-1 entry without impairing either ligand binding or signaling.  Taken together, our first detailed characterization of the different functional roles of CXCR4 TM domains may suggest a mechanistic basis for the discovery of new selective anti-HIV agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXg5dHajQEK7Vg90H21EOLACvtfcHk0lhP_emFyuiiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisb%252FE&md5=8ff44231cfe1c7dc729d9b7f71de6e80</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.20.12667-12673.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.20.12667-12673.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPesavento%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DDistinct%2520functional%2520sites%2520for%2520human%2520immunodeficiency%2520virus%2520type%25201%2520and%2520stromal%2520cell-derived%2520factor%25201%25CE%25B1%2520on%2520CXCR4%2520transmembrane%2520helical%2520domains%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D12667%26epage%3D12673%26doi%3D10.1128%2FJVI.79.20.12667-12673.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Y.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0lhP_emFyuiiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%2BY.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Brelot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heveker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adema, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alizon, M.</span><span> </span><span class="NLM_article-title">Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2576</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10074102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFygu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=2576-2586&author=A.+Brelotauthor=N.+Hevekerauthor=K.+Ademaauthor=M.+J.+Hosieauthor=B.+Willettauthor=M.+Alizon&title=Effect+of+mutations+in+the+second+extracellular+loop+of+CXCR4+on+its+utilization+by+human+and+feline+immunodeficiency+viruses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses</span></div><div class="casAuthors">Brelot, Anne; Heveker, Nikolaus; Adema, Karen; Hosie, Margaret J.; Willett, Brian; Alizon, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2576-2586</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">CCR5 and CXCR4 are the principal CD4-assocd. coreceptors used by human immunodeficiency virus type 1 (HIV-1).  CXCR4 is also a receptor for the feline immunodeficiency virus (FIV).  The rat CXCR4 cannot mediate infection by HIV-1NDK or by FIVPET (both cell line-adapted strains) because of sequence differences with human CXCR4 in the second extracellular loop (ECL2).  Here the authors made similar observations for HIV-189.6 (a strain also using CCR5) and for a primary HIV-1 isolate.  It showed the role of ECL2 in the coreceptor activity of CXCR4 for different types of HIV-1 strains.  By exchanging ECL2 residues between human and rat CXCR4, the authors found that several amino acid differences contributed to the inactivity of the rat CXCR4 toward HIV-189.6.  In contrast, its inactivity toward HIV-1NDK seemed principally due to a serine at position 193 instead of to an aspartic acid (Asp193) in human CXCR4.  Likewise, a mutation of Asp187 prevented usage of CXCR4 by FIVPET.  Different mutations of Asp193, including its replacement by a glutamic acid, markedly reduced or suppressed the activity of CXCR4 for HIV-1NDK infection, indicating that the neg. charge was not the only requirement.  Mutations of Asp193 and of arginine residues (Arg183 and Arg188) of CXCR4 reduced the efficiency of HIV-1 infection for all HIV-1 strains tested.  Other ECL2 mutations tested had strain-specific effects or no apparent effect on HIV-1 infection.  The ECL2 mutants allowed the authors to identify residues contributing to the epitope of the 12G5 monoclonal antibody.  Overall, residues with different charges and interspersed in ECL2 seem to participate in the coreceptor activity of CXCR4.  This suggests that a conformational rather than linear epitope of ECL2 contributes to the HIV-1 binding site.  However, certain HIV-1 and FIV strains seem to require the presence of a particular ECL2 residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowuf8HIQfjwLVg90H21EOLACvtfcHk0lhP_emFyuiiMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFygu7Y%253D&md5=eb8739cd8cefbd8737286ae53c7e4282</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrelot%26aufirst%3DA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DAdema%26aufirst%3DK.%26aulast%3DHosie%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DB.%26aulast%3DAlizon%26aufirst%3DM.%26atitle%3DEffect%2520of%2520mutations%2520in%2520the%2520second%2520extracellular%2520loop%2520of%2520CXCR4%2520on%2520its%2520utilization%2520by%2520human%2520and%2520feline%2520immunodeficiency%2520viruses%26jtitle%3DJ.%2520Virol.%26date%3D1999%26volume%3D73%26spage%3D2576%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure-function of the G protein-coupled receptor superfamily</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1146/annurev-pharmtox-032112-135923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1146%2Fannurev-pharmtox-032112-135923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=23140243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=531-556&author=V.+Katritchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure-function+of+the+G+protein-coupled+receptor+superfamily&doi=10.1146%2Fannurev-pharmtox-032112-135923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function of the G protein-coupled receptor superfamily</span></div><div class="casAuthors">Katritch, Vsevolod; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">531-556</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  During the past few years, crystallog. of G protein-coupled receptors (GPCRs) has experienced exponential growth, resulting in the detn. of the structures of 16 distinct receptors-9 of them in 2012 alone.  Including closely related subtype homol. models, this coverage amts. to approx. 12% of the human GPCR superfamily.  The adrenergic, rhodopsin, and adenosine receptor systems are also described by agonist-bound active-state structures, including a structure of the receptor-G protein complex for the β2-adrenergic receptor.  Biochem. and biophys. techniques, such as NMR and hydrogen-deuterium exchange coupled with mass spectrometry, are providing complementary insights into ligand-dependent dynamic equil. between different functional states.  Addnl. details revealed by high-resoln. structures illustrate the receptors as allosteric machines that are controlled not only by ligands but also by ions, lipids, cholesterol, and water.  This wealth of data is helping redefine the authors' knowledge of how GPCRs recognize such a diverse array of ligands and how they transmit signals 30 angstroms across the cell membrane; it also is shedding light on a structural basis of GPCR allosteric modulation and biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmUVW-rEZbvrVg90H21EOLACvtfcHk0lho6I7s6hxmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wgurc%253D&md5=5e8c26100a9eb33a32755af09199138d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-032112-135923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-032112-135923%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-function%2520of%2520the%2520G%2520protein-coupled%2520receptor%2520superfamily%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D531%26epage%3D556%26doi%3D10.1146%2Fannurev-pharmtox-032112-135923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Bridger, G. J.; Skerlj, R. T.</span><span> </span><span class="NLM_article-title">Bicyclam derivatives as HIV inhibitors</span>. In  <span class="citation_source-book">Advances in Antiviral Drug Design</span>; <span class="NLM_contrib-group">De Clercq, E.</span>, Ed.; <span class="NLM_publisher-name">JAI Press</span>: <span class="NLM_publisher-loc">Stamford, CT, USA</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>Vol. 3, pp  <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1075-8593%2899%2980007-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=161-229&author=G.+J.+Bridger&author=R.+T.+Skerljauthor=E.+De+Clercq&title=Advances+in+Antiviral+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1075-8593%2899%2980007-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1075-8593%252899%252980007-0%26sid%3Dliteratum%253Aachs%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26atitle%3DBicyclam%2520derivatives%2520as%2520HIV%2520inhibitors%26btitle%3DAdvances%2520in%2520Antiviral%2520Drug%2520Design%26aulast%3DDe%2BClercq%26aufirst%3DE.%26pub%3DJAI%2520Press%26date%3D1999%26spage%3D161%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>Schrödinger Suite 2012 Induced Fit Docking protocol; Glide version 5.8, S., LLC, New York, NY, 2012; Prime version 3.1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012+Induced+Fit+Docking+protocol%3B+Glide+version+5.8%2C+S.%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Prime+version+3.1%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Dragic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajumo, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmar, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span> </span><span class="NLM_article-title">A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5639</span><span class="NLM_x">–</span> <span class="NLM_lpage">5644</span><span class="refDoi"> DOI: 10.1073/pnas.090576697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.090576697" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5639-5644&author=T.+Dragicauthor=A.+Trkolaauthor=D.+A.+D.+Thompsonauthor=E.+G.+Cormierauthor=F.+A.+Kajumoauthor=E.+Maxwellauthor=S.+W.+Linauthor=W.+W.+Yingauthor=S.+O.+Smithauthor=T.+P.+Sakmarauthor=J.+P.+Moore&title=A+binding+pocket+for+a+small+molecule+inhibitor+of+HIV-1+entry+within+the+transmembrane+helices+of+CCR5&doi=10.1073%2Fpnas.090576697"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.090576697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.090576697%26sid%3Dliteratum%253Aachs%26aulast%3DDragic%26aufirst%3DT.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DD.%2BA.%2BD.%26aulast%3DCormier%26aufirst%3DE.%2BG.%26aulast%3DKajumo%26aufirst%3DF.%2BA.%26aulast%3DMaxwell%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DS.%2BW.%26aulast%3DYing%26aufirst%3DW.%2BW.%26aulast%3DSmith%26aufirst%3DS.%2BO.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DA%2520binding%2520pocket%2520for%2520a%2520small%2520molecule%2520inhibitor%2520of%2520HIV-1%2520entry%2520within%2520the%2520transmembrane%2520helices%2520of%2520CCR5%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5639%26epage%3D5644%26doi%3D10.1073%2Fpnas.090576697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Tsamis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajumo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span> </span><span class="NLM_article-title">Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5201</span><span class="NLM_x">–</span> <span class="NLM_lpage">5208</span><span class="refDoi"> DOI: 10.1128/JVI.77.9.5201-5208.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.77.9.5201-5208.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=12692222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFykur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=5201-5208&author=F.+Tsamisauthor=S.+Gavrilovauthor=F.+Kajumoauthor=C.+Seibertauthor=S.+Kuhmannauthor=T.+Ketasauthor=A.+Trkolaauthor=A.+Palaniauthor=J.+W.+Claderauthor=J.+R.+Tagat&title=Analysis+of+the+mechanism+by+which+the+small-molecule+CCR5+antagonists+SCH-351125+and+SCH-350581+inhibit+human+immunodeficiency+virus+type+1+entry&doi=10.1128%2FJVI.77.9.5201-5208.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry</span></div><div class="casAuthors">Tsamis, Fotini; Gavrilov, Svetlana; Kajumo, Francis; Seibert, Christoph; Kuhmann, Shawn; Ketas, Tom; Trkola, Alexandra; Palani, Anadan; Clader, John W.; Tagat, Jayaram R.; McCombie, Stuart; Baroudy, Bahige; Moore, John P.; Sakmar, Thomas P.; Dragic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5201-5208</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the consecutive interaction of the envelope glycoprotein gp120 with CD4 and a coreceptor such as CCR5 or CXCR4.  The CCR5 coreceptor is used by the most commonly transmitted HIV-1 strains that often persist throughout the course of infection.  Compds. targeting CCR5-mediated entry are a novel class of drugs being developed to treat HIV-1 infection.  In this study, we have identified the mechanism of action of two inhibitors of CCR5 function, SCH-350581 (AD101) and SCH-351125 (SCH-C).  AD101 is more potent than SCH-C at inhibiting HIV-1 replication in primary lymphocytes, as well as viral entry and gp120 binding to cell lines.  Both mols. also block the binding of several anti-CCR5 monoclonal antibodies that recognize epitopes in the second extracellular loop of CCR5.  Alanine mutagenesis of the transmembrane domain of CCR5 suggests that AD101 and SCH-C bind to overlapping but nonidentical sites within a putative ligand-binding cavity formed by transmembrane helixes 1, 2, 3, and 7.  We propose that the binding of small mols. to the transmembrane domain of CCR5 may disrupt the conformation of its extracellular domain, thereby inhibiting ligand binding to CCR5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGjIUAj5eebVg90H21EOLACvtfcHk0lho6I7s6hxmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFykur0%253D&md5=976ed3aaec6c49cb5ff43d35ebaf9030</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.9.5201-5208.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.9.5201-5208.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTsamis%26aufirst%3DF.%26aulast%3DGavrilov%26aufirst%3DS.%26aulast%3DKajumo%26aufirst%3DF.%26aulast%3DSeibert%26aufirst%3DC.%26aulast%3DKuhmann%26aufirst%3DS.%26aulast%3DKetas%26aufirst%3DT.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26atitle%3DAnalysis%2520of%2520the%2520mechanism%2520by%2520which%2520the%2520small-molecule%2520CCR5%2520antagonists%2520SCH-351125%2520and%2520SCH-350581%2520inhibit%2520human%2520immunodeficiency%2520virus%2520type%25201%2520entry%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D5201%26epage%3D5208%26doi%3D10.1128%2FJVI.77.9.5201-5208.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GluVII:06 - A highly conserved and selective anchor point for non-peptide ligands in chemokine receptors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.2174/15680266106061319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F15680266106061319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16918451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Sltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1319-1333&author=M.+M.+Rosenkildeauthor=T.+W.+Schwartz&title=GluVII%3A06+-+A+highly+conserved+and+selective+anchor+point+for+non-peptide+ligands+in+chemokine+receptors&doi=10.2174%2F15680266106061319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">GluVII:06 - a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors</span></div><div class="casAuthors">Rosenkilde, Mette M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1319-1333</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A majority of small mol. non-peptide ligands for chemokine receptors in general are characterized by the presence of one or two centrally located, pos. charged nitrogen atoms and these compds. are also often of relatively similar elongated overall structure with terminal arom. moieties.  In the corresponding main ligand-binding crevice of the chemokine 7TM receptors is found a centrally located glutamic acid residue in position 6 of transmembrane segment VII in 74% of the chemokine receptors but only in approx. 1% of non-chemokine receptors.  GluVII:06 has been demonstrated to be crucially important for the binding and action of a no. of non-peptide ligands in for example the CCR1, CCR2 and CCR5 receptors.  It is proposed that in chemokine receptors in general GluVII:06 serves as a selective anchor point for the centrally located, pos. charged nitrogen of the small mol. ligands and that the two peripheral chem. moieties of the ligands from this central point in the receptor structure explore each of the two halves of the main ligand binding pocket.  It is envisioned that knowledge of this binding mode can be exploited in structure-based discovery and design of novel chemokine receptor ligands and esp. ligands with specifically optimized properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsOUUuijOKG7Vg90H21EOLACvtfcHk0lhYR1l2FiBC6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Sltr8%253D&md5=07b855d5056c78d049a6ba88f51ec9a9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F15680266106061319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266106061319%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGluVII%253A06%2520-%2520A%2520highly%2520conserved%2520and%2520selective%2520anchor%2520point%2520for%2520non-peptide%2520ligands%2520in%2520chemokine%2520receptors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1319%26epage%3D1333%26doi%3D10.2174%2F15680266106061319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span> </span><span class="NLM_article-title">Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4–FC131 interactions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2150</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bmcl.2012.01.134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2146-2150&author=Y.+Yoshikawaauthor=K.+Kobayashiauthor=S.+Oishiauthor=N.+Fujiiauthor=T.+Furuya&title=Molecular+modeling+study+of+cyclic+pentapeptide+CXCR4+antagonists%3A+New+insight+into+CXCR4%E2%80%93FC131+interactions&doi=10.1016%2Fj.bmcl.2012.01.134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.134%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DFuruya%26aufirst%3DT.%26atitle%3DMolecular%2520modeling%2520study%2520of%2520cyclic%2520pentapeptide%2520CXCR4%2520antagonists%253A%2520New%2520insight%2520into%2520CXCR4%25E2%2580%2593FC131%2520interactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2146%26epage%3D2150%26doi%3D10.1016%2Fj.bmcl.2012.01.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Glickman, F.; Streiff, M.; Thoma, G.; Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Preparation of thiazolyl isothiourea derivatives as CXCR4 antagonists</span>. WO2005085219A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Glickman&author=M.+Streiff&author=G.+Thoma&author=H.-G.+Zerwes&title=Preparation+of+thiazolyl+isothiourea+derivatives+as+CXCR4+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGlickman%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520thiazolyl%2520isothiourea%2520derivatives%2520as%2520CXCR4%2520antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span> </span><span class="NLM_article-title">Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.+G.+Zerwes&title=Orally+bioavailable+isothioureas+block+function+of+the+chemokine+receptor+CXCR4+in+vitro+and+in+vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26atitle%3DOrally%2520bioavailable%2520isothioureas%2520block%2520function%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benned-Jensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">The minor binding pocket: a major player in 7TM receptor activation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.tips.2010.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20870300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=567-574&author=M.+M.+Rosenkildeauthor=T.+Benned-Jensenauthor=T.+M.+Frimurerauthor=T.+W.+Schwartz&title=The+minor+binding+pocket%3A+a+major+player+in+7TM+receptor+activation&doi=10.1016%2Fj.tips.2010.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The minor binding pocket: a major player in 7TM receptor activation</span></div><div class="casAuthors">Rosenkilde, Mette M.; Benned-Jensen, Tau; Frimurer, Thomas M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  From the deep part of the main ligand-binding crevice, a minor, often shallower pocket extends between the extracellular ends of transmembrane domains (TM)-I, II, III and VII of seven-transmembrane/G protein-coupled receptors (7TM receptors).  This minor binding pocket is defined by a highly conserved kink in TM-II that is induced by a Pro residue located in 1 of 2 adjacent positions.  Here, the authors argue that this minor binding pocket is important for receptor activation.  Functional coupling of the receptors seems to be mediated through the H-bond network located between the intracellular segments of these TMs, with the allosteric interface between TM-II and TM-VII being of particular significance.  Importantly, the minor binding pocket, esp. the Pro-kink in TM-II, is involved in G protein vs. arrestin pathway-biased signaling, e.g., in the angiotensin AT1 system.  Consequently, this pocket could be specifically targeted in the development of functionally biased drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrk7NyRGRgx7Vg90H21EOLACvtfcHk0lhYR1l2FiBC6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbF&md5=9cdf07a4741b7184f754ae609d6f9882</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DBenned-Jensen%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DThe%2520minor%2520binding%2520pocket%253A%2520a%2520major%2520player%2520in%25207TM%2520receptor%2520activation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D567%26epage%3D574%26doi%3D10.1016%2Fj.tips.2010.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforovich, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2006.00387.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fj.1747-0285.2006.00387.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16784459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=346-354&author=J.+V%C3%A5ben%C3%B8author=G.+V.+Nikiforovichauthor=G.+R.+Marshall&title=Insight+into+the+binding+mode+for+cyclopentapeptide+antagonists+of+the+CXCR4+receptor&doi=10.1111%2Fj.1747-0285.2006.00387.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor</span></div><div class="casAuthors">Vabeno, Jon; Nikiforovich, Gregory V.; Marshall, Garland R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-354</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The finding that the chemokine receptor CXCR4 is involved in T-cell HIV entry has encouraged the development of antiretroviral drugs targeting this receptor.  Addnl. evidence that CXCR4 plays a crucial role in both angiogenesis and metastasis provides further motivation for the development of a CXCR4 inhibitor for therapeutic applications in oncol.  To facilitate the design of such ligands, the authors have investigated the possible binding modes for cyclopentapeptide CXCR4 antagonists by docking 11 high/medium affinity cyclopentapeptides to a developed three-dimensional model of the CXCR4 G-protein-coupled receptor's transmembrane region.  These ligands, expected to bind in the same mode to the receptor, were docked in the previously deduced receptor-bound conformation.  Ligand-receptor complexes were generated using an automated docking procedure that allowed ligand flexibility.  By comparing the resulting ligand poses, only two binding modes common for all 11 compds. were identified.  Inspection of these two ligand-receptor complexes identified several CXCR4 contact residues shown by mutation to be interaction sites for ligands and important for HIV gp120 binding.  Thus, the results provide further insight into the mechanism by which these cyclopentapeptides block HIV entry as well as a basis for rational design of CXCR4 mutants to map potential contacts with small peptide ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3r4H9kvXV8LVg90H21EOLACvtfcHk0ljLk6-T6WTwGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsb0%253D&md5=9fa48118baf007cdcf5f125bbec86027</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00387.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00387.x%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DNikiforovich%26aufirst%3DG.%2BV.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DInsight%2520into%2520the%2520binding%2520mode%2520for%2520cyclopentapeptide%2520antagonists%2520of%2520the%2520CXCR4%2520receptor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D346%26epage%3D354%26doi%3D10.1111%2Fj.1747-0285.2006.00387.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Kawatkar, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span><span class="refDoi"> DOI: 10.1258/ebm.2011.010345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1258%2Febm.2011.010345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFeqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2011&pages=844-850&author=S.+P.+Kawatkarauthor=M.+Yanauthor=H.+Gevariyaauthor=M.+Y.+Limauthor=S.+Eisoldauthor=X.+Zhuauthor=Z.+Huangauthor=J.+An&title=Computational+analysis+of+the+structural+mechanism+of+inhibition+of+chemokine+receptor+CXCR4+by+small+molecule+antagonists&doi=10.1258%2Febm.2011.010345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists</span></div><div class="casAuthors">Kawatkar, Sameer P.; Yan, Maocai; Gevariya, Harsukh; Lim, Mi Youn; Eisold, Steven; Zhu, Xuejun; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Understanding the structural mechanism of receptor-ligand interactions for the chemokine receptor CXCR4 is essential for detg. its physiol. and pathol. functions and for developing new therapies targeted to CXCR4.  We have recently reported a structural mechanism for CXCR4 antagonism by a novel synthetic CXCR4 antagonist RCP168 and compared its effectiveness against the natural agonist SDF-1α.  In the present study, using mol. docking, we further investigate the binding modes of another seven small mols. known to act as CXCR4 antagonists.  The predicted binding modes were compared with previously published mutagenesis data for two of these (AMD3100 and AMD11070).  Four antagonists, including AMD3100, AMD11070, FC131 and KRH-1636, bound in a similar fashion to CXCR4.  Two important acidic amino acid residues (Asp262 and Glu288) on CXCR4, previously found essential for AMD3100 binding, were also involved in binding of the other ligands.  These four antagonists use a binding site in common with that used by RCP168, which is a novel synthetic deriv. of vMIP-II in which the first 10 residues are replaced by D-amino acids.  Comparison of binding modes modes suggested that this binding site is different from the binding region occupied by the N-terminus of SDF-1α, the only known natural ligand of CXCR4.  These observations suggest the presence of a ligand-binding site (site A) that co-exists with the agonist (SDF-1α) binding site (site B).  The other three antagonists, including MSX123, MSX202 and WZ811, are smaller in size and had very similar binding poses, but binding was quite different from that of AMD3100.  These three antagonists bound at both sites A and B, thereby blocking both binding and signaling by SDF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfkXAYLzEAYbVg90H21EOLACvtfcHk0ljLk6-T6WTwGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFeqsr0%253D&md5=8e850ef27c28acd34e0e372e8ec3c027</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1258%2Febm.2011.010345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2011.010345%26sid%3Dliteratum%253Aachs%26aulast%3DKawatkar%26aufirst%3DS.%2BP.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DM.%2BY.%26aulast%3DEisold%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DComputational%2520analysis%2520of%2520the%2520structural%2520mechanism%2520of%2520inhibition%2520of%2520chemokine%2520receptor%2520CXCR4%2520by%2520small%2520molecule%2520antagonists%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2011%26volume%3D236%26spage%3D844%26epage%3D850%26doi%3D10.1258%2Febm.2011.010345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Planesas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Nueno, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, J.</span><span> </span><span class="NLM_article-title">Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2012.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.jmgm.2012.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslaqtbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=123-136&author=J.+M.+Planesasauthor=V.+I.+Perez-Nuenoauthor=J.+I.+Borrellauthor=J.+Teixido&title=Impact+of+the+CXCR4+structure+on+docking-based+virtual+screening+of+HIV+entry+inhibitors&doi=10.1016%2Fj.jmgm.2012.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors</span></div><div class="casAuthors">Planesas, Jesus M.; Perez-Nueno, Violeta I.; Borrell, Jose I.; Teixido, Jordi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Herein we analyze in depth the receptor-based virtual screening (VS) performance of the five recent crystd. CXCR4 structures along with a CXCR4 rhodopsin-based homol. model.  All CXCR4 Protein Data Bank (PDB) structures are co-crystd. with a small org. antagonist except structure 3OE0, which is co-crystd. with a cyclic peptide analog.  Evaluation of the CXCR4 models was done by retrospective docking-based VS using a test set of 248 known CXCR4 inhibitors from 4 different chemotype families and 4696 different presumed inactives.  The performance of the docking protocol using the five different protein structures was assessed in terms of pose prediction and hits detection using 12 different docking scoring functions and a scoring function with rescoring.  Results show that 3OE6 structure achieves the highest docking-based performance with an av. area under the curve (aAUC) of 0.84 and an av. enrichment factor (aEF) of 11.7 at 1% of decoys screened.  CXCR4 rhodopsin-like homol. model performs comparable to the crystd. structures in the 1% of database screened.  Moreover, a detailed anal. of the retrospective docking results using the CXCR4 homol. model in Discovery Studio allows us to hypothesize the existence of multiple binding sub-sites in CXCR4 binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuixBpt21UArVg90H21EOLACvtfcHk0ljLk6-T6WTwGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslaqtbrL&md5=068fb63baa9a866700b5ce0404da3a6b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2012.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2012.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DPlanesas%26aufirst%3DJ.%2BM.%26aulast%3DPerez-Nueno%26aufirst%3DV.%2BI.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26aulast%3DTeixido%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520the%2520CXCR4%2520structure%2520on%2520docking-based%2520virtual%2520screening%2520of%2520HIV%2520entry%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2012%26volume%3D38%26spage%3D123%26epage%3D136%26doi%3D10.1016%2Fj.jmgm.2012.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Leonard, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">The HIV entry inhibitors revisited</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.2174/092986706776361030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F092986706776361030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16611075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=911-934&author=J.+T.+Leonardauthor=K.+Roy&title=The+HIV+entry+inhibitors+revisited&doi=10.2174%2F092986706776361030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV entry inhibitors revisited</span></div><div class="casAuthors">Leonard, J. Thomas; Roy, Kunal</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">911-934</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The new generation of antiviral drugs intended to counter HIV-1 entry into susceptible cells is emerging swiftly.  The antiviral agents that inhibit HIV entry to the target cells (denoted as HIV entry inhibitors) are already in different phases of clin. trials.  Operating early in the viral life cycle, they prevent viral entry, and have a novel, highly specific mechanism of action with a low toxicity profile.  Entry inhibitors have different toxicity and resistance profiles than the existing reverse transcriptase and protease inhibitors.  Some of these compds. demonstrated in vitro synergism with other classes of antivirals, thus offering the rationale for their combination in therapies for HIV-infected individuals.  It is worth focusing on recent developments in HIV entry inhibitors, as most of the current drug regimens suffer from the events of developing resistance against existing combination therapies.  Recent advances in the understanding of the cellular and mol. mechanisms of HIV-1 entry provide the basis for novel therapeutic strategies that prevent viral penetration of the target cell membrane, while reducing detrimental virus and treatment effects on cells and prolonging virion exposure to immune defenses.  A no. of potential sites for therapeutic intervention become accessible during the narrow window between virus attachment and the subsequent fusion of viral envelope with the cell membrane.  The HIV-1 coreceptors are particularly attractive from the perspective of identifying new antiviral compds., since they are seven-transmembrane motif G protein-coupled receptors (GPCRs), a family of proteins that is a well-validated target for drug development.  Among the many chemokine receptors that can mediate HIV-1 entry in vitro, only CCR5 and CXCR4 are of frontline pharmacol. importance.  In particular, CCR5 is essential for viral transmission and replication during the early and clin. latent phase of disease.  Several small-mol. antagonists of CCR5 and CXCR4 that block chemokine binding and HIV-1 entry have been identified in recent years.  Considerable advances have been made in the last years in the design of derivs. acting as inhibitors of HIV entry.  The mol. mechanism involved in viral entry and the structural and functional aspects of entry inhibitors are reviewed here.  The authors have also summarized the recent insights into how small-mol. antagonists interact with CCR5 and CXCR4, focusing on drug development programs that are well documented in the scientific literature.  An overview of the entry inhibitors that are in preclin. or early clin. development, and the Quant. Structure-Activity Relationship (QSAR) studies reported for the coreceptor antagonists, are also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDvFH6SyMb3LVg90H21EOLACvtfcHk0ljLk6-T6WTwGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygsb0%253D&md5=cae6cfe2914af301548e33e4e9754893</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2174%2F092986706776361030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361030%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DJ.%2BT.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DThe%2520HIV%2520entry%2520inhibitors%2520revisited%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D911%26epage%3D934%26doi%3D10.2174%2F092986706776361030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1620</span><span class="refDoi"> DOI: 10.1002/cbic.201402056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fcbic.201402056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1614-1620&author=B.+D.+Coxauthor=A.+R.+Prosserauthor=B.+M.+Katzmanauthor=A.+A.+Alcarazauthor=D.+C.+Liottaauthor=L.+J.+Wilsonauthor=J.+P.+Snyder&title=Anti-HIV+small-molecule+binding+in+the+peptide+subpocket+of+the+CXCR4%3ACVX15+crystal+structure&doi=10.1002%2Fcbic.201402056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402056%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DAnti-HIV%2520small-molecule%2520binding%2520in%2520the%2520peptide%2520subpocket%2520of%2520the%2520CXCR4%253ACVX15%2520crystal%2520structure%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26spage%3D1614%26epage%3D1620%26doi%3D10.1002%2Fcbic.201402056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, F.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Functional characterization of a series of mutant G protein αq subunits displaying promiscuous receptor coupling properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17886</span><span class="NLM_x">–</span> <span class="NLM_lpage">17892</span><span class="refDoi"> DOI: 10.1074/jbc.273.28.17886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.273.28.17886" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17886-17892&author=E.+Kostenisauthor=F.-Y.+Zengauthor=J.+Wess&title=Functional+characterization+of+a+series+of+mutant+G+protein+%CE%B1q+subunits+displaying+promiscuous+receptor+coupling+properties&doi=10.1074%2Fjbc.273.28.17886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.28.17886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.28.17886%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DZeng%26aufirst%3DF.-Y.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DFunctional%2520characterization%2520of%2520a%2520series%2520of%2520mutant%2520G%2520protein%2520%25CE%25B1q%2520subunits%2520displaying%2520promiscuous%2520receptor%2520coupling%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17886%26epage%3D17892%26doi%3D10.1074%2Fjbc.273.28.17886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Ho, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. R.</span><span> </span><span class="NLM_article-title">Site-directed mutagenesis by overlap extension using the polymerase chain reaction</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1016/0378-1119(89)90358-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2F0378-1119%2889%2990358-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=2744487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaL1MXktVaitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1989&pages=51-59&author=S.+N.+Hoauthor=H.+D.+Huntauthor=R.+M.+Hortonauthor=J.+K.+Pullenauthor=L.+R.+Pease&title=Site-directed+mutagenesis+by+overlap+extension+using+the+polymerase+chain+reaction&doi=10.1016%2F0378-1119%2889%2990358-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed mutagenesis by overlap extension using the polymerase chain reaction</span></div><div class="casAuthors">Ho, Steffan N.; Hunt, Henry D.; Horton, Robert M.; Pullen, Jeffrey K.; Pease, Larry R.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">Overlap extension represents a new approach to genetic engineering.  Complementary oligodeoxyribonucleotide (oligo) primers and the polymerase chain reaction are used to generate two DNA fragments having overlapping ends.  These fragments are combined in a subsequent fusion reaction in which the overlapping ends anneal, allowing the 3' overlap of each strand to serve as a primer for the 3' extension of the complementary strand.  The resulting fusion product is amplified further by PCR.  Specific alterations in the nucleotide (nt) sequence can be introduced by incorporating nucleotide changes into the overlapping oligo primers.  Using this technique of site-directed mutagenesis, 3 variants of a mouse major histocompatibility complex class-I gene have been generated, cloned and analyzed.  Screening of mutant clones revealed at least a 98% efficiency of mutagenesis.  All clones sequenced contained the desired mutations, and a low frequency of random substitution estd. to occur at approx. 1 in 400 nt was detected.  This method represents a significant improvement over std. methods of site-directed mutagenesis because it is much faster, simpler and approaches 100% efficiency in the generation of mutant product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqebn9qfaVP9rVg90H21EOLACvtfcHk0lgjNxF8Id91Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVaitrk%253D&md5=a2587cbdaec79a12306c022825570e19</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2889%2990358-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252889%252990358-2%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BN.%26aulast%3DHunt%26aufirst%3DH.%2BD.%26aulast%3DHorton%26aufirst%3DR.%2BM.%26aulast%3DPullen%26aufirst%3DJ.%2BK.%26aulast%3DPease%26aufirst%3DL.%2BR.%26atitle%3DSite-directed%2520mutagenesis%2520by%2520overlap%2520extension%2520using%2520the%2520polymerase%2520chain%2520reaction%26jtitle%3DGene%26date%3D1989%26volume%3D77%26spage%3D51%26epage%3D59%26doi%3D10.1016%2F0378-1119%2889%2990358-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldhoer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norregaard, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span> </span><span class="NLM_article-title">A highly conserved glycine within linker I and the extreme C terminus of G protein α subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1124/jpet.104.080424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1124%2Fjpet.104.080424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=15615862" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2004&pages=78-87&author=E.+Kostenisauthor=L.+Martiniauthor=J.+Ellisauthor=M.+Waldhoerauthor=A.+Heydornauthor=M.+M.+Rosenkildeauthor=P.+K.+Norregaardauthor=R.+Jorgensenauthor=J.+L.+Whistlerauthor=G.+Milligan&title=A+highly+conserved+glycine+within+linker+I+and+the+extreme+C+terminus+of+G+protein+%CE%B1+subunits+interact+cooperatively+in+switching+G+protein-coupled+receptor-to-effector+specificity&doi=10.1124%2Fjpet.104.080424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.080424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.080424%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DMartini%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DWaldhoer%26aufirst%3DM.%26aulast%3DHeydorn%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DNorregaard%26aufirst%3DP.%2BK.%26aulast%3DJorgensen%26aufirst%3DR.%26aulast%3DWhistler%26aufirst%3DJ.%2BL.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520highly%2520conserved%2520glycine%2520within%2520linker%2520I%2520and%2520the%2520extreme%2520C%2520terminus%2520of%2520G%2520protein%2520%25CE%25B1%2520subunits%2520interact%2520cooperatively%2520in%2520switching%2520G%2520protein-coupled%2520receptor-to-effector%2520specificity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D313%26spage%3D78%26epage%3D87%26doi%3D10.1124%2Fjpet.104.080424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Schrödinger</span><span class="NLM_x">. </span><a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a> (accessed July 27,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger.+http%3A%2F%2Fwww.schrodinger.com%2F+%28accessed+July+27%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span>Schrödinger Suite 2012 Protein Preparation Wizard; Epik version 2.2, S., LLC, New York, NY, 2012; Impact version 5.7, Schrödinger, LLC, New York, NY, 2012; Prime version 2.3.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012+Protein+Preparation+Wizard%3B+Epik+version+2.2%2C+S.%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Impact+version+5.7%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Prime+version+2.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Huang  Wu</span>, <span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Hsuan-Hao  Kuan</span>, <span class="hlFld-ContribAuthor ">Szu-Huei  Wu</span>, <span class="hlFld-ContribAuthor ">Ming-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Jiing-Jyh  Jan</span>, <span class="hlFld-ContribAuthor ">Lun K.  Tsou</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Chiung-Tong  Chen</span>, <span class="hlFld-ContribAuthor ">Kai-Chia  Yeh</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Chen-Tso  Tseng</span>, <span class="hlFld-ContribAuthor ">Chen-Lung  Huang</span>, <span class="hlFld-ContribAuthor ">Mine-Hsine  Wu</span>, <span class="hlFld-ContribAuthor ">Po-Chu  Kuo</span>, <span class="hlFld-ContribAuthor ">Chia-Jui  Lee</span>, and <span class="hlFld-ContribAuthor ">Kak-Shan  Shia</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Stem-Cell-Mobilizing Agents Targeting CXCR4 Receptor for Peripheral Blood Stem Cell Transplantation and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 818-833. <a href="https://doi.org/10.1021/acs.jmedchem.7b01322" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01322%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BStem-Cell-Mobilizing%252BAgents%252BTargeting%252BCXCR4%252BReceptor%252Bfor%252BPeripheral%252BBlood%252BStem%252BCell%252BTransplantation%252Band%252BBeyond%26aulast%3DWu%26aufirst%3DChien-Huang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D08092017%26date%3D27012018%26date%3D08022018%26date%3D09012018%26volume%3D61%26issue%3D3%26spage%3D818%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Salvatore  Di Maro</span>, <span class="hlFld-ContribAuthor ">Francesco Saverio  Di Leva</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Trotta</span>, <span class="hlFld-ContribAuthor ">Diego  Brancaccio</span>, <span class="hlFld-ContribAuthor ">Luigi  Portella</span>, <span class="hlFld-ContribAuthor ">Michela  Aurilio</span>, <span class="hlFld-ContribAuthor ">Stefano  Tomassi</span>, <span class="hlFld-ContribAuthor ">Anna  Messere</span>, <span class="hlFld-ContribAuthor ">Deborah  Sementa</span>, <span class="hlFld-ContribAuthor ">Secondo  Lastoria</span>, <span class="hlFld-ContribAuthor ">Alfonso  Carotenuto</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>, and <span class="hlFld-ContribAuthor ">Luciana  Marinelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9641-9652. <a href="https://doi.org/10.1021/acs.jmedchem.7b01062" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01062%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BBiological%252BCharacterization%252Bof%252Ba%252BNovel%25252C%252BPotent%25252C%252Band%252BSerum%252BStable%252BC-X-C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%252BAntagonist%26aulast%3DDi%2BMaro%26aufirst%3DSalvatore%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D24072017%26date%3D20112017%26date%3D14122017%26date%3D10112017%26volume%3D60%26issue%3D23%26spage%3D9641%26epage%3D9652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Arimont</span>, <span class="hlFld-ContribAuthor ">Shan-Liang  Sun</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Martine  Smit</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of Chemokine Receptor–Ligand Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (12)
                                     , 4735-4779. <a href="https://doi.org/10.1021/acs.jmedchem.6b01309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01309%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BAnalysis%252Bof%252BChemokine%252BReceptor%2525E2%252580%252593Ligand%252BInteractions%26aulast%3DArimont%26aufirst%3DMarta%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D31082016%26date%3D10032017%26date%3D22062017%26date%3D06022017%26volume%3D60%26issue%3D12%26spage%3D4735%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano  Tomassi</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Trotta</span>, <span class="hlFld-ContribAuthor ">Caterina  Ieranò</span>, <span class="hlFld-ContribAuthor ">Francesco  Merlino</span>, <span class="hlFld-ContribAuthor ">Anna  Messere</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Rea</span>, <span class="hlFld-ContribAuthor ">Federica  Santoro</span>, <span class="hlFld-ContribAuthor ">Diego  Brancaccio</span>, <span class="hlFld-ContribAuthor ">Alfonso  Carotenuto</span>, <span class="hlFld-ContribAuthor ">Vincenzo Maria  D'Amore</span>, <span class="hlFld-ContribAuthor ">Francesco Saverio  Di Leva</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Luciana  Marinelli</span>, <span class="hlFld-ContribAuthor ">Stefania  Scala</span>, <span class="hlFld-ContribAuthor ">Salvatore  Di Maro</span>. </span><span class="cited-content_cbyCitation_article-title">Disulfide Bond Replacement with 1,4‐ and 1,5‐Disubstituted [1,2,3]‐Triazole on C‐X‐C Chemokine Receptor Type 4 (CXCR4) Peptide Ligands: Small Changes that Make Big Differences. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (44)
                                     , 10113-10125. <a href="https://doi.org/10.1002/chem.202002468" title="DOI URL">https://doi.org/10.1002/chem.202002468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202002468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202002468%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDisulfide%252BBond%252BReplacement%252Bwith%252B1%25252C4%2525E2%252580%252590%252Band%252B1%25252C5%2525E2%252580%252590Disubstituted%252B%25255B1%25252C2%25252C3%25255D%2525E2%252580%252590Triazole%252Bon%252BC%2525E2%252580%252590X%2525E2%252580%252590C%252BChemokine%252BReceptor%252BType%252B4%252B%252528CXCR4%252529%252BPeptide%252BLigands%25253A%252BSmall%252BChanges%252Bthat%252BMake%252BBig%252BDifferences%26aulast%3DTomassi%26aufirst%3DStefano%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D44%26spage%3D10113%26epage%3D10125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiong  Fang</span>, <span class="hlFld-ContribAuthor ">Qian  Meng</span>, <span class="hlFld-ContribAuthor ">Huijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Boqiang  Liang</span>, <span class="hlFld-ContribAuthor ">Siyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Lina S.  Huang</span>, <span class="hlFld-ContribAuthor ">Xingquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert T.  Schooley</span>, <span class="hlFld-ContribAuthor ">Jing  An</span>, <span class="hlFld-ContribAuthor ">Yan  Xu</span>, <span class="hlFld-ContribAuthor ">Ziwei  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological characterization of a new class of symmetrical polyamine-based small molecule CXCR4 antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112410. <a href="https://doi.org/10.1016/j.ejmech.2020.112410" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112410%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bcharacterization%252Bof%252Ba%252Bnew%252Bclass%252Bof%252Bsymmetrical%252Bpolyamine-based%252Bsmall%252Bmolecule%252BCXCR4%252Bantagonists%26aulast%3DFang%26aufirst%3DXiong%26date%3D2020%26volume%3D200%26spage%3D112410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominique  Bruns</span>, <span class="hlFld-ContribAuthor ">Erik  Gawehn</span>, <span class="hlFld-ContribAuthor ">Karthiga Santhana  Kumar</span>, <span class="hlFld-ContribAuthor ">Petra  Schneider</span>, <span class="hlFld-ContribAuthor ">Martin  Baumgartner</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Synthetic Activators of Cancer Cell Migration by Hybrid Deep Learning. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (4)
                                     , 500-507. <a href="https://doi.org/10.1002/cbic.201900346" title="DOI URL">https://doi.org/10.1002/cbic.201900346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201900346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201900346%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DIdentification%252Bof%252BSynthetic%252BActivators%252Bof%252BCancer%252BCell%252BMigration%252Bby%252BHybrid%252BDeep%252BLearning%26aulast%3DBruns%26aufirst%3DDominique%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D4%26spage%3D500%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominique  Bruns</span>, <span class="hlFld-ContribAuthor ">Daniel  Merk</span>, <span class="hlFld-ContribAuthor ">Karthiga  Santhana Kumar</span>, <span class="hlFld-ContribAuthor ">Martin  Baumgartner</span>, <span class="hlFld-ContribAuthor ">Gisbert  Schneider</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Activators of Cell Migration Designed by Constructive Machine Learning. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2019,</strong> <em>8 </em>
                                    (10)
                                     , 1303-1308. <a href="https://doi.org/10.1002/open.201900222" title="DOI URL">https://doi.org/10.1002/open.201900222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.201900222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.201900222%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DSynthetic%252BActivators%252Bof%252BCell%252BMigration%252BDesigned%252Bby%252BConstructive%252BMachine%252BLearning%26aulast%3DBruns%26aufirst%3DDominique%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D10%26spage%3D1303%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  Adlere</span>, <span class="hlFld-ContribAuthor ">S.  Sun</span>, <span class="hlFld-ContribAuthor ">A.  Zarca</span>, <span class="hlFld-ContribAuthor ">L.  Roumen</span>, <span class="hlFld-ContribAuthor ">M.  Gozelle</span>, <span class="hlFld-ContribAuthor ">C. Perpiñá  Viciano</span>, <span class="hlFld-ContribAuthor ">B.  Caspar</span>, <span class="hlFld-ContribAuthor ">M.  Arimont</span>, <span class="hlFld-ContribAuthor ">J.P.  Bebelman</span>, <span class="hlFld-ContribAuthor ">S.J.  Briddon</span>, <span class="hlFld-ContribAuthor ">C.  Hoffmann</span>, <span class="hlFld-ContribAuthor ">S.J.  Hill</span>, <span class="hlFld-ContribAuthor ">M.J.  Smit</span>, <span class="hlFld-ContribAuthor ">H.F.  Vischer</span>, <span class="hlFld-ContribAuthor ">M.  Wijtmans</span>, <span class="hlFld-ContribAuthor ">C.  de Graaf</span>, <span class="hlFld-ContribAuthor ">I.J.P.  de Esch</span>, <span class="hlFld-ContribAuthor ">R.  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 631-649. <a href="https://doi.org/10.1016/j.ejmech.2018.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bexploration%252Band%252Bpharmacological%252Bevaluation%252Bof%252BN-substituted%252Bpiperidin-4-yl-methanamine%252BCXCR4%252Bchemokine%252Breceptor%252Bantagonists%26aulast%3DAdlere%26aufirst%3DI.%26date%3D2019%26volume%3D162%26spage%3D631%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Chemistry and Chemotherapy</span><span> <strong>2019,</strong> <em>27 </em>, 204020661982938. <a href="https://doi.org/10.1177/2040206619829382" title="DOI URL">https://doi.org/10.1177/2040206619829382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040206619829382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040206619829382%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Chemistry%2520and%2520Chemotherapy%26atitle%3DMozobil%2525C2%2525AE%252B%252528Plerixafor%25252C%252BAMD3100%252529%25252C%252B10%252Byears%252Bafter%252Bits%252Bapproval%252Bby%252Bthe%252BUS%252BFood%252Band%252BDrug%252BAdministration%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2019%26date%3D2019%26volume%3D27%26spage%3D204020661982938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dian  Peng</span>, <span class="hlFld-ContribAuthor ">Bin  Cao</span>, <span class="hlFld-ContribAuthor ">Ying-Jun  Zhou</span>, <span class="hlFld-ContribAuthor ">Ya-Qiu  Long</span>. </span><span class="cited-content_cbyCitation_article-title">The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>149 </em>, 148-169. <a href="https://doi.org/10.1016/j.ejmech.2018.02.043" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.043%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bchemical%252Bdiversity%252Band%252Bstructure-based%252Bevolution%252Bof%252Bnon-peptide%252BCXCR4%252Bantagonists%252Bwith%252Bdiverse%252Btherapeutic%252Bpotential%26aulast%3DPeng%26aufirst%3DDian%26date%3D2018%26volume%3D149%26spage%3D148%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fedora  Grande</span>, <span class="hlFld-ContribAuthor ">Gilda  Giancotti</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Ioele</span>, <span class="hlFld-ContribAuthor ">Maria A.  Occhiuzzi</span>, <span class="hlFld-ContribAuthor ">Antonio  Garofalo</span>. </span><span class="cited-content_cbyCitation_article-title">An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>139 </em>, 519-530. <a href="https://doi.org/10.1016/j.ejmech.2017.08.027" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.08.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.08.027%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Bupdate%252Bon%252Bsmall%252Bmolecules%252Btargeting%252BCXCR4%252Bas%252Bstarting%252Bpoints%252Bfor%252Bthe%252Bdevelopment%252Bof%252Banti-cancer%252Btherapeutics%26aulast%3DGrande%26aufirst%3DFedora%26date%3D2017%26volume%3D139%26spage%3D519%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leilei  Fu</span>, <span class="hlFld-ContribAuthor ">Shuya  Wang</span>, <span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Peiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yaxin  Zheng</span>, <span class="hlFld-ContribAuthor ">Dahong  Yao</span>, <span class="hlFld-ContribAuthor ">Mingrui  Guo</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-016-0007-2" title="DOI URL">https://doi.org/10.1038/s41598-016-0007-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-016-0007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-016-0007-2%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCrystal%252Bstructure-based%252Bdiscovery%252Bof%252Ba%252Bnovel%252Bsynthesized%252BPARP1%252Binhibitor%252B%252528OL-1%252529%252Bwith%252Bapoptosis-inducing%252Bmechanisms%252Bin%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DFu%26aufirst%3DLeilei%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of selected CXCR4 antagonists: (A) bicyclam AMD3100; (B) cyclopentapeptide FC131; (C) prototype arginine-based tripeptidomimetic <b>1</b>; (D) 16-mer peptide <b>2</b>; (E) isothiourea derivative <b>3</b>; (F) tetrahydroquinoline derivative <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of compounds <b>1</b> and <b>5</b>–<b>9</b>. The modified groups (R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>) in the lead compound <b>1</b> are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound 1<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) NaH, DMF, 0 °C; (ii) methyl 4-(bromomethyl)benzoate, DMF, 0 °C to room temperature; (b) 1 M NaOH/THF/MeOH (1:1:1); (c) (<i>S</i>)-1-(naphthalen-1-yl)ethanamine, PyBOP, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> 0 °C to room temperature; (d) Et<sub>2</sub>HN, DMF; (e) <b>11</b>, EDCI, HOBt, DMF; (f) TFA/TIS/H<sub>2</sub>O (95:2.5:2.5).</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures and reported potencies of the monocyclam AMD3465 and the two analogues <b>13</b> and <b>14</b>,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> also showing the structural analogy of these monocyclams with the R<sup>1</sup> substituent in compounds <b>1</b>, <b>5</b>, and <b>7</b> in the present study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A–C) Bar-graphs representations of fold reduction in potency (<i>F</i><sub>mut</sub>) for compounds <b>1</b>, <b>5</b>, and <b>6</b> for each mutant with respect to WT-CXCR4 (functional data, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Gray bars, mutants in TMs 1–4 and ECL2; black bars, mutants in TMs 5–7. (D–F) Residues identified to be important for the potency of compounds <b>1</b>, <b>5</b>, and <b>6</b> (functional data, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), shown in a helical wheel diagram of CXCR4. Red background color, >25-fold decrease; orange, 10–25-fold decrease; yellow, 5–10-fold decrease.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Ability of lead compound <b>1</b> and analogues <b>5</b> and <b>6</b> to inhibit CXCL12-induced activation of WT-CXCR4 and (B) to displace <sup>125</sup>I-12G5 from WT-CXCR4.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/medium/jm-2015-00987s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Effects of the H113A and D171N mutations on the inhibition of CXCL12-induced PI turnover by <b>1</b>. (B) Proposed binding model for <b>1</b>, showing the key interacting residues in CXCR4. The ligand is shown in orange sticks, the receptor in gray-white sticks and ribbons, and the water molecule as a red sphere; H-bonds are shown in magenta and π–π interactions in green. (C) Effects of the H281A and D262N mutations on the inhibition of CXCL12-induced PI turnover by <b>1</b>. (D) 2D representation of the docking pose for <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-20/acs.jmedchem.5b00987/20151016/images/large/jm-2015-00987s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00987&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88854" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88854" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Murphy, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charo, I. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hébert, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horuk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oppenheim, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, C. A.</span><span> </span><span class="NLM_article-title">International union of pharmacology. XXII. Nomenclature for chemokine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2000&pages=145-176&author=P.+M.+Murphyauthor=M.+Baggioliniauthor=I.+F.+Charoauthor=C.+A.+H%C3%A9bertauthor=R.+Horukauthor=K.+Matsushimaauthor=L.+H.+Millerauthor=J.+J.+Oppenheimauthor=C.+A.+Power&title=International+union+of+pharmacology.+XXII.+Nomenclature+for+chemokine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DP.%2BM.%26aulast%3DBaggiolini%26aufirst%3DM.%26aulast%3DCharo%26aufirst%3DI.%2BF.%26aulast%3DH%25C3%25A9bert%26aufirst%3DC.%2BA.%26aulast%3DHoruk%26aufirst%3DR.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DL.%2BH.%26aulast%3DOppenheim%26aufirst%3DJ.%2BJ.%26aulast%3DPower%26aufirst%3DC.%2BA.%26atitle%3DInternational%2520union%2520of%2520pharmacology.%2520XXII.%2520Nomenclature%2520for%2520chemokine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2000%26volume%3D52%26spage%3D145%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Laing, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secombes, C. J.</span><span> </span><span class="NLM_article-title">Chemokines</span> <span class="citation_source-journal">Dev. Comp. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span><span class="refDoi"> DOI: 10.1016/j.dci.2003.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.dci.2003.09.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2004&pages=443-460&author=K.+J.+Laingauthor=C.+J.+Secombes&title=Chemokines&doi=10.1016%2Fj.dci.2003.09.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.dci.2003.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dci.2003.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DLaing%26aufirst%3DK.%2BJ.%26aulast%3DSecombes%26aufirst%3DC.%2BJ.%26atitle%3DChemokines%26jtitle%3DDev.%2520Comp.%2520Immunol.%26date%3D2004%26volume%3D28%26spage%3D443%26epage%3D460%26doi%3D10.1016%2Fj.dci.2003.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Sugiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span> </span><span class="NLM_article-title">Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">988</span><span class="refDoi"> DOI: 10.1016/j.immuni.2006.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.immuni.2006.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=17174120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=977-988&author=T.+Sugiyamaauthor=H.+Koharaauthor=M.+Nodaauthor=T.+Nagasawa&title=Maintenance+of+the+hematopoietic+stem+cell+pool+by+CXCL12-CXCR4+chemokine+signaling+in+bone+marrow+stromal+cell+niches&doi=10.1016%2Fj.immuni.2006.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches</span></div><div class="casAuthors">Sugiyama, Tatsuki; Kohara, Hiroshi; Noda, Mamiko; Nagasawa, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">977-988</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">In the bone marrow, the special microenvironment niches nurture a pool of hematopoietic stem cells (HSCs).  Many HSCs reside near the vasculature, but the mol. regulatory mechanism of niches for HSC maintenance remains unclear.  Here the authors showed that the induced deletion of CXCR4, a receptor for CXC chemokine ligand (CXCL) 12 in adult mice, resulted in severe redn. of HSC nos. and increased sensitivity to myelotoxic injury, although it did not impair expansion of the more mature progenitors.  Most HSCs were found in contact with the cells expressing high amts. of CXCL12, which the authors have called CXCL12-abundant reticular (CAR) cells.  CAR cells surrounded sinusoidal endothelial cells or were located near the endosteum.  CXCL12-CXCR4 signaling plays an essential role in maintaining the quiescent HSC pool, and CAR cells appear to be a key component of HSC niches, including both vascular and endosteal niches in adult bone marrow.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-fmlTq8fMPbVg90H21EOLACvtfcHk0ljQFpE_rSR1vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFehsg%253D%253D&md5=61fbe88427e33601f8d3b72a7d94253f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2006.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2006.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DT.%26aulast%3DKohara%26aufirst%3DH.%26aulast%3DNoda%26aufirst%3DM.%26aulast%3DNagasawa%26aufirst%3DT.%26atitle%3DMaintenance%2520of%2520the%2520hematopoietic%2520stem%2520cell%2520pool%2520by%2520CXCL12-CXCR4%2520chemokine%2520signaling%2520in%2520bone%2520marrow%2520stromal%2520cell%2520niches%26jtitle%3DImmunity%26date%3D2006%26volume%3D25%26spage%3D977%26epage%3D988%26doi%3D10.1016%2Fj.immuni.2006.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ward, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwick, J.</span><span> </span><span class="NLM_article-title">Chemokines: understanding their role in T-lymphocyte biology</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">333</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span><span class="refDoi"> DOI: 10.1042/bj3330457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1042%2Fbj3330457" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=333&publication_year=1998&pages=457-470&author=S.+G.+Wardauthor=J.+Westwick&title=Chemokines%3A+understanding+their+role+in+T-lymphocyte+biology&doi=10.1042%2Fbj3330457"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1042%2Fbj3330457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3330457%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BG.%26aulast%3DWestwick%26aufirst%3DJ.%26atitle%3DChemokines%253A%2520understanding%2520their%2520role%2520in%2520T-lymphocyte%2520biology%26jtitle%3DBiochem.%2520J.%26date%3D1998%26volume%3D333%26spage%3D457%26epage%3D470%26doi%3D10.1042%2Fbj3330457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Horuk, R.</span><span> </span><span class="NLM_article-title">Chemokine receptors</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span><span class="refDoi"> DOI: 10.1016/S1359-6101(01)00014-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1359-6101%2801%2900014-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=11544102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFChtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=313-335&author=R.+Horuk&title=Chemokine+receptors&doi=10.1016%2FS1359-6101%2801%2900014-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokine receptors</span></div><div class="casAuthors">Horuk, R.</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">313-335</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Although chemokines were originally defined as host defense proteins it is now clear that their repertoire of functions extend well beyond this role.  For example chemokines such as MGSA have growth regulatory properties while members of the CXC chemokine family can be mediators or inhibitors of angiogenesis and may be important targets for oncol.  Recent work shows that the chemokine receptor CXCR4 and its cognate ligand SDF play important roles in the development of the immune, circulatory, and central nervous systems.  In addn., chemokine receptors play an important role in the pathogenesis of the AIDS virus, HIV-1.  Taken together, these findings expand the biol. importance of chemokines from that of simple immune modulators to a much broader biol. role than was at first appreciated and these and other properties of the chemokine receptor family are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5yVUY1wRsbVg90H21EOLACvtfcHk0lhNgxo_MIvsfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFChtLw%253D&md5=b828ebf6fcb99f9884b802d4cc5112fd</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS1359-6101%2801%2900014-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6101%252801%252900014-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoruk%26aufirst%3DR.%26atitle%3DChemokine%2520receptors%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2001%26volume%3D12%26spage%3D313%26epage%3D335%26doi%3D10.1016%2FS1359-6101%2801%2900014-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bleul, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farzan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parolin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span><span class="refDoi"> DOI: 10.1038/382829a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F382829a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=1996&pages=829-833&author=C.+C.+Bleulauthor=M.+Farzanauthor=H.+Choeauthor=C.+Parolinauthor=I.+Clark-Lewisauthor=J.+Sodroskiauthor=T.+A.+Springer&title=The+lymphocyte+chemoattractant+SDF-1+is+a+ligand+for+LESTR%2Ffusin+and+blocks+HIV-1+entry&doi=10.1038%2F382829a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2F382829a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F382829a0%26sid%3Dliteratum%253Aachs%26aulast%3DBleul%26aufirst%3DC.%2BC.%26aulast%3DFarzan%26aufirst%3DM.%26aulast%3DChoe%26aufirst%3DH.%26aulast%3DParolin%26aufirst%3DC.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DThe%2520lymphocyte%2520chemoattractant%2520SDF-1%2520is%2520a%2520ligand%2520for%2520LESTR%252Ffusin%2520and%2520blocks%2520HIV-1%2520entry%26jtitle%3DNature%26date%3D1996%26volume%3D382%26spage%3D829%26epage%3D833%26doi%3D10.1038%2F382829a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Oberlin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachelerie, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virelizier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenzana-Seisdedos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legler, D.</span><span> </span><span class="NLM_article-title">The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">382</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">835</span><span class="refDoi"> DOI: 10.1038/382833a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F382833a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=1996&pages=833-835&author=E.+Oberlinauthor=A.+Amaraauthor=F.+Bachelerieauthor=C.+Bessiaauthor=J.+Virelizierauthor=F.+Arenzana-Seisdedosauthor=O.+Schwartzauthor=J.+Heardauthor=I.+Clark-Lewisauthor=D.+Legler&title=The+CXC+chemokine+SDF-1+is+the+ligand+for+LESTR%2Ffusin+and+prevents+infection+by+T-cell-line-adapted+HIV-1&doi=10.1038%2F382833a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2F382833a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F382833a0%26sid%3Dliteratum%253Aachs%26aulast%3DOberlin%26aufirst%3DE.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DBachelerie%26aufirst%3DF.%26aulast%3DBessia%26aufirst%3DC.%26aulast%3DVirelizier%26aufirst%3DJ.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DSchwartz%26aufirst%3DO.%26aulast%3DHeard%26aufirst%3DJ.%26aulast%3DClark-Lewis%26aufirst%3DI.%26aulast%3DLegler%26aufirst%3DD.%26atitle%3DThe%2520CXC%2520chemokine%2520SDF-1%2520is%2520the%2520ligand%2520for%2520LESTR%252Ffusin%2520and%2520prevents%2520infection%2520by%2520T-cell-line-adapted%2520HIV-1%26jtitle%3DNature%26date%3D1996%26volume%3D382%26spage%3D833%26epage%3D835%26doi%3D10.1038%2F382833a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghesani, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">9448</span><span class="NLM_x">–</span> <span class="NLM_lpage">9453</span><span class="refDoi"> DOI: 10.1073/pnas.95.16.9448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.95.16.9448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=9689100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=9448-9453&author=Q.+Maauthor=D.+Jonesauthor=P.+R.+Borghesaniauthor=R.+A.+Segalauthor=T.+Nagasawaauthor=T.+Kishimotoauthor=R.+T.+Bronsonauthor=T.+A.+Springer&title=Impaired+B-lymphopoiesis%2C+myelopoiesis%2C+and+derailed+cerebellar+neuron+migration+in+CXCR4-+and+SDF-1-deficient+mice&doi=10.1073%2Fpnas.95.16.9448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span></div><div class="casAuthors">Ma, Qing; Jones, Dan; Borghesani, Paul R.; Segal, Rosalind A.; Nagasawa, Takashi; Kishimoto, Tadamitsu; Bronson, Roderick T.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9448-9453</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor 1, SDF-1, is an important regulator of leukocyte and hematopoietic precursor migration and pre-B cell proliferation.  The receptor for SDF-1, CXCR4, also functions as a coreceptor for T-tropic HIV-1 entry.  The authors find that mice deficient for CXCR4 die perinatally and display profound defects in the hematopoietic and nervous systems.  CXCR4-deficient mice have severely reduced B-lymphopoiesis, reduced myelopoiesis in fetal liver, and a virtual absence of myelopoiesis in bone marrow.  However, T-lymphopoiesis is unaffected.  Furthermore, the cerebellum develops abnormally with an irregular external granule cell layer, ectopically located Purkinje cells, and numerous chromophilic cell clumps of abnormally migrated granule cells within the cerebellar anlage.  Identical defects are obsd. in mice lacking SDF-1, suggesting a monogamous relation between CXCR4 and SDF-1.  This receptor-ligand selectivity is unusual among chemokines and their receptors, as is the function in migration of nonhematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ag_HDqKuUrVg90H21EOLACvtfcHk0lhNgxo_MIvsfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D&md5=8a71d69046ba28782c4cffdef33b77ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.16.9448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.16.9448%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DBorghesani%26aufirst%3DP.%2BR.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DImpaired%2520B-lymphopoiesis%252C%2520myelopoiesis%252C%2520and%2520derailed%2520cerebellar%2520neuron%2520migration%2520in%2520CXCR4-%2520and%2520SDF-1-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D9448%26epage%3D9453%26doi%3D10.1073%2Fpnas.95.16.9448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tachibana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iizasa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, S.-i.</span><span> </span><span class="NLM_article-title">The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">393</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span><span class="refDoi"> DOI: 10.1038/31261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1038%2F31261" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=1998&pages=591-594&author=K.+Tachibanaauthor=S.+Hirotaauthor=H.+Iizasaauthor=H.+Yoshidaauthor=K.+Kawabataauthor=Y.+Kataokaauthor=Y.+Kitamuraauthor=K.+Matsushimaauthor=N.+Yoshidaauthor=S.-i.+Nishikawa&title=The+chemokine+receptor+CXCR4+is+essential+for+vascularization+of+the+gastrointestinal+tract&doi=10.1038%2F31261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2F31261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F31261%26sid%3Dliteratum%253Aachs%26aulast%3DTachibana%26aufirst%3DK.%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DIizasa%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DKawabata%26aufirst%3DK.%26aulast%3DKataoka%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DY.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DNishikawa%26aufirst%3DS.-i.%26atitle%3DThe%2520chemokine%2520receptor%2520CXCR4%2520is%2520essential%2520for%2520vascularization%2520of%2520the%2520gastrointestinal%2520tract%26jtitle%3DNature%26date%3D1998%26volume%3D393%26spage%3D591%26epage%3D594%26doi%3D10.1038%2F31261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Busillo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benovic, J. L.</span><span> </span><span class="NLM_article-title">Regulation of CXCR4 signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2006.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bbamem.2006.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=17169327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=952-963&author=J.+M.+Busilloauthor=J.+L.+Benovic&title=Regulation+of+CXCR4+signaling&doi=10.1016%2Fj.bbamem.2006.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of CXCR4 signaling</span></div><div class="casAuthors">Busillo, John M.; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1768</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">952-963</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The chemokine receptor CXCR4 belongs to the large superfamily of G protein-coupled receptors, and is directly involved in a no. of biol. processes including organogenesis, hematopoiesis, and immune response.  Recent evidence has highlighted the role of CXCR4 in a variety of diseases including HIV, cancer, and WHIM syndrome.  Importantly, the involvement of CXCR4 in cancer metastasis and WHIM syndrome appears to be due to dysregulation of the receptor leading to enhanced signaling.  Herein we review what is currently known regarding the regulation of CXCR4 and how dysregulation contributes to disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlc7mFuaCt8LVg90H21EOLACvtfcHk0lhDffii68RFPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLY%253D&md5=95bf1618df71400975d9543c391b6ac7</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DBusillo%26aufirst%3DJ.%2BM.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DRegulation%2520of%2520CXCR4%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2007%26volume%3D1768%26spage%3D952%26epage%3D963%26doi%3D10.1016%2Fj.bbamem.2006.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span> </span><span class="NLM_article-title">Molecular cloning and structure of a pre-B-cell growth-stimulating factor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span><span class="refDoi"> DOI: 10.1073/pnas.91.6.2305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.91.6.2305" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2305-2309&author=T.+Nagasawaauthor=H.+Kikutaniauthor=T.+Kishimoto&title=Molecular+cloning+and+structure+of+a+pre-B-cell+growth-stimulating+factor&doi=10.1073%2Fpnas.91.6.2305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.6.2305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.6.2305%26sid%3Dliteratum%253Aachs%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKikutani%26aufirst%3DH.%26aulast%3DKishimoto%26aufirst%3DT.%26atitle%3DMolecular%2520cloning%2520and%2520structure%2520of%2520a%2520pre-B-cell%2520growth-stimulating%2520factor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D2305%26epage%3D2309%26doi%3D10.1073%2Fpnas.91.6.2305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broder, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, E. A.</span><span> </span><span class="NLM_article-title">HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">872</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span><span class="refDoi"> DOI: 10.1126/science.272.5263.872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.272.5263.872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=8629022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK28XivFajsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1996&pages=872-877&author=Y.+Fengauthor=C.+C.+Broderauthor=P.+E.+Kennedyauthor=E.+A.+Berger&title=HIV-1+entry+cofactor%3A+functional+cDNA+cloning+of+a+seven-transmembrane%2C+G+protein-coupled+receptor&doi=10.1126%2Fscience.272.5263.872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor</span></div><div class="casAuthors">Feng, Yu; Broder, Christopher C.; Kennedy, Paul E.; Berger, Edward A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5263</span>),
    <span class="NLM_cas:pages">872-877</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A cofactor for HIV-1 (human immunodeficiency virus-type 1) fusion and entry was identified with the use of a novel functional complementary DNA (cDNA) cloning strategy.  This protein, designated "fusin," is a putative G protein-coupled receptor with seven transmembrane segments.  Recombinant fusin enabled CD4-expressing nonhuman cell types to support HIV-1 Env-mediated cell fusion and HIV-1 infection.  Antibodies to fusin blocked cell fusion and infection with normal CD4-pos. human target cells.  Fusin mRNA levels correlated with HIV-1 permissiveness in diverse human cell types.  Fusin acted preferentially for T cell line-tropic isolates, in comparison to its activity with macrophage-tropic HIV-1 isolates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3gJxnzdhzo7Vg90H21EOLACvtfcHk0lhDffii68RFPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFajsLc%253D&md5=4a23c79f5fee5cadb979430fc1f550b3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.272.5263.872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.272.5263.872%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DBroder%26aufirst%3DC.%2BC.%26aulast%3DKennedy%26aufirst%3DP.%2BE.%26aulast%3DBerger%26aufirst%3DE.%2BA.%26atitle%3DHIV-1%2520entry%2520cofactor%253A%2520functional%2520cDNA%2520cloning%2520of%2520a%2520seven-transmembrane%252C%2520G%2520protein-coupled%2520receptor%26jtitle%3DScience%26date%3D1996%26volume%3D272%26spage%3D872%26epage%3D877%26doi%3D10.1126%2Fscience.272.5263.872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Berson, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doranz, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jirik, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doms, R. W.</span><span> </span><span class="NLM_article-title">A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">6288</span><span class="NLM_x">–</span> <span class="NLM_lpage">6295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=8709256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGgsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1996&pages=6288-6295&author=J.+F.+Bersonauthor=D.+Longauthor=B.+J.+Doranzauthor=J.+Ruckerauthor=F.+R.+Jirikauthor=R.+W.+Doms&title=A+seven-transmembrane+domain+receptor+involved+in+fusion+and+entry+of+T-cell-tropic+human+immunodeficiency+virus+type+1+strains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains</span></div><div class="casAuthors">Berson, Joanne F.; Long, Deborah; Doranz, Benjamin J.; Rucker, Joseph; Jirik, Frank R.; Doms, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">6288-6295</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Entry of human immunodeficiency virus type 1 (HIV-1) into cells requires binding to CD4 and fusion with a cellular membrane.  Fusion does not occur in most nonhuman cells even when they express human CD4, indicating that one or more human accessory factors are required for virus infection.  Recently, a seven-transmembrane domain protein has been shown to serve as an accessory factor for T-cell-tropic (T-tropic) HIV-1 isolates (Y. Feng, et al., 1996).  Here we show that expression of this glycoprotein, termed fusin, in murine, feline, simian, and quail cell lines, in conjunction with human CD4, rendered these cells fully permissive for HIV-1 envelope glycoprotein (Env)-mediated membrane fusion.  Expression of CD4 or fusin alone did not permit fusion.  In addn., introduction of fusin and CD4 into a human cell line, U87MG, that is resistant to HIV-1-induced syncytium formation and to infection by HIV-1 when expressing CD4 alone made this cell line permissive for Env-mediated cell-cell fusion.  Fusion was obsd. only with T-tropic Env proteins.  Macrophage-tropic (M-tropic) Env proteins from the SF162, ADA, and Ba-L HIV-1 strains did not fuse with cells expressing fusin and CD4, suggesting that M-tropic viruses utilize an accessory mol. other than fusin.  Finally, coexpression of fusin and CD4 made both a murine and feline cell line susceptible to virus infection by T-tropic, but not M-tropic, HIV-1 strains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsR_9vTNV9TbVg90H21EOLACvtfcHk0lisoiy0ZY5MyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGgsLs%253D&md5=052e1d5ea522ab5cfe527ff8aeda1112</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerson%26aufirst%3DJ.%2BF.%26aulast%3DLong%26aufirst%3DD.%26aulast%3DDoranz%26aufirst%3DB.%2BJ.%26aulast%3DRucker%26aufirst%3DJ.%26aulast%3DJirik%26aufirst%3DF.%2BR.%26aulast%3DDoms%26aufirst%3DR.%2BW.%26atitle%3DA%2520seven-transmembrane%2520domain%2520receptor%2520involved%2520in%2520fusion%2520and%2520entry%2520of%2520T-cell-tropic%2520human%2520immunodeficiency%2520virus%2520type%25201%2520strains%26jtitle%3DJ.%2520Virol.%26date%3D1996%26volume%3D70%26spage%3D6288%26epage%3D6295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">977</span><span class="NLM_x">–</span> <span class="NLM_lpage">994</span><span class="refDoi"> DOI: 10.1021/jm200568c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200568c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=977-994&author=W.+T.+Choiauthor=S.+Duggineniauthor=Y.+Xuauthor=Z.+Huangauthor=J.+An&title=Drug+discovery+research+targeting+the+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm200568c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Discovery Research Targeting the CXC Chemokine Receptor 4 (CXCR4)</span></div><div class="casAuthors">Choi, Won-Tak; Duggineni, Srinivas; Xu, Yan; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">977-994</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The CXC chemokine receptor 4 (CXCR4) is an attractive target for therapeutic intervention because of its involvement in the pathogenesis of a wide range of infectious, inflammatory, and other diseases.  There has been intensive biol., chem., and pharmaceutical research to understand the mol. mechanisms of chemokine-receptor interactions and the modulation of chemokine-receptor functions.  The ultimate goal is to translate these discoveries into novel treatment strategies for clin. applications.  This review describes and discusses some of the recent advances in medicinal chem. and drug discovery that involve CXCR4, which is implicated in human immunodeficiency virus (HIV)-1 infection, normal hematopoietic and neural stem cell migration, cancer-stromal cell interaction, solid tumors, and inflammation and autoimmune diseases such as rheumatoid arthritis and allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvvqHX-IPaxrVg90H21EOLACvtfcHk0lisoiy0ZY5MyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVOlt7jF&md5=c996a29f564ca4197139f4802dcbe061</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm200568c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200568c%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DDuggineni%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DDrug%2520discovery%2520research%2520targeting%2520the%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D977%26epage%3D994%26doi%3D10.1021%2Fjm200568c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Scholten, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maussang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roumen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijtmans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graaf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span> </span><span class="NLM_article-title">Pharmacological modulation of chemokine receptor function</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">1617</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01551.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fj.1476-5381.2011.01551.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=21699506" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsVKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1617-1643&author=D.+Scholtenauthor=M.+Canalsauthor=D.+Maussangauthor=L.+Roumenauthor=M.+Smitauthor=M.+Wijtmansauthor=C.+de+Graafauthor=H.+Vischerauthor=R.+Leurs&title=Pharmacological+modulation+of+chemokine+receptor+function&doi=10.1111%2Fj.1476-5381.2011.01551.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of chemokine receptor function</span></div><div class="casAuthors">Scholten, D. J.; Canals, M.; Maussang, D.; Roumen, L.; Smit, M. J.; Wijtmans, M.; de Graaf, C.; Vischer, H. F.; Leurs, R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1617-1643</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  G protein-coupled chemokine receptors and their peptidergic ligands are interesting therapeutic targets due to their involvement in various immune-related diseases, including rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, chronic obstructive pulmonary disease, HIV-1 infection, and cancer.  To tackle these diseases, a lot of effort was focused on discovery and development of small-mol. chemokine receptor antagonists.  This was rewarded by the market approval of 2 novel chemokine receptor inhibitors, AMD3100 (CXCR4) and Maraviroc (CCR5) for stem cell mobilization and treatment of HIV-1 infection resp.  The recent GPCR crystal structures together with mutagenesis and pharmacol. studies have aided in understanding how small-mol. ligands interact with chemokine receptors.  Many of these ligands display behavior deviating from simple competition and do not interact with the chemokine binding site, providing evidence for an allosteric mode of action.  This review aims to give an overview of the evidence supporting modulation of this intriguing receptor family by a range of ligands, including small mols., peptides and antibodies.  Moreover, the computer-assisted modeling of chemokine receptor-ligand interactions is discussed in view of GPCR crystal structures.  Finally, the implications of concepts such as functional selectivity and chemokine receptor dimerization are considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-NeldtD0vf7Vg90H21EOLACvtfcHk0lisoiy0ZY5MyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsVKqtbY%253D&md5=481acf0786ab696ab1fc7eadc09c3aa8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01551.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01551.x%26sid%3Dliteratum%253Aachs%26aulast%3DScholten%26aufirst%3DD.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DMaussang%26aufirst%3DD.%26aulast%3DRoumen%26aufirst%3DL.%26aulast%3DSmit%26aufirst%3DM.%26aulast%3DWijtmans%26aufirst%3DM.%26aulast%3Dde%2BGraaf%26aufirst%3DC.%26aulast%3DVischer%26aufirst%3DH.%26aulast%3DLeurs%26aufirst%3DR.%26atitle%3DPharmacological%2520modulation%2520of%2520chemokine%2520receptor%2520function%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1617%26epage%3D1643%26doi%3D10.1111%2Fj.1476-5381.2011.01551.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Singh, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauthe, S. K.</span><span> </span><span class="NLM_article-title">Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004–2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1517/13543776.2011.542412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1517%2F13543776.2011.542412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=21219250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=227-269&author=I.+P.+Singhauthor=S.+K.+Chauthe&title=Small+molecule+HIV+entry+inhibitors%3A+Part+I.+Chemokine+receptor+antagonists%3A+2004%E2%80%932010&doi=10.1517%2F13543776.2011.542412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004 - 2010</span></div><div class="casAuthors">Singh, Inder Pal; Chauthe, Siddheshwar K.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">227-269</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HIV/AIDS is one of the most devastating diseases in the world affecting > 40 million people worldwide.  Morbidity and mortality from AIDS are significantly reduced due to the advent of highly active antiretroviral therapy (HAART).  Long-term toxicity, emergence of drug resistant HIV strains and drug-drug interactions limit the effectiveness of HAART therapy.  Chemokine receptor antagonists can provide drugs with lesser side effects and enhanced anti-HIV activity.  Maraviroc, a chemokine co-receptor 5 (CCR5) antagonist from Pfizer, is already in clin. use.  This review covers patents and patent applications for small mol. CCR5 and CXC chemokine receptor 4 (CXCR4) antagonists published between 2004 and 2010 and related literature with a focus on recent developments based on lead generation and lead modification.  The reader will gain information about the development of small mol. CCR5 and CXCR4 antagonists from the major pharmaceutical and biopharmaceutical companies.  Several small lead mols. (CCR5 and CXCR4 antagonists) have been modified over this period for enhanced therapeutic activity and to obtain drug-like properties.  CCR5 antagonists such as TBK-652 and TBK-220 from Tobira Therapeutics, and vicriviroc from Schering Plough showed a lot of promise in the developmental stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN7_q_L4BFF7Vg90H21EOLACvtfcHk0lisoiy0ZY5MyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentLo%253D&md5=e22a0175d7b87b2ae6d7d63b41aeadfd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.542412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.542412%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DI.%2BP.%26aulast%3DChauthe%26aufirst%3DS.%2BK.%26atitle%3DSmall%2520molecule%2520HIV%2520entry%2520inhibitors%253A%2520Part%2520I.%2520Chemokine%2520receptor%2520antagonists%253A%25202004%25E2%2580%25932010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D227%26epage%3D269%26doi%3D10.1517%2F13543776.2011.542412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauwels, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debyser, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrer, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picker, D.</span><span> </span><span class="NLM_article-title">Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">5286</span><span class="NLM_x">–</span> <span class="NLM_lpage">5290</span><span class="refDoi"> DOI: 10.1073/pnas.89.12.5286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.89.12.5286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1608936" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK38XkvVaqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1992&pages=5286-5290&author=E.+De+Clercqauthor=N.+Yamamotoauthor=R.+Pauwelsauthor=M.+Babaauthor=D.+Scholsauthor=H.+Nakashimaauthor=J.+Balzariniauthor=Z.+Debyserauthor=B.+A.+Murrerauthor=D.+Schwartzauthor=D.+Thorntonauthor=G.+Bridgerauthor=S.+Frickerauthor=G.+Hensonauthor=M.+Abramsauthor=D.+Picker&title=Potent+and+selective+inhibition+of+human+immunodeficiency+virus+%28HIV%29-1+and+HIV-2+replication+by+a+class+of+bicyclams+interacting+with+a+viral+uncoating+event&doi=10.1073%2Fpnas.89.12.5286"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of cicyclams interacting with a viral uncoating event</span></div><div class="casAuthors">De Clercq, Erik; Yamamoto, Naohiko; Pauwels, Rudi; Baba, Masanori; Schols, Dominique; Nakashima, Hideki; Balzarini, Jan; Debyser, Zeger; Murrer, Barry A.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5286-90</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A series of bicyclams have been shown to be potent and selective inhibitors of human immunodeficiency virus (HIV).  The compds. are inhibitory to the replication of various HIV-1 and HIV-2 strains in various human T-cell systems, including peripheral blood lymphocytes, at 0.14-1.4 μM, without being toxic to the host cells at 2.2 mM.  The bicyclam JM2763 (I) is active against 3'-azido-3'-deoxythymidine (zidovudine; AZT)-resistant HIV-1 strains and acts additively with AZT.  Mechanism of action studies revealed that the bicyclams (i.e., I) interact with an early event of the retrovirus replicative cycle, which could be tentatively identified as a viral uncoating event.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdkZ-WLPGwyLVg90H21EOLACvtfcHk0lj5bp4LIuZy7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVaqtro%253D&md5=67db6384097fedeb73572d8f7628be34</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1073%2Fpnas.89.12.5286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.89.12.5286%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPauwels%26aufirst%3DR.%26aulast%3DBaba%26aufirst%3DM.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DMurrer%26aufirst%3DB.%2BA.%26aulast%3DSchwartz%26aufirst%3DD.%26aulast%3DThornton%26aufirst%3DD.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DFricker%26aufirst%3DS.%26aulast%3DHenson%26aufirst%3DG.%26aulast%3DAbrams%26aufirst%3DM.%26aulast%3DPicker%26aufirst%3DD.%26atitle%3DPotent%2520and%2520selective%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529-1%2520and%2520HIV-2%2520replication%2520by%2520a%2520class%2520of%2520bicyclams%2520interacting%2520with%2520a%2520viral%2520uncoating%2520event%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1992%26volume%3D89%26spage%3D5286%26epage%3D5290%26doi%3D10.1073%2Fpnas.89.12.5286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">509</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2010.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.pharmthera.2010.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20826182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2010&pages=509-518&author=E.+De+Clercq&title=Recent+advances+on+the+use+of+the+CXCR4+antagonist+plerixafor+%28AMD3100%2C+Mozobil%29+and+potential+of+other+CXCR4+antagonists+as+stem+cell+mobilizers&doi=10.1016%2Fj.pharmthera.2010.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil) and potential of other CXCR4 antagonists as stem cell mobilizers</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">509-518</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  AMD3100 was originally discovered as an anti-HIV agent effective in inhibiting the replication of HIV in vitro at nanomolar concns.  We found it to be a potent and selective antagonist of CXCR4, the receptor for the chemokine SDF-1 (now called CXCL12).  AMD3100 was then developed, and marketed, as a stem cell mobilizer, and renamed plerixafor (Mozobil).  The path to the discovery of Mozobil as a stem cell mobilizer was described in Biochem.  Pharmacol. 77: 1655-1664 (2009).  Here I review the recent advances that have consolidated the role of plerixafor in mobilizing hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) from the bone marrow into the blood circulation.  Plerixafor acts synergistically with granulocyte colony-stimulating factor (G-CSF), and its usefulness has been proven particularly for the mobilization of HSCs and HPCs for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma (NHL) or multiple myeloma (MM).  Plerixafor also has great potential for the treatment of hematol. malignancies other than NHL and MM, and non-hematol. malignancies, and, eventually, several other diseases depending on the CXCL12-CXCR4 interaction.  Various AMD3100 analogs have been described (i.e. AMD11070, AMD3465, KRH-3955, T-140, and 4F-benzoyl-TN14003), primarily as potential anti-HIV agents.  They are all strong CXCR4 antagonists.  Their role in stem cell mobilization remains to be assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNBMywfEvpbVg90H21EOLACvtfcHk0lj5bp4LIuZy7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKhs7zO&md5=cb344c4a5966627126ec462e271e3d9e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2010.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2010.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DRecent%2520advances%2520on%2520the%2520use%2520of%2520the%2520CXCR4%2520antagonist%2520plerixafor%2520%2528AMD3100%252C%2520Mozobil%2529%2520and%2520potential%2520of%2520other%2520CXCR4%2520antagonists%2520as%2520stem%2520cell%2520mobilizers%26jtitle%3DPharmacol.%2520Ther.%26date%3D2010%26volume%3D128%26spage%3D509%26epage%3D518%26doi%3D10.1016%2Fj.pharmthera.2010.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiramatsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terakubo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broach, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span> </span><span class="NLM_article-title">Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3251</span><span class="NLM_x">–</span> <span class="NLM_lpage">3253</span><span class="refDoi"> DOI: 10.1002/anie.200351024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fanie.200351024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtF2rtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=3251-3253&author=N.+Fujiiauthor=S.+Oishiauthor=K.+Hiramatsuauthor=T.+Arakiauthor=S.+Uedaauthor=H.+Tamamuraauthor=A.+Otakaauthor=S.+Kusanoauthor=S.+Terakuboauthor=H.+Nakashimaauthor=J.+A.+Broachauthor=J.+O.+Trentauthor=Z.+X.+Wangauthor=S.+C.+Peiper&title=Molecular-size+reduction+of+a+potent+CXCR4-chemokine+antagonist+using+orthogonal+combination+of+conformation-+and+sequence-based+libraries&doi=10.1002%2Fanie.200351024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular-size reduction of a potent CXCR4-chemokine antagonist using orthogonal combination of conformation- and sequence-based libraries</span></div><div class="casAuthors">Fujii, Nobutaka; Oishi, Shinya; Hiramatsu, Kenichi; Araki, Takanobu; Ueda, Satoshi; Tamamura, Hirokazu; Otaka, Akira; Kusano, Shuichi; Terakubo, Shigemi; Nakashima, Hideki; Broach, James A.; Trent, John O.; Wang, Zi-xuan; Peiper, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3251-3253</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report a new strategy for the downsizing of bioactive peptides using 2 orthogonal small libraries o cyclic peptides, which allowed us to identify a novel CXCR4 antagonist equipotent to the parent peptide.  By combination of two orthogonal "conformation-based" and "sequence-based" libraries, the cyclic pentapeptide cyclo-(-L-Nal1-Gly2-D-Tyr3-L-Arg4-L-Arg5-) (Nal=L-3-(2-naphthyl)alanine), which exhibited strong CXCR4 antagonism (IC50=4 nM) comparable to that of a 14-residue lead compd., T140, was discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonplDn8xbOq7Vg90H21EOLACvtfcHk0lj4PEYv4DKR7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtF2rtb4%253D&md5=4f284b00b93935628be8c3d29eb52c79</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fanie.200351024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200351024%26sid%3Dliteratum%253Aachs%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DHiramatsu%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DTerakubo%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DBroach%26aufirst%3DJ.%2BA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26atitle%3DMolecular-size%2520reduction%2520of%2520a%2520potent%2520CXCR4-chemokine%2520antagonist%2520using%2520orthogonal%2520combination%2520of%2520conformation-%2520and%2520sequence-based%2520libraries%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D3251%26epage%3D3253%26doi%3D10.1002%2Fanie.200351024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies on CXCR4 antagonists having cyclic pentapeptide scaffolds</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">4392</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span><span class="refDoi"> DOI: 10.1039/b513145f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1039%2Fb513145f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=4392-4394&author=H.+Tamamuraauthor=A.+Esakaauthor=T.+Ogawaauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=J.+O.+Trentauthor=H.+Tsutsumiauthor=H.+Masunoauthor=H.+Nakashima&title=Structure%E2%80%93activity+relationship+studies+on+CXCR4+antagonists+having+cyclic+pentapeptide+scaffolds&doi=10.1039%2Fb513145f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fb513145f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb513145f%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DOgawa%26aufirst%3DT.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DTsutsumi%26aufirst%3DH.%26aulast%3DMasuno%26aufirst%3DH.%26aulast%3DNakashima%26aufirst%3DH.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520on%2520CXCR4%2520antagonists%2520having%2520cyclic%2520pentapeptide%2520scaffolds%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D4392%26epage%3D4394%26doi%3D10.1039%2Fb513145f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3280</span><span class="NLM_x">–</span> <span class="NLM_lpage">3289</span><span class="refDoi"> DOI: 10.1021/jm050009h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050009h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3280-3289&author=H.+Tamamuraauthor=T.+Arakiauthor=S.+Uedaauthor=Z.+Wangauthor=S.+Oishiauthor=A.+Esakaauthor=J.+O.+Trentauthor=H.+Nakashimaauthor=N.+Yamamotoauthor=S.+C.+Peiperauthor=A.+Otakaauthor=N.+Fujii&title=Identification+of+novel+low+molecular+weight+CXCR4+antagonists+by+structural+tuning+of+cyclic+tetrapeptide+scaffolds&doi=10.1021%2Fjm050009h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm050009h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050009h%26sid%3Dliteratum%253Aachs%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DOtaka%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520novel%2520low%2520molecular%2520weight%2520CXCR4%2520antagonists%2520by%2520structural%2520tuning%2520of%2520cyclic%2520tetrapeptide%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3280%26epage%3D3289%26doi%3D10.1021%2Fjm050009h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ueda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trent, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peiper, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span> </span><span class="NLM_article-title">Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">192</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1021/jm0607350</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607350" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=192-198&author=S.+Uedaauthor=S.+Oishiauthor=Z.+X.+Wangauthor=T.+Arakiauthor=H.+Tamamuraauthor=J.+Cluzeauauthor=H.+Ohnoauthor=S.+Kusanoauthor=H.+Nakashimaauthor=J.+O.+Trentauthor=S.+C.+Peiperauthor=N.+Fujii&title=Structure-activity+relationships+of+cyclic+peptide-based+chemokine+receptor+CXCR4+antagonists%3A+disclosing+the+importance+of+side-chain+and+backbone+functionalities&doi=10.1021%2Fjm0607350"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0607350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607350%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DZ.%2BX.%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DTamamura%26aufirst%3DH.%26aulast%3DCluzeau%26aufirst%3DJ.%26aulast%3DOhno%26aufirst%3DH.%26aulast%3DKusano%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DJ.%2BO.%26aulast%3DPeiper%26aufirst%3DS.%2BC.%26aulast%3DFujii%26aufirst%3DN.%26atitle%3DStructure-activity%2520relationships%2520of%2520cyclic%2520peptide-based%2520chemokine%2520receptor%2520CXCR4%2520antagonists%253A%2520disclosing%2520the%2520importance%2520of%2520side-chain%2520and%2520backbone%2520functionalities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D192%26epage%3D198%26doi%3D10.1021%2Fjm0607350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eksteen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Rational design of conformationally constrained cyclopentapeptide antagonists for CXC chemokine receptor 4 (CXCR4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10287</span><span class="NLM_x">–</span> <span class="NLM_lpage">10291</span><span class="refDoi"> DOI: 10.1021/jm300926y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300926y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10287-10291&author=J.+Mungalparaauthor=S.+Thieleauthor=%C3%98.+Eriksenauthor=J.+Eksteenauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Rational+design+of+conformationally+constrained+cyclopentapeptide+antagonists+for+CXC+chemokine+receptor+4+%28CXCR4%29&doi=10.1021%2Fjm300926y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm300926y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300926y%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3D%25C3%2598.%26aulast%3DEksteen%26aufirst%3DJ.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DRational%2520design%2520of%2520conformationally%2520constrained%2520cyclopentapeptide%2520antagonists%2520for%2520CXC%2520chemokine%2520receptor%25204%2520%2528CXCR4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10287%26epage%3D10291%26doi%3D10.1021%2Fjm300926y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zachariassen, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Structure-activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">8202</span><span class="NLM_x">–</span> <span class="NLM_lpage">8208</span><span class="refDoi"> DOI: 10.1039/c3ob41941j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1039%2Fc3ob41941j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=8202-8208&author=J.+Mungalparaauthor=Z.+G.+Zachariassenauthor=S.+Thieleauthor=M.+M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Structure-activity+relationship+studies+of+the+aromatic+positions+in+cyclopentapeptide+CXCR4+antagonists&doi=10.1039%2Fc3ob41941j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1039%2Fc3ob41941j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob41941j%26sid%3Dliteratum%253Aachs%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DZachariassen%26aufirst%3DZ.%2BG.%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DStructure-activity%2520relationship%2520studies%2520of%2520the%2520aromatic%2520positions%2520in%2520cyclopentapeptide%2520CXCR4%2520antagonists%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D8202%26epage%3D8208%26doi%3D10.1039%2Fc3ob41941j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Yamazaki, T.; Saitou, A.; Ono, M.; Yokoyama, S.; Bannai, K.; Hirose, K.; Yanaka, M.</span><span> </span><span class="NLM_article-title">Preparation of amino acid amide derivatives as antagonists of chemokine CXCR4 receptor</span>. WO2003029218A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=T.+Yamazaki&author=A.+Saitou&author=M.+Ono&author=S.+Yokoyama&author=K.+Bannai&author=K.+Hirose&author=M.+Yanaka&title=Preparation+of+amino+acid+amide+derivatives+as+antagonists+of+chemokine+CXCR4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520amino%2520acid%2520amide%2520derivatives%2520as%2520antagonists%2520of%2520chemokine%2520CXCR4%2520receptor%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yamazaki, T.; Kikumoto, S.; Ono, M.; Saitou, A.; Takahashi, H.; Kumakura, S.; Hirose, K.; Yanaka, M.; Takemura, Y.; Suzuki, S.; Matsui, R.</span><span> </span><span class="NLM_article-title">Preparation of bis(heterocyclylmethyl)amine compounds as chemokine receptor CXCR4 antagonists</span>. WO2004024697A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+Yamazaki&author=S.+Kikumoto&author=M.+Ono&author=A.+Saitou&author=H.+Takahashi&author=S.+Kumakura&author=K.+Hirose&author=M.+Yanaka&author=Y.+Takemura&author=S.+Suzuki&author=R.+Matsui&title=Preparation+of+bis%28heterocyclylmethyl%29amine+compounds+as+chemokine+receptor+CXCR4+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamazaki%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520bis%2528heterocyclylmethyl%2529amine%2520compounds%2520as%2520chemokine%2520receptor%2520CXCR4%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamatake, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span> </span><span class="NLM_article-title">The novel CXCR4 antagonist KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virus type 1 infection: comparative studies with AMD3100</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2940</span><span class="NLM_x">–</span> <span class="NLM_lpage">2948</span><span class="refDoi"> DOI: 10.1128/AAC.01727-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FAAC.01727-08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=2940-2948&author=T.+Murakamiauthor=S.+Kumakuraauthor=T.+Yamazakiauthor=R.+Tanakaauthor=M.+Hamatakeauthor=K.+Okumaauthor=W.+Huangauthor=J.+Tomaauthor=J.+Komanoauthor=M.+Yanaka&title=The+novel+CXCR4+antagonist+KRH-3955+is+an+orally+bioavailable+and+extremely+potent+inhibitor+of+human+immunodeficiency+virus+type+1+infection%3A+comparative+studies+with+AMD3100&doi=10.1128%2FAAC.01727-08"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1128%2FAAC.01727-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01727-08%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DKumakura%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHamatake%26aufirst%3DM.%26aulast%3DOkuma%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DToma%26aufirst%3DJ.%26aulast%3DKomano%26aufirst%3DJ.%26aulast%3DYanaka%26aufirst%3DM.%26atitle%3DThe%2520novel%2520CXCR4%2520antagonist%2520KRH-3955%2520is%2520an%2520orally%2520bioavailable%2520and%2520extremely%2520potent%2520inhibitor%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520infection%253A%2520comparative%2520studies%2520with%2520AMD3100%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D2940%26epage%3D2948%26doi%3D10.1128%2FAAC.01727-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ichiyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama-Kumakura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edamatsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyano-Kurosaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4185</span><span class="NLM_x">–</span> <span class="NLM_lpage">4190</span><span class="refDoi"> DOI: 10.1073/pnas.0630420100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.0630420100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4185-4190&author=K.+Ichiyamaauthor=S.+Yokoyama-Kumakuraauthor=Y.+Tanakaauthor=R.+Tanakaauthor=K.+Hiroseauthor=K.+Bannaiauthor=T.+Edamatsuauthor=M.+Yanakaauthor=Y.+Niitaniauthor=N.+Miyano-Kurosakiauthor=H.+Takakuauthor=Y.+Koyanagiauthor=N.+Yamamoto&title=A+duodenally+absorbable+CXC+chemokine+receptor+4+antagonist%2C+KRH-1636%2C+exhibits+a+potent+and+selective+anti-HIV-1+activity&doi=10.1073%2Fpnas.0630420100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0630420100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0630420100%26sid%3Dliteratum%253Aachs%26aulast%3DIchiyama%26aufirst%3DK.%26aulast%3DYokoyama-Kumakura%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DHirose%26aufirst%3DK.%26aulast%3DBannai%26aufirst%3DK.%26aulast%3DEdamatsu%26aufirst%3DT.%26aulast%3DYanaka%26aufirst%3DM.%26aulast%3DNiitani%26aufirst%3DY.%26aulast%3DMiyano-Kurosaki%26aufirst%3DN.%26aulast%3DTakaku%26aufirst%3DH.%26aulast%3DKoyanagi%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520duodenally%2520absorbable%2520CXC%2520chemokine%2520receptor%25204%2520antagonist%252C%2520KRH-1636%252C%2520exhibits%2520a%2520potent%2520and%2520selective%2520anti-HIV-1%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D4185%26epage%3D4190%26doi%3D10.1073%2Fpnas.0630420100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yanaka, M.; Yamazaki, T.; Bannai, K.; Hirose, K.</span><span> </span><span class="NLM_article-title">CXCR4-antagonistic drugs composed of nitrogen-containing compound</span>. US 0157818, August 12,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Yanaka&author=T.+Yamazaki&author=K.+Bannai&author=K.+Hirose&title=CXCR4-antagonistic+drugs+composed+of+nitrogen-containing+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYanaka%26aufirst%3DM.%26atitle%3DCXCR4-antagonistic%2520drugs%2520composed%2520of%2520nitrogen-containing%2520compound%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span> </span><span class="NLM_article-title">Small molecules anti-HIV therapeutics targeting CXCR4</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span><span class="refDoi"> DOI: 10.2174/138161208783497714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F138161208783497714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=18289065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtFCntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=385-404&author=N.+Neamatiauthor=F.+Grandeauthor=A.+Garofalo&title=Small+molecules+anti-HIV+therapeutics+targeting+CXCR4&doi=10.2174%2F138161208783497714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecules anti-HIV therapeutics targeting CXCR4</span></div><div class="casAuthors">Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">385-404</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  HIV cellular entry is a multistep process that requires the interaction of a viral envelope glycoprotein (gp120) and a host receptor (CD4) followed by binding to a co-receptor.  The CC-chemokine receptor 5 (CCR5) and CXC-chemokine receptor 4 (CXCR4) have been identified as the major HIV co-receptors and therefore are promising targets for the development of new anti-HIV drugs.  CXCR4 is also involved in several diseases such as angiogenesis, metabolic and neurol. disorders, rheumatoid arthritis and in different forms of metastatic cancer.  Herein, we present a review focusing on small mol. CXCR4 antagonists.  These compds. are divided into 11 classes that include cyclic penta- and tetrapeptides, diketopiperazine mimetics, bicyclams, non-bicyclams, tetrahydroquinolines, thiazolylisothiourea derivs., benzodiazepines, alkyl amine analogs and non-peptides derivs., dipicolylamine-zinc(II) complexes, ampelopsin and distamycin analogs.  The most advanced CXCR4 antagonists documented are bicyclam derivs., which are specific CXCR4 antagonists and exhibit potency in the nanomolar range.  Further development of selective CXCR4 antagonists continues to be crucial for the design of second generation of anti-HIV drugs.  We aim to provide a comprehensive summary of diverse structural templates that could be useful for optimization and discovery of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr748B8doAAOrVg90H21EOLACvtfcHk0lgchFpjXhSzqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtFCntr4%253D&md5=b6a409ddd76bfee59fcd407ca04f629e</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.2174%2F138161208783497714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208783497714%26sid%3Dliteratum%253Aachs%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26atitle%3DSmall%2520molecules%2520anti-HIV%2520therapeutics%2520targeting%2520CXCR4%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D385%26epage%3D404%26doi%3D10.2174%2F138161208783497714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small molecule inhibitors of CXCR4</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.7150/thno.5376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.7150%2Fthno.5376" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=47-75&author=B.+Debnathauthor=S.+Xuauthor=F.+Grandeauthor=A.+Garofaloauthor=N.+Neamati&title=Small+molecule+inhibitors+of+CXCR4&doi=10.7150%2Fthno.5376"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.7150%2Fthno.5376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5376%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520CXCR4%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26spage%3D47%26epage%3D75%26doi%3D10.7150%2Fthno.5376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforovich, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span><span class="refDoi"> DOI: 10.1002/bip.20508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fbip.20508" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2006&pages=459-471&author=J.+V%C3%A5ben%C3%B8author=G.+V.+Nikiforovichauthor=G.+R.+Marshall&title=A+minimalistic+3D+pharmacophore+model+for+cyclopentapeptide+CXCR4+antagonists&doi=10.1002%2Fbip.20508"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fbip.20508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbip.20508%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DNikiforovich%26aufirst%3DG.%2BV.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DA%2520minimalistic%25203D%2520pharmacophore%2520model%2520for%2520cyclopentapeptide%2520CXCR4%2520antagonists%26jtitle%3DBiopolymers%26date%3D2006%26volume%3D84%26spage%3D459%26epage%3D471%26doi%3D10.1002%2Fbip.20508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bi, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamel, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1071</span><span class="refDoi"> DOI: 10.1126/science.1194396</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.1194396" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20929726" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2010&pages=1066-1071&author=B.+Wuauthor=E.+Y.+Chienauthor=C.+D.+Molauthor=G.+Fenaltiauthor=W.+Liuauthor=V.+Katritchauthor=R.+Abagyanauthor=A.+Broounauthor=P.+Wellsauthor=F.+C.+Biauthor=D.+J.+Hamelauthor=P.+Kuhnauthor=T.+M.+Handelauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structures+of+the+CXCR4+chemokine+GPCR+with+small-molecule+and+cyclic+peptide+antagonists&doi=10.1126%2Fscience.1194396"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists</span></div><div class="casAuthors">Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">6007</span>),
    <span class="NLM_cas:pages">1066-1071</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokine receptors are crit. regulators of cell migration in the context of immune surveillance, inflammation, and development.  The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection.  Here we report five independent crystal structures of CXCR4 bound to an antagonist small mol. IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resoln.  All structures reveal a consistent homodimer with an interface including helixes V and VI that may be involved in regulating signaling.  The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface.  These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeofqcIJsBzLVg90H21EOLACvtfcHk0lgl0erkmxeINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVahurnM&md5=2d39cc2cff4adce72e63f427e568e35d</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1126%2Fscience.1194396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1194396%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DB.%26aulast%3DChien%26aufirst%3DE.%2BY.%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DBi%26aufirst%3DF.%2BC.%26aulast%3DHamel%26aufirst%3DD.%2BJ.%26aulast%3DKuhn%26aufirst%3DP.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructures%2520of%2520the%2520CXCR4%2520chemokine%2520GPCR%2520with%2520small-molecule%2520and%2520cyclic%2520peptide%2520antagonists%26jtitle%3DScience%26date%3D2010%26volume%3D330%26spage%3D1066%26epage%3D1071%26doi%3D10.1126%2Fscience.1194396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenalti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handel, T. M.</span><span> </span><span class="NLM_article-title">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1122</span><span class="refDoi"> DOI: 10.1126/science.1261064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1126%2Fscience.1261064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=25612609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1117-1122&author=L.+Qinauthor=I.+Kufarevaauthor=L.+G.+Holdenauthor=C.+Wangauthor=Y.+Zhengauthor=C.+Zhaoauthor=G.+Fenaltiauthor=H.+Wuauthor=G.+W.+Hanauthor=V.+Cherezovauthor=R.+Abagyanauthor=R.+C.+Stevensauthor=T.+M.+Handel&title=Crystal+structure+of+the+chemokine+receptor+CXCR4+in+complex+with+a+viral+chemokine&doi=10.1126%2Fscience.1261064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine</span></div><div class="casAuthors">Qin, Ling; Kufareva, Irina; Holden, Lauren G.; Wang, Chong; Zheng, Yi; Zhao, Chunxia; Fenalti, Gustavo; Wu, Huixian; Han, Gye Won; Cherezov, Vadim; Abagyan, Ruben; Stevens, Raymond C.; Handel, Tracy M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6226</span>),
    <span class="NLM_cas:pages">1117-1122</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chemokines and their receptors control cell migration during development, immune system responses, and in numerous diseases, including inflammation and cancer.  The structural basis of receptor:chemokine recognition has been a long-standing unanswered question due to the challenges of structure detn. for membrane protein complexes.  Here, we report the crystal structure of the chemokine receptor CXCR4 in complex with the viral chemokine antagonist vMIP-II at 3.1 angstrom resoln.  The structure revealed a 1:1 stoichiometry and a more extensive binding interface than anticipated from the paradigmatic two-site model.  The structure helped rationalize a large body of mutagenesis data and together with modeling provided insights into CXCR4 interactions with its endogenous ligand CXCL12, its ability to recognize diverse ligands, and the specificity of CC and CXC receptors for their resp. chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnK7RbAxjiYrVg90H21EOLACvtfcHk0lgl0erkmxeINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsF2hs78%253D&md5=9f3955c6afbd253be237bcf028d2e2dc</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fscience.1261064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1261064%26sid%3Dliteratum%253Aachs%26aulast%3DQin%26aufirst%3DL.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DHolden%26aufirst%3DL.%2BG.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DFenalti%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DHandel%26aufirst%3DT.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520complex%2520with%2520a%2520viral%2520chemokine%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1117%26epage%3D1122%26doi%3D10.1126%2Fscience.1261064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Thiele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mungalpara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Våbenø, J.</span><span> </span><span class="NLM_article-title">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">5313</span><span class="NLM_x">–</span> <span class="NLM_lpage">5329</span><span class="refDoi"> DOI: 10.1111/bph.12842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fbph.12842" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=25039237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2014&pages=5313-5329&author=S.+Thieleauthor=J.+Mungalparaauthor=A.+Steenauthor=M.+Rosenkildeauthor=J.+V%C3%A5ben%C3%B8&title=Determination+of+the+binding+mode+for+the+cyclopentapeptide+CXCR4+antagonist+FC131+using+a+dual+approach+of+ligand+modifications+and+receptor+mutagenesis&doi=10.1111%2Fbph.12842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis</span></div><div class="casAuthors">Thiele, S.; Mungalpara, J.; Steen, A.; Rosenkilde, M. M.; Vabeno, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">171</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5313-5329</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The cyclopentapeptide FC131 (cyclo(-L-Arg1-L-Arg2-L-2-Nal3-Gly4-D-Tyr5-)) is an antagonist at the CXC chemokine receptor CXCR4, which plays a role in human immunodeficiency virus infection, cancer and stem cell recruitment.  Binding modes for FC131 in CXCR4 have previously been suggested based on mol. docking guided by structure-activity relationship (SAR) data; however, none of these have been verified by in vitro expts.  Exptl. Approach : Heterologous 125I-12G5-competition binding and functional assays (inhibition of CXCL12-mediated activation) of FC131 and three analogs were performed on wild-type CXCR4 and 25 receptor mutants.  Computational modeling was used to rationalize the exptl. data.  Key Results : The Arg2 and 2-Nal3 side chains of FC131 interact with residues in TM-3 (His113, Asp171) and TM-5 (hydrophobic pocket) resp.  Arg1 forms charge-charge interactions with Asp187 in ECL-2, while D-Tyr5 points to the extracellular side of CXCR4.  Furthermore, the backbone of FC131 interacts with the chemokine receptor-conserved Glu288 via two water mols.  Intriguingly, Tyr116 and Glu288 form a H-bond in CXCR4 crystal structures and mutation of either residue to Ala abolishes CXCR4 activity.  Conclusions and Implications : Ligand modification, receptor mutagenesis and computational modeling approaches were used to identify the binding mode of FC131 in CXCR4, which was in agreement with binding modes suggested from previous SAR studies.  Furthermore, insights into the mechanism for CXCR4 activation by CXCL12 were gained.  The combined findings will facilitate future design of novel CXCR4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTJVv4tLiRYrVg90H21EOLACvtfcHk0lgl0erkmxeINQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVamt7nE&md5=de979e35933c1b6566e6b4b43034e875</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fbph.12842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12842%26sid%3Dliteratum%253Aachs%26aulast%3DThiele%26aufirst%3DS.%26aulast%3DMungalpara%26aufirst%3DJ.%26aulast%3DSteen%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26atitle%3DDetermination%2520of%2520the%2520binding%2520mode%2520for%2520the%2520cyclopentapeptide%2520CXCR4%2520antagonist%2520FC131%2520using%2520a%2520dual%2520approach%2520of%2520ligand%2520modifications%2520and%2520receptor%2520mutagenesis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2014%26volume%3D171%26spage%3D5313%26epage%3D5329%26doi%3D10.1111%2Fbph.12842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">14153</span><span class="NLM_x">–</span> <span class="NLM_lpage">14160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=14153-14160&author=L.+O.+Gerlachauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+interactions+of+cyclam+and+bicyclam+non-peptide+antagonists+with+the+CXCR4+chemokine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520interactions%2520of%2520cyclam%2520and%2520bicyclam%2520non-peptide%2520antagonists%2520with%2520the%2520CXCR4%2520chemokine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D14153%26epage%3D14160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3041</span><span class="refDoi"> DOI: 10.1074/jbc.M309546200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M309546200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=3033-3041&author=M.+M.+Rosenkildeauthor=L.+O.+Gerlachauthor=J.+S.+Jakobsenauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+mechanism+of+AMD3100+antagonism+in+the+CXCR4+receptor&doi=10.1074%2Fjbc.M309546200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M309546200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M309546200%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DJakobsen%26aufirst%3DJ.%2BS.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520AMD3100%2520antagonism%2520in%2520the%2520CXCR4%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D3033%26epage%3D3041%26doi%3D10.1074%2Fjbc.M309546200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x">, </span> <span class="NLM_fpage">300</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span><span class="refDoi"> DOI: 10.1016/S0014-5793(03)00609-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS0014-5793%2803%2900609-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2003&pages=300-306&author=S.+Hatseauthor=K.+Princenauthor=K.+Vermeireauthor=L.+O.+Gerlachauthor=M.+M.+Rosenkildeauthor=T.+W.+Schwartzauthor=G.+Bridgerauthor=E.+De+Clercqauthor=D.+Schols&title=Mutations+at+the+CXCR4+interaction+sites+for+AMD3100+influence+anti-CXCR4+antibody+binding+and+HIV-1+entry&doi=10.1016%2FS0014-5793%2803%2900609-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2900609-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252900609-4%26sid%3Dliteratum%253Aachs%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DMutations%2520at%2520the%2520CXCR4%2520interaction%2520sites%2520for%2520AMD3100%2520influence%2520anti-CXCR4%2520antibody%2520binding%2520and%2520HIV-1%2520entry%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D546%26spage%3D300%26epage%3D306%26doi%3D10.1016%2FS0014-5793%2803%2900609-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">27354</span><span class="NLM_x">–</span> <span class="NLM_lpage">27365</span><span class="refDoi"> DOI: 10.1074/jbc.M704739200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M704739200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27354-27365&author=M.+M.+Rosenkildeauthor=L.+O.+Gerlachauthor=S.+Hatseauthor=R.+T.+Skerljauthor=D.+Scholsauthor=G.+J.+Bridgerauthor=T.+W.+Schwartz&title=Molecular+mechanism+of+action+of+monocyclam+versus+bicyclam+non-peptide+antagonists+in+the+CXCR4+chemokine+receptor&doi=10.1074%2Fjbc.M704739200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M704739200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M704739200%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DGerlach%26aufirst%3DL.%2BO.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DMolecular%2520mechanism%2520of%2520action%2520of%2520monocyclam%2520versus%2520bicyclam%2520non-peptide%2520antagonists%2520in%2520the%2520CXCR4%2520chemokine%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D27354%26epage%3D27365%26doi%3D10.1074%2Fjbc.M704739200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1495</span><span class="refDoi"> DOI: 10.1124/mol.108.049775</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1124%2Fmol.108.049775" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1485-1495&author=R.+S.+Y.+Wongauthor=V.+Bodartauthor=M.+Metzauthor=J.+Labrecqueauthor=G.+Bridgerauthor=S.+P.+Fricker&title=Comparison+of+the+potential+multiple+binding+modes+of+bicyclam%2C+monocylam%2C+and+noncyclam+small-molecule+CXC+chemokine+receptor+4+inhibitors&doi=10.1124%2Fmol.108.049775"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.049775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.049775%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26aulast%3DBodart%26aufirst%3DV.%26aulast%3DMetz%26aufirst%3DM.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DComparison%2520of%2520the%2520potential%2520multiple%2520binding%2520modes%2520of%2520bicyclam%252C%2520monocylam%252C%2520and%2520noncyclam%2520small-molecule%2520CXC%2520chemokine%2520receptor%25204%2520inhibitors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1485%26epage%3D1495%26doi%3D10.1124%2Fmol.108.049775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clercq, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Abad, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">761</span><span class="refDoi"> DOI: 10.1016/j.bcp.2005.05.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bcp.2005.05.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=752-761&author=S.+Hatseauthor=K.+Princenauthor=E.+D.+Clercqauthor=M.+M.+Rosenkildeauthor=T.+W.+Schwartzauthor=P.+E.+Hernandez-Abadauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=D.+Schols&title=AMD3465%2C+a+monomacrocyclic+CXCR4+antagonist+and+potent+HIV+entry+inhibitor&doi=10.1016%2Fj.bcp.2005.05.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2005.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2005.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DClercq%26aufirst%3DE.%2BD.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26aulast%3DHernandez-Abad%26aufirst%3DP.%2BE.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DAMD3465%252C%2520a%2520monomacrocyclic%2520CXCR4%2520antagonist%2520and%2520potent%2520HIV%2520entry%2520inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2005%26volume%3D70%26spage%3D752%26epage%3D761%26doi%3D10.1016%2Fj.bcp.2005.05.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Baldwin, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St Charles, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clore, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gronenborn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wlodawer, A.</span><span> </span><span class="NLM_article-title">Crystal structure of interleukin 8: symbiosis of NMR and crystallography</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span><span class="refDoi"> DOI: 10.1073/pnas.88.2.502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.88.2.502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1988949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK3MXpvFOhsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=502-506&author=E.+T.+Baldwinauthor=I.+T.+Weberauthor=R.+St+Charlesauthor=J.+C.+Xuanauthor=E.+Appellaauthor=M.+Yamadaauthor=K.+Matsushimaauthor=B.+F.+Edwardsauthor=G.+M.+Cloreauthor=A.+M.+Gronenbornauthor=A.+Wlodawer&title=Crystal+structure+of+interleukin+8%3A+symbiosis+of+NMR+and+crystallography&doi=10.1073%2Fpnas.88.2.502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of interleukin 8:  symbiosis of NMR and crystallography</span></div><div class="casAuthors">Baldwin, Eric T.; Weber, Irene T.; St. Charles, Robert; Xuan, Jian Cheng; Appella, Ettore; Yamada, Masaki; Matsushima, Kouji; Edwards, Brian F. P.; Clore, G. Marius; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">502-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The crystal structure of a host defense system chemotactic factor, interleukin 8, was solved by mol. replacement using as a model the soln. structure derived from NMR expts.  The structure was refined with 2 Å x-ray data to an R factor of 0.187 (0.217 at 1.6 Å).  A comparison indicates some potential differences between the structure in soln. and in the cryst. state.  The anal. also predicts that residues 4-9 on the N terminus and the β-bend, which includes His-33, may be important for receptor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh5c-Ty3aiibVg90H21EOLACvtfcHk0lhKE0BBvVwRCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXpvFOhsA%253D%253D&md5=cf028d5e1efcf197e1b59984cb58cf53</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.2.502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.2.502%26sid%3Dliteratum%253Aachs%26aulast%3DBaldwin%26aufirst%3DE.%2BT.%26aulast%3DWeber%26aufirst%3DI.%2BT.%26aulast%3DSt%2BCharles%26aufirst%3DR.%26aulast%3DXuan%26aufirst%3DJ.%2BC.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DYamada%26aufirst%3DM.%26aulast%3DMatsushima%26aufirst%3DK.%26aulast%3DEdwards%26aufirst%3DB.%2BF.%26aulast%3DClore%26aufirst%3DG.%2BM.%26aulast%3DGronenborn%26aufirst%3DA.%2BM.%26aulast%3DWlodawer%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520interleukin%25208%253A%2520symbiosis%2520of%2520NMR%2520and%2520crystallography%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D502%26epage%3D506%26doi%3D10.1073%2Fpnas.88.2.502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">Locating ligand-binding sites in 7TM receptors by protein engineering</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">434</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span><span class="refDoi"> DOI: 10.1016/0958-1669(94)90054-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2F0958-1669%2894%2990054-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=7765177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK2cXmtVSgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=434-444&author=T.+W.+Schwartz&title=Locating+ligand-binding+sites+in+7TM+receptors+by+protein+engineering&doi=10.1016%2F0958-1669%2894%2990054-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Locating ligand-binding sites in 7TM receptors by protein engineering</span></div><div class="casAuthors">Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">434-44</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    </div><div class="casAbstract">Over the past year, mutational anal. of peptide receptors has started to change our understanding of the interaction between G protein coupled receptors and their ligands, an area previously almost totally dominated by results from studies of monoamine receptors.  A picture is currently emerging, in which small ligands appear to bind in three (more or less) overlapping ligand-binding pockets in between the transmembrane segments.  In contrast, contact residues for peptide and protein ligands have mainly been found in exterior regions of peptide and protein receptors.  It is also becoming increasingly clear that agonists and antagonists may interact in vastly different manners, even though they are competitive ligands for a common receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosQm6mxsg1RbVg90H21EOLACvtfcHk0lhKE0BBvVwRCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmtVSgsb4%253D&md5=b7ca10b3197c991f2efcf5d367705065</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2F0958-1669%2894%2990054-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0958-1669%252894%252990054-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DLocating%2520ligand-binding%2520sites%2520in%25207TM%2520receptors%2520by%2520protein%2520engineering%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D1994%26volume%3D5%26spage%3D434%26epage%3D444%26doi%3D10.1016%2F0958-1669%2894%2990054-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ballesteros, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, H.</span><span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span> <span class="citation_source-journal">Methods Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span><span class="refDoi"> DOI: 10.1016/S1043-9471(05)80049-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=366-428&author=J.+A.+Ballesterosauthor=H.+Weinstein&title=Integrated+methods+for+the+construction+of+three-dimensional+models+and+computational+probing+of+structure-function+relations+in+G+protein-coupled+receptors&doi=10.1016%2FS1043-9471%2805%2980049-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span></div><div class="casAuthors">Ballesteros, Juan A.; Weinstein, Harel</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Neurosciences</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">366-428</span>CODEN:
                <span class="NLM_cas:coden">MENEE5</span>;
        ISSN:<span class="NLM_cas:issn">1043-9471</span>.
    </div><div class="casAbstract">A review, with 135 refs., on approaches that can be used to resolve the apparent ambiguities that burden the pharmacol. testing of G protein-coupled receptor (GPCR) models, based on the integration of structural information about the receptor, about mutants, and about the changes induced by ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfENoRspqa7LVg90H21EOLACvtfcHk0lhKE0BBvVwRCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1Kmtrk%253D&md5=d3f99e9d07cea245a770f3f099bc8cc7</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DWeinstein%26aufirst%3DH.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26jtitle%3DMethods%2520Neurosci.%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428%26doi%3D10.1016%2FS1043-9471%2805%2980049-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Brelot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heveker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alizon, M.</span><span> </span><span class="NLM_article-title">Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">23736</span><span class="NLM_x">–</span> <span class="NLM_lpage">23744</span><span class="refDoi"> DOI: 10.1074/jbc.M000776200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M000776200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10825158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12murg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=23736-23744&author=A.+Brelotauthor=N.+Hevekerauthor=M.+Montesauthor=M.+Alizon&title=Identification+of+residues+of+CXCR4+critical+for+human+immunodeficiency+virus+coreceptor+and+chemokine+receptor+activities&doi=10.1074%2Fjbc.M000776200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities</span></div><div class="casAuthors">Brelot, Anne; Heveker, Nikolaus; Montes, Monica; Alizon, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">23736-23744</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CXCR4 is a G-coupled receptor for the stromal cell-derived factor (SDF-1) chemokine, and a CD4-assocd. human immunodeficiency virus type 1 (HIV-1) coreceptor.  These functions were studied in a panel of CXCR4 mutants bearing deletions in the NH2-terminal extracellular domain (NT) or substitutions in the NT, the extracellular loops (ECL), or the transmembrane domains (TMs).  The coreceptor activity of CXCR4 was markedly impaired by mutations of two Tyr residues in NT (Y7A/Y12A) or at a single Asp residue in ECL2 (D193A), ECL3 (D262A), or TMII (D97N).  These acidic residues could engage electrostatical interactions with basic residues of the HIV-1 envelope protein gp120, known to contribute to the selectivity for CXCR4.  The ability of CXCR4 mutants to bind SDF-1 and mediate cell signal was consistent with the two-site model of chemokine-receptor interaction.  Site I involved in SDF-1 binding but not signaling was located in NT with particular importance of Glu14 and/or Glu15 and Tyr21.  Residues required for both SDF-1 binding and signaling, and thus probably part of site II, were identified in ECL2 (Asp187), TMII (Asp97), and TMVII (Glu288).  The first residues (2-9) of NT also seem required for SDF-1 binding and signaling.  A deletion in the third intracellular loop abolished signaling, probably by disrupting the coupling with G proteins.  The identification of CXCR4 residues involved in the interaction with both SDF-1 and HIV-1 may account for the signaling activity of gp120 and has implications for the development of antiviral compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkduYACuzA2bVg90H21EOLACvtfcHk0lhBUHYNcDW4WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12murg%253D&md5=e0b778ce19ed5a084a4d5711901f2cb0</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M000776200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M000776200%26sid%3Dliteratum%253Aachs%26aulast%3DBrelot%26aufirst%3DA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DMontes%26aufirst%3DM.%26aulast%3DAlizon%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520residues%2520of%2520CXCR4%2520critical%2520for%2520human%2520immunodeficiency%2520virus%2520coreceptor%2520and%2520chemokine%2520receptor%2520activities%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D23736%26epage%3D23744%26doi%3D10.1074%2Fjbc.M000776200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Crump, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loetscher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajarathnam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenzana-Seisdedos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virelizier, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baggiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sykes, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark-Lewis, I.</span><span> </span><span class="NLM_article-title">Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6996</span><span class="NLM_x">–</span> <span class="NLM_lpage">7007</span><span class="refDoi"> DOI: 10.1093/emboj/16.23.6996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1093%2Femboj%2F16.23.6996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=9384579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1cXisVChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=6996-7007&author=M.+P.+Crumpauthor=J.+H.+Gongauthor=P.+Loetscherauthor=K.+Rajarathnamauthor=A.+Amaraauthor=F.+Arenzana-Seisdedosauthor=J.+L.+Virelizierauthor=M.+Baggioliniauthor=B.+D.+Sykesauthor=I.+Clark-Lewis&title=Solution+structure+and+basis+for+functional+activity+of+stromal+cell-derived+factor-1%3B+dissociation+of+CXCR4+activation+from+binding+and+inhibition+of+HIV-1&doi=10.1093%2Femboj%2F16.23.6996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1</span></div><div class="casAuthors">Crump, Matthew P.; Gong, Jiang-Hong; Loetscher, Pius; Rajarathnam, Krishna; Amara, Ali; Arenzana-Seisdedos, Fernando; Virelizier, Jean-Louis; Baggiolini, Marco; Sykes, Brian D.; Clark-Lewis, Ian</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6996-7007</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was detd. by NMR spectroscopy.  SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution.  Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation.  Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists.  Residues 12-17 of the loop region, which the authors term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure.  The RFFESH formed a receptor binding site, which the authors propose to be an important initial docking site of SDF-1 with its receptor.  The ability of the SDF-1 analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for the virus in addn. to being the receptor for SDF-1, correlated with their affinity for CXCR4.  Activation of the receptor is not required for HIV-1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmMsriBtMZq7Vg90H21EOLACvtfcHk0lhBUHYNcDW4WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVChtw%253D%253D&md5=ccf51d9ca51561e4da2aab95d886be22</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F16.23.6996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F16.23.6996%26sid%3Dliteratum%253Aachs%26aulast%3DCrump%26aufirst%3DM.%2BP.%26aulast%3DGong%26aufirst%3DJ.%2BH.%26aulast%3DLoetscher%26aufirst%3DP.%26aulast%3DRajarathnam%26aufirst%3DK.%26aulast%3DAmara%26aufirst%3DA.%26aulast%3DArenzana-Seisdedos%26aufirst%3DF.%26aulast%3DVirelizier%26aufirst%3DJ.%2BL.%26aulast%3DBaggiolini%26aufirst%3DM.%26aulast%3DSykes%26aufirst%3DB.%2BD.%26aulast%3DClark-Lewis%26aufirst%3DI.%26atitle%3DSolution%2520structure%2520and%2520basis%2520for%2520functional%2520activity%2520of%2520stromal%2520cell-derived%2520factor-1%253B%2520dissociation%2520of%2520CXCR4%2520activation%2520from%2520binding%2520and%2520inhibition%2520of%2520HIV-1%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D6996%26epage%3D7007%26doi%3D10.1093%2Femboj%2F16.23.6996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomerantz, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">42826</span><span class="NLM_x">–</span> <span class="NLM_lpage">42833</span><span class="refDoi"> DOI: 10.1074/jbc.M106582200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.M106582200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=42826-42833&author=N.+Zhouauthor=Z.+Luoauthor=J.+Luoauthor=D.+Liuauthor=J.+W.+Hallauthor=R.+J.+Pomerantzauthor=Z.+Huang&title=Structural+and+functional+characterization+of+human+CXCR4+as+a+chemokine+receptor+and+HIV-1+co-receptor+by+mutagenesis+and+molecular+modeling+studies&doi=10.1074%2Fjbc.M106582200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M106582200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M106582200%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DJ.%2BW.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DStructural%2520and%2520functional%2520characterization%2520of%2520human%2520CXCR4%2520as%2520a%2520chemokine%2520receptor%2520and%2520HIV-1%2520co-receptor%2520by%2520mutagenesis%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D42826%26epage%3D42833%26doi%3D10.1074%2Fjbc.M106582200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Choi, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">15398</span><span class="NLM_x">–</span> <span class="NLM_lpage">15404</span><span class="refDoi"> DOI: 10.1128/JVI.79.24.15398-15404.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.79.24.15398-15404.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16306611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28XhslOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=15398-15404&author=W.+T.+Choiauthor=S.+Tianauthor=C.+Z.+Dongauthor=S.+Kumarauthor=D.+Liuauthor=N.+Madaniauthor=J.+Anauthor=J.+G.+Sodroskiauthor=Z.+Huang&title=Unique+ligand+binding+sites+on+CXCR4+probed+by+a+chemical+biology+approach%3A+implications+for+the+design+of+selective+human+immunodeficiency+virus+type+1+inhibitors&doi=10.1128%2FJVI.79.24.15398-15404.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Unique ligand binding sites on CXCR4 probed by a chemical biology approach: Implications for the design of selective human immunodeficiency virus type 1 inhibitors</span></div><div class="casAuthors">Choi, Won-Tak; Tian, Shaomin; Dong, Chang-Zhi; Kumar, Santosh; Liu, Dongxiang; Madani, Navid; An, Jing; Sodroski, Joseph G.; Huang, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15398-15404</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The chemokine receptor CXCR4 plays an important role as the receptor for the normal physiol. function of stromal cell-derived factor 1α (SDF-1α) and the coreceptor for the entry of human immunodeficiency virus type 1 (HIV-1) into the cell.  Many residues throughout CXCR4 transmembrane (TM) and extracellular loop 2 domains are known to be specifically involved in interaction with HIV-1 gp120, as most of these sites did not play a role in either SDF-1α binding or signaling.  These results provided direct exptl. evidence for the distinct functional sites on CXCR4 for HIV-1 and the normal ligand SDF-1α.  To further understand the CXCR4-ligand interaction and to develop new CXCR4 inhibitors to block HIV-1 entry, a new family of unnatural chemokines, termed synthetically and modularly modified (SMM) chemokines, were recently generated from the native sequence of SDF-1α or viral macrophage inflammatory protein II (vMIP-II).  These SMM chemokines contain various de novo-designed sequence replacements and substitutions by D-amino acids and display more enhanced CXCR4 selectivity, binding affinities, and/or anti-HIV activities than natural chemokines.  Using these novel CXCR4-targeting SMM chemokines as receptor probes, ligand binding site mapping expts. were conducted on a panel of site-directed mutants of CXCR4.  This provides the first exptl. evidence demonstrating that SMM chemokines interact with many residues on CXCR4 TM and extracellular domains that are important for HIV-1 entry, but not SDF-1α binding or signaling.  The preferential overlapping in the CXCR4 binding residues of SMM chemokines with HIV-1 over SDF-1α illustrates a mechanism for the potent HIV-1 inhibition by these SMM chemokines.  The discovery of distinct functional sites or conformational states influenced by these receptor sites mediating different functions of the natural ligand vs. the viral or synthetic ligands has important implications for drug discovery, since the sites shared by SMM chemokines and HIV-1 but not by SDF-1α can be targeted for the development of selective HIV-1 inhibitors devoid of interference with normal SDF-1α function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2IZtIiF1BpbVg90H21EOLACvtfcHk0lhBUHYNcDW4WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhslOgtw%253D%253D&md5=057a8120327933fa77ab2461cbcdcde3</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.24.15398-15404.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.24.15398-15404.2005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DW.%2BT.%26aulast%3DTian%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DC.%2BZ.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMadani%26aufirst%3DN.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DUnique%2520ligand%2520binding%2520sites%2520on%2520CXCR4%2520probed%2520by%2520a%2520chemical%2520biology%2520approach%253A%2520implications%2520for%2520the%2520design%2520of%2520selective%2520human%2520immunodeficiency%2520virus%2520type%25201%2520inhibitors%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D15398%26epage%3D15404%26doi%3D10.1128%2FJVI.79.24.15398-15404.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, W.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesavento, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodroski, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span> </span><span class="NLM_article-title">Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">12667</span><span class="NLM_x">–</span> <span class="NLM_lpage">12673</span><span class="refDoi"> DOI: 10.1128/JVI.79.20.12667-12673.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.79.20.12667-12673.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16188969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFWisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2005&pages=12667-12673&author=S.+Tianauthor=W.-T.+Choiauthor=D.+Liuauthor=J.+Pesaventoauthor=Y.+Wangauthor=J.+Anauthor=J.+G.+Sodroskiauthor=Z.+Huang&title=Distinct+functional+sites+for+human+immunodeficiency+virus+type+1+and+stromal+cell-derived+factor+1%CE%B1+on+CXCR4+transmembrane+helical+domains&doi=10.1128%2FJVI.79.20.12667-12673.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1α on CXCR4 transmembrane helical domains</span></div><div class="casAuthors">Tian, Shaomin; Choi, Won-Tak; Liu, Dongxiang; Pesavento, James; Wang, Youli; An, Jing; Sodroski, Joseph G.; Huang, Ziwei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">12667-12673</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The entry of human immunodeficiency virus type 1 (HIV-1) into the cell is initiated by the interaction of the viral surface envelope protein with two cell surface components of the target cell, CD4 and a chemokine coreceptor, usually CXCR4 or CCR5.  The natural ligand of CXCR4 is stromal cell-derived factor 1α (SDF-1α).  Whereas the overlap between HIV-1 and SDF-1α functional sites on the extracellular domains of CXCR4 has been well documented, it has yet to be detd. whether there are sites in the transmembrane (TM) helixes of CXCR4 important for HIV-1 and/or SDF-1α functions, and if such sites do exist, whether they are overlapping or distinctive for the sep. functions of CXCR4.  For this study, by employing alanine-scanning mutagenesis, 125I-SDF-1α competition binding, Ca2+ mobilization, and cell-cell fusion assays, we found that the mutation of many CXCR4 TM residues, including Tyr45, His79, Asp97, Pro163, Trp252, Tyr255, Asp262, Glu288, His294, and Asn298, could selectively decrease HIV-1-mediated cell fusion but not the binding activity of SDF-1α.  Phe87 and Phe292, which were involved in SDF-1α binding, did not play a significant role in the coreceptor activity of CXCR4, further demonstrating the disconnection between physiol. and pathol. activities of CXCR4 TM domains.  Our data also show that four mutations of the second extracellular loop, D182A, D187A, F189A, and P191A, could reduce HIV-1 entry without impairing either ligand binding or signaling.  Taken together, our first detailed characterization of the different functional roles of CXCR4 TM domains may suggest a mechanistic basis for the discovery of new selective anti-HIV agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXg5dHajQEK7Vg90H21EOLACvtfcHk0lipuo94Dz2raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFWisb%252FE&md5=8ff44231cfe1c7dc729d9b7f71de6e80</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1128%2FJVI.79.20.12667-12673.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.79.20.12667-12673.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DS.%26aulast%3DChoi%26aufirst%3DW.-T.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DPesavento%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DAn%26aufirst%3DJ.%26aulast%3DSodroski%26aufirst%3DJ.%2BG.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DDistinct%2520functional%2520sites%2520for%2520human%2520immunodeficiency%2520virus%2520type%25201%2520and%2520stromal%2520cell-derived%2520factor%25201%25CE%25B1%2520on%2520CXCR4%2520transmembrane%2520helical%2520domains%26jtitle%3DJ.%2520Virol.%26date%3D2005%26volume%3D79%26spage%3D12667%26epage%3D12673%26doi%3D10.1128%2FJVI.79.20.12667-12673.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of tetrahydroisoquinoline-based CXCR4 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Y.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+tetrahydroisoquinoline-based+CXCR4+antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0lipuo94Dz2raw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%2BY.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520tetrahydroisoquinoline-based%2520CXCR4%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Brelot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heveker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adema, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alizon, M.</span><span> </span><span class="NLM_article-title">Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">2576</span><span class="NLM_x">–</span> <span class="NLM_lpage">2586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10074102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaK1MXhvFygu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1999&pages=2576-2586&author=A.+Brelotauthor=N.+Hevekerauthor=K.+Ademaauthor=M.+J.+Hosieauthor=B.+Willettauthor=M.+Alizon&title=Effect+of+mutations+in+the+second+extracellular+loop+of+CXCR4+on+its+utilization+by+human+and+feline+immunodeficiency+viruses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses</span></div><div class="casAuthors">Brelot, Anne; Heveker, Nikolaus; Adema, Karen; Hosie, Margaret J.; Willett, Brian; Alizon, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2576-2586</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">CCR5 and CXCR4 are the principal CD4-assocd. coreceptors used by human immunodeficiency virus type 1 (HIV-1).  CXCR4 is also a receptor for the feline immunodeficiency virus (FIV).  The rat CXCR4 cannot mediate infection by HIV-1NDK or by FIVPET (both cell line-adapted strains) because of sequence differences with human CXCR4 in the second extracellular loop (ECL2).  Here the authors made similar observations for HIV-189.6 (a strain also using CCR5) and for a primary HIV-1 isolate.  It showed the role of ECL2 in the coreceptor activity of CXCR4 for different types of HIV-1 strains.  By exchanging ECL2 residues between human and rat CXCR4, the authors found that several amino acid differences contributed to the inactivity of the rat CXCR4 toward HIV-189.6.  In contrast, its inactivity toward HIV-1NDK seemed principally due to a serine at position 193 instead of to an aspartic acid (Asp193) in human CXCR4.  Likewise, a mutation of Asp187 prevented usage of CXCR4 by FIVPET.  Different mutations of Asp193, including its replacement by a glutamic acid, markedly reduced or suppressed the activity of CXCR4 for HIV-1NDK infection, indicating that the neg. charge was not the only requirement.  Mutations of Asp193 and of arginine residues (Arg183 and Arg188) of CXCR4 reduced the efficiency of HIV-1 infection for all HIV-1 strains tested.  Other ECL2 mutations tested had strain-specific effects or no apparent effect on HIV-1 infection.  The ECL2 mutants allowed the authors to identify residues contributing to the epitope of the 12G5 monoclonal antibody.  Overall, residues with different charges and interspersed in ECL2 seem to participate in the coreceptor activity of CXCR4.  This suggests that a conformational rather than linear epitope of ECL2 contributes to the HIV-1 binding site.  However, certain HIV-1 and FIV strains seem to require the presence of a particular ECL2 residue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowuf8HIQfjwLVg90H21EOLACvtfcHk0lg344P3S0UmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvFygu7Y%253D&md5=eb8739cd8cefbd8737286ae53c7e4282</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrelot%26aufirst%3DA.%26aulast%3DHeveker%26aufirst%3DN.%26aulast%3DAdema%26aufirst%3DK.%26aulast%3DHosie%26aufirst%3DM.%2BJ.%26aulast%3DWillett%26aufirst%3DB.%26aulast%3DAlizon%26aufirst%3DM.%26atitle%3DEffect%2520of%2520mutations%2520in%2520the%2520second%2520extracellular%2520loop%2520of%2520CXCR4%2520on%2520its%2520utilization%2520by%2520human%2520and%2520feline%2520immunodeficiency%2520viruses%26jtitle%3DJ.%2520Virol.%26date%3D1999%26volume%3D73%26spage%3D2576%26epage%3D2586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">Structure-function of the G protein-coupled receptor superfamily</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">531</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1146/annurev-pharmtox-032112-135923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1146%2Fannurev-pharmtox-032112-135923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=23140243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjt1Wgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2013&pages=531-556&author=V.+Katritchauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure-function+of+the+G+protein-coupled+receptor+superfamily&doi=10.1146%2Fannurev-pharmtox-032112-135923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function of the G protein-coupled receptor superfamily</span></div><div class="casAuthors">Katritch, Vsevolod; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">531-556</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  During the past few years, crystallog. of G protein-coupled receptors (GPCRs) has experienced exponential growth, resulting in the detn. of the structures of 16 distinct receptors-9 of them in 2012 alone.  Including closely related subtype homol. models, this coverage amts. to approx. 12% of the human GPCR superfamily.  The adrenergic, rhodopsin, and adenosine receptor systems are also described by agonist-bound active-state structures, including a structure of the receptor-G protein complex for the β2-adrenergic receptor.  Biochem. and biophys. techniques, such as NMR and hydrogen-deuterium exchange coupled with mass spectrometry, are providing complementary insights into ligand-dependent dynamic equil. between different functional states.  Addnl. details revealed by high-resoln. structures illustrate the receptors as allosteric machines that are controlled not only by ligands but also by ions, lipids, cholesterol, and water.  This wealth of data is helping redefine the authors' knowledge of how GPCRs recognize such a diverse array of ligands and how they transmit signals 30 angstroms across the cell membrane; it also is shedding light on a structural basis of GPCR allosteric modulation and biased signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmUVW-rEZbvrVg90H21EOLACvtfcHk0lg344P3S0UmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjt1Wgurc%253D&md5=5e8c26100a9eb33a32755af09199138d</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1146%2Fannurev-pharmtox-032112-135923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-pharmtox-032112-135923%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure-function%2520of%2520the%2520G%2520protein-coupled%2520receptor%2520superfamily%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2013%26volume%3D53%26spage%3D531%26epage%3D556%26doi%3D10.1146%2Fannurev-pharmtox-032112-135923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Bridger, G. J.; Skerlj, R. T.</span><span> </span><span class="NLM_article-title">Bicyclam derivatives as HIV inhibitors</span>. In  <span class="citation_source-book">Advances in Antiviral Drug Design</span>; <span class="NLM_contrib-group">De Clercq, E.</span>, Ed.; <span class="NLM_publisher-name">JAI Press</span>: <span class="NLM_publisher-loc">Stamford, CT, USA</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>Vol. 3, pp  <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2FS1075-8593%2899%2980007-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=161-229&author=G.+J.+Bridger&author=R.+T.+Skerljauthor=E.+De+Clercq&title=Advances+in+Antiviral+Drug+Design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS1075-8593%2899%2980007-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1075-8593%252899%252980007-0%26sid%3Dliteratum%253Aachs%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26atitle%3DBicyclam%2520derivatives%2520as%2520HIV%2520inhibitors%26btitle%3DAdvances%2520in%2520Antiviral%2520Drug%2520Design%26aulast%3DDe%2BClercq%26aufirst%3DE.%26pub%3DJAI%2520Press%26date%3D1999%26spage%3D161%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>Schrödinger Suite 2012 Induced Fit Docking protocol; Glide version 5.8, S., LLC, New York, NY, 2012; Prime version 3.1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012+Induced+Fit+Docking+protocol%3B+Glide+version+5.8%2C+S.%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Prime+version+3.1%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Dragic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cormier, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajumo, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxwell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakmar, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, J. P.</span><span> </span><span class="NLM_article-title">A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5639</span><span class="NLM_x">–</span> <span class="NLM_lpage">5644</span><span class="refDoi"> DOI: 10.1073/pnas.090576697</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1073%2Fpnas.090576697" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5639-5644&author=T.+Dragicauthor=A.+Trkolaauthor=D.+A.+D.+Thompsonauthor=E.+G.+Cormierauthor=F.+A.+Kajumoauthor=E.+Maxwellauthor=S.+W.+Linauthor=W.+W.+Yingauthor=S.+O.+Smithauthor=T.+P.+Sakmarauthor=J.+P.+Moore&title=A+binding+pocket+for+a+small+molecule+inhibitor+of+HIV-1+entry+within+the+transmembrane+helices+of+CCR5&doi=10.1073%2Fpnas.090576697"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.090576697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.090576697%26sid%3Dliteratum%253Aachs%26aulast%3DDragic%26aufirst%3DT.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DThompson%26aufirst%3DD.%2BA.%2BD.%26aulast%3DCormier%26aufirst%3DE.%2BG.%26aulast%3DKajumo%26aufirst%3DF.%2BA.%26aulast%3DMaxwell%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DS.%2BW.%26aulast%3DYing%26aufirst%3DW.%2BW.%26aulast%3DSmith%26aufirst%3DS.%2BO.%26aulast%3DSakmar%26aufirst%3DT.%2BP.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DA%2520binding%2520pocket%2520for%2520a%2520small%2520molecule%2520inhibitor%2520of%2520HIV-1%2520entry%2520within%2520the%2520transmembrane%2520helices%2520of%2520CCR5%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D5639%26epage%3D5644%26doi%3D10.1073%2Fpnas.090576697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Tsamis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gavrilov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajumo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagat, J. R.</span><span> </span><span class="NLM_article-title">Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5201</span><span class="NLM_x">–</span> <span class="NLM_lpage">5208</span><span class="refDoi"> DOI: 10.1128/JVI.77.9.5201-5208.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1128%2FJVI.77.9.5201-5208.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=12692222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtFykur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2003&pages=5201-5208&author=F.+Tsamisauthor=S.+Gavrilovauthor=F.+Kajumoauthor=C.+Seibertauthor=S.+Kuhmannauthor=T.+Ketasauthor=A.+Trkolaauthor=A.+Palaniauthor=J.+W.+Claderauthor=J.+R.+Tagat&title=Analysis+of+the+mechanism+by+which+the+small-molecule+CCR5+antagonists+SCH-351125+and+SCH-350581+inhibit+human+immunodeficiency+virus+type+1+entry&doi=10.1128%2FJVI.77.9.5201-5208.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry</span></div><div class="casAuthors">Tsamis, Fotini; Gavrilov, Svetlana; Kajumo, Francis; Seibert, Christoph; Kuhmann, Shawn; Ketas, Tom; Trkola, Alexandra; Palani, Anadan; Clader, John W.; Tagat, Jayaram R.; McCombie, Stuart; Baroudy, Bahige; Moore, John P.; Sakmar, Thomas P.; Dragic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5201-5208</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the consecutive interaction of the envelope glycoprotein gp120 with CD4 and a coreceptor such as CCR5 or CXCR4.  The CCR5 coreceptor is used by the most commonly transmitted HIV-1 strains that often persist throughout the course of infection.  Compds. targeting CCR5-mediated entry are a novel class of drugs being developed to treat HIV-1 infection.  In this study, we have identified the mechanism of action of two inhibitors of CCR5 function, SCH-350581 (AD101) and SCH-351125 (SCH-C).  AD101 is more potent than SCH-C at inhibiting HIV-1 replication in primary lymphocytes, as well as viral entry and gp120 binding to cell lines.  Both mols. also block the binding of several anti-CCR5 monoclonal antibodies that recognize epitopes in the second extracellular loop of CCR5.  Alanine mutagenesis of the transmembrane domain of CCR5 suggests that AD101 and SCH-C bind to overlapping but nonidentical sites within a putative ligand-binding cavity formed by transmembrane helixes 1, 2, 3, and 7.  We propose that the binding of small mols. to the transmembrane domain of CCR5 may disrupt the conformation of its extracellular domain, thereby inhibiting ligand binding to CCR5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGjIUAj5eebVg90H21EOLACvtfcHk0lgToun1RcAkQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtFykur0%253D&md5=976ed3aaec6c49cb5ff43d35ebaf9030</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1128%2FJVI.77.9.5201-5208.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.77.9.5201-5208.2003%26sid%3Dliteratum%253Aachs%26aulast%3DTsamis%26aufirst%3DF.%26aulast%3DGavrilov%26aufirst%3DS.%26aulast%3DKajumo%26aufirst%3DF.%26aulast%3DSeibert%26aufirst%3DC.%26aulast%3DKuhmann%26aufirst%3DS.%26aulast%3DKetas%26aufirst%3DT.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DPalani%26aufirst%3DA.%26aulast%3DClader%26aufirst%3DJ.%2BW.%26aulast%3DTagat%26aufirst%3DJ.%2BR.%26atitle%3DAnalysis%2520of%2520the%2520mechanism%2520by%2520which%2520the%2520small-molecule%2520CCR5%2520antagonists%2520SCH-351125%2520and%2520SCH-350581%2520inhibit%2520human%2520immunodeficiency%2520virus%2520type%25201%2520entry%26jtitle%3DJ.%2520Virol.%26date%3D2003%26volume%3D77%26spage%3D5201%26epage%3D5208%26doi%3D10.1128%2FJVI.77.9.5201-5208.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">GluVII:06 - A highly conserved and selective anchor point for non-peptide ligands in chemokine receptors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.2174/15680266106061319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F15680266106061319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16918451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1Sltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=1319-1333&author=M.+M.+Rosenkildeauthor=T.+W.+Schwartz&title=GluVII%3A06+-+A+highly+conserved+and+selective+anchor+point+for+non-peptide+ligands+in+chemokine+receptors&doi=10.2174%2F15680266106061319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">GluVII:06 - a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors</span></div><div class="casAuthors">Rosenkilde, Mette M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1319-1333</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A majority of small mol. non-peptide ligands for chemokine receptors in general are characterized by the presence of one or two centrally located, pos. charged nitrogen atoms and these compds. are also often of relatively similar elongated overall structure with terminal arom. moieties.  In the corresponding main ligand-binding crevice of the chemokine 7TM receptors is found a centrally located glutamic acid residue in position 6 of transmembrane segment VII in 74% of the chemokine receptors but only in approx. 1% of non-chemokine receptors.  GluVII:06 has been demonstrated to be crucially important for the binding and action of a no. of non-peptide ligands in for example the CCR1, CCR2 and CCR5 receptors.  It is proposed that in chemokine receptors in general GluVII:06 serves as a selective anchor point for the centrally located, pos. charged nitrogen of the small mol. ligands and that the two peripheral chem. moieties of the ligands from this central point in the receptor structure explore each of the two halves of the main ligand binding pocket.  It is envisioned that knowledge of this binding mode can be exploited in structure-based discovery and design of novel chemokine receptor ligands and esp. ligands with specifically optimized properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsOUUuijOKG7Vg90H21EOLACvtfcHk0lgToun1RcAkQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1Sltr8%253D&md5=07b855d5056c78d049a6ba88f51ec9a9</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.2174%2F15680266106061319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F15680266106061319%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DGluVII%253A06%2520-%2520A%2520highly%2520conserved%2520and%2520selective%2520anchor%2520point%2520for%2520non-peptide%2520ligands%2520in%2520chemokine%2520receptors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D1319%26epage%3D1333%26doi%3D10.2174%2F15680266106061319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Yoshikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oishi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span> </span><span class="NLM_article-title">Molecular modeling study of cyclic pentapeptide CXCR4 antagonists: New insight into CXCR4–FC131 interactions</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2146</span><span class="NLM_x">–</span> <span class="NLM_lpage">2150</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.bmcl.2012.01.134" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2146-2150&author=Y.+Yoshikawaauthor=K.+Kobayashiauthor=S.+Oishiauthor=N.+Fujiiauthor=T.+Furuya&title=Molecular+modeling+study+of+cyclic+pentapeptide+CXCR4+antagonists%3A+New+insight+into+CXCR4%E2%80%93FC131+interactions&doi=10.1016%2Fj.bmcl.2012.01.134"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.134%26sid%3Dliteratum%253Aachs%26aulast%3DYoshikawa%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DOishi%26aufirst%3DS.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DFuruya%26aufirst%3DT.%26atitle%3DMolecular%2520modeling%2520study%2520of%2520cyclic%2520pentapeptide%2520CXCR4%2520antagonists%253A%2520New%2520insight%2520into%2520CXCR4%25E2%2580%2593FC131%2520interactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2146%26epage%3D2150%26doi%3D10.1016%2Fj.bmcl.2012.01.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Glickman, F.; Streiff, M.; Thoma, G.; Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Preparation of thiazolyl isothiourea derivatives as CXCR4 antagonists</span>. WO2005085219A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=F.+Glickman&author=M.+Streiff&author=G.+Thoma&author=H.-G.+Zerwes&title=Preparation+of+thiazolyl+isothiourea+derivatives+as+CXCR4+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGlickman%26aufirst%3DF.%26atitle%3DPreparation%2520of%2520thiazolyl%2520isothiourea%2520derivatives%2520as%2520CXCR4%2520antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H. G.</span><span> </span><span class="NLM_article-title">Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.+G.+Zerwes&title=Orally+bioavailable+isothioureas+block+function+of+the+chemokine+receptor+CXCR4+in+vitro+and+in+vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.%2BG.%26atitle%3DOrally%2520bioavailable%2520isothioureas%2520block%2520function%2520of%2520the%2520chemokine%2520receptor%2520CXCR4%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benned-Jensen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frimurer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, T. W.</span><span> </span><span class="NLM_article-title">The minor binding pocket: a major player in 7TM receptor activation</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span><span class="refDoi"> DOI: 10.1016/j.tips.2010.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.tips.2010.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=20870300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=567-574&author=M.+M.+Rosenkildeauthor=T.+Benned-Jensenauthor=T.+M.+Frimurerauthor=T.+W.+Schwartz&title=The+minor+binding+pocket%3A+a+major+player+in+7TM+receptor+activation&doi=10.1016%2Fj.tips.2010.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The minor binding pocket: a major player in 7TM receptor activation</span></div><div class="casAuthors">Rosenkilde, Mette M.; Benned-Jensen, Tau; Frimurer, Thomas M.; Schwartz, Thue W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">567-574</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  From the deep part of the main ligand-binding crevice, a minor, often shallower pocket extends between the extracellular ends of transmembrane domains (TM)-I, II, III and VII of seven-transmembrane/G protein-coupled receptors (7TM receptors).  This minor binding pocket is defined by a highly conserved kink in TM-II that is induced by a Pro residue located in 1 of 2 adjacent positions.  Here, the authors argue that this minor binding pocket is important for receptor activation.  Functional coupling of the receptors seems to be mediated through the H-bond network located between the intracellular segments of these TMs, with the allosteric interface between TM-II and TM-VII being of particular significance.  Importantly, the minor binding pocket, esp. the Pro-kink in TM-II, is involved in G protein vs. arrestin pathway-biased signaling, e.g., in the angiotensin AT1 system.  Consequently, this pocket could be specifically targeted in the development of functionally biased drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrk7NyRGRgx7Vg90H21EOLACvtfcHk0lgM5fnJDdeggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGisbbF&md5=9cdf07a4741b7184f754ae609d6f9882</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2010.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2010.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DBenned-Jensen%26aufirst%3DT.%26aulast%3DFrimurer%26aufirst%3DT.%2BM.%26aulast%3DSchwartz%26aufirst%3DT.%2BW.%26atitle%3DThe%2520minor%2520binding%2520pocket%253A%2520a%2520major%2520player%2520in%25207TM%2520receptor%2520activation%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2010%26volume%3D31%26spage%3D567%26epage%3D574%26doi%3D10.1016%2Fj.tips.2010.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Våbenø, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikiforovich, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, G. R.</span><span> </span><span class="NLM_article-title">Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">354</span><span class="refDoi"> DOI: 10.1111/j.1747-0285.2006.00387.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1111%2Fj.1747-0285.2006.00387.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16784459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVeqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=346-354&author=J.+V%C3%A5ben%C3%B8author=G.+V.+Nikiforovichauthor=G.+R.+Marshall&title=Insight+into+the+binding+mode+for+cyclopentapeptide+antagonists+of+the+CXCR4+receptor&doi=10.1111%2Fj.1747-0285.2006.00387.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor</span></div><div class="casAuthors">Vabeno, Jon; Nikiforovich, Gregory V.; Marshall, Garland R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-354</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The finding that the chemokine receptor CXCR4 is involved in T-cell HIV entry has encouraged the development of antiretroviral drugs targeting this receptor.  Addnl. evidence that CXCR4 plays a crucial role in both angiogenesis and metastasis provides further motivation for the development of a CXCR4 inhibitor for therapeutic applications in oncol.  To facilitate the design of such ligands, the authors have investigated the possible binding modes for cyclopentapeptide CXCR4 antagonists by docking 11 high/medium affinity cyclopentapeptides to a developed three-dimensional model of the CXCR4 G-protein-coupled receptor's transmembrane region.  These ligands, expected to bind in the same mode to the receptor, were docked in the previously deduced receptor-bound conformation.  Ligand-receptor complexes were generated using an automated docking procedure that allowed ligand flexibility.  By comparing the resulting ligand poses, only two binding modes common for all 11 compds. were identified.  Inspection of these two ligand-receptor complexes identified several CXCR4 contact residues shown by mutation to be interaction sites for ligands and important for HIV gp120 binding.  Thus, the results provide further insight into the mechanism by which these cyclopentapeptides block HIV entry as well as a basis for rational design of CXCR4 mutants to map potential contacts with small peptide ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3r4H9kvXV8LVg90H21EOLACvtfcHk0lgM5fnJDdeggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVeqsb0%253D&md5=9fa48118baf007cdcf5f125bbec86027</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2006.00387.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2006.00387.x%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A5ben%25C3%25B8%26aufirst%3DJ.%26aulast%3DNikiforovich%26aufirst%3DG.%2BV.%26aulast%3DMarshall%26aufirst%3DG.%2BR.%26atitle%3DInsight%2520into%2520the%2520binding%2520mode%2520for%2520cyclopentapeptide%2520antagonists%2520of%2520the%2520CXCR4%2520receptor%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D346%26epage%3D354%26doi%3D10.1111%2Fj.1747-0285.2006.00387.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Kawatkar, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevariya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, J.</span><span> </span><span class="NLM_article-title">Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists</span> <span class="citation_source-journal">Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">844</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span><span class="refDoi"> DOI: 10.1258/ebm.2011.010345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1258%2Febm.2011.010345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvFeqsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=2011&pages=844-850&author=S.+P.+Kawatkarauthor=M.+Yanauthor=H.+Gevariyaauthor=M.+Y.+Limauthor=S.+Eisoldauthor=X.+Zhuauthor=Z.+Huangauthor=J.+An&title=Computational+analysis+of+the+structural+mechanism+of+inhibition+of+chemokine+receptor+CXCR4+by+small+molecule+antagonists&doi=10.1258%2Febm.2011.010345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Computational analysis of the structural mechanism of inhibition of chemokine receptor CXCR4 by small molecule antagonists</span></div><div class="casAuthors">Kawatkar, Sameer P.; Yan, Maocai; Gevariya, Harsukh; Lim, Mi Youn; Eisold, Steven; Zhu, Xuejun; Huang, Ziwei; An, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">236</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">844-850</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Medicine Press Ltd.</span>)
        </div><div class="casAbstract">Understanding the structural mechanism of receptor-ligand interactions for the chemokine receptor CXCR4 is essential for detg. its physiol. and pathol. functions and for developing new therapies targeted to CXCR4.  We have recently reported a structural mechanism for CXCR4 antagonism by a novel synthetic CXCR4 antagonist RCP168 and compared its effectiveness against the natural agonist SDF-1α.  In the present study, using mol. docking, we further investigate the binding modes of another seven small mols. known to act as CXCR4 antagonists.  The predicted binding modes were compared with previously published mutagenesis data for two of these (AMD3100 and AMD11070).  Four antagonists, including AMD3100, AMD11070, FC131 and KRH-1636, bound in a similar fashion to CXCR4.  Two important acidic amino acid residues (Asp262 and Glu288) on CXCR4, previously found essential for AMD3100 binding, were also involved in binding of the other ligands.  These four antagonists use a binding site in common with that used by RCP168, which is a novel synthetic deriv. of vMIP-II in which the first 10 residues are replaced by D-amino acids.  Comparison of binding modes modes suggested that this binding site is different from the binding region occupied by the N-terminus of SDF-1α, the only known natural ligand of CXCR4.  These observations suggest the presence of a ligand-binding site (site A) that co-exists with the agonist (SDF-1α) binding site (site B).  The other three antagonists, including MSX123, MSX202 and WZ811, are smaller in size and had very similar binding poses, but binding was quite different from that of AMD3100.  These three antagonists bound at both sites A and B, thereby blocking both binding and signaling by SDF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfkXAYLzEAYbVg90H21EOLACvtfcHk0lgM5fnJDdeggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvFeqsr0%253D&md5=8e850ef27c28acd34e0e372e8ec3c027</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1258%2Febm.2011.010345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2011.010345%26sid%3Dliteratum%253Aachs%26aulast%3DKawatkar%26aufirst%3DS.%2BP.%26aulast%3DYan%26aufirst%3DM.%26aulast%3DGevariya%26aufirst%3DH.%26aulast%3DLim%26aufirst%3DM.%2BY.%26aulast%3DEisold%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAn%26aufirst%3DJ.%26atitle%3DComputational%2520analysis%2520of%2520the%2520structural%2520mechanism%2520of%2520inhibition%2520of%2520chemokine%2520receptor%2520CXCR4%2520by%2520small%2520molecule%2520antagonists%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2011%26volume%3D236%26spage%3D844%26epage%3D850%26doi%3D10.1258%2Febm.2011.010345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Planesas, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Nueno, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borrell, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teixido, J.</span><span> </span><span class="NLM_article-title">Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span><span class="refDoi"> DOI: 10.1016/j.jmgm.2012.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2Fj.jmgm.2012.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslaqtbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=123-136&author=J.+M.+Planesasauthor=V.+I.+Perez-Nuenoauthor=J.+I.+Borrellauthor=J.+Teixido&title=Impact+of+the+CXCR4+structure+on+docking-based+virtual+screening+of+HIV+entry+inhibitors&doi=10.1016%2Fj.jmgm.2012.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of the CXCR4 structure on docking-based virtual screening of HIV entry inhibitors</span></div><div class="casAuthors">Planesas, Jesus M.; Perez-Nueno, Violeta I.; Borrell, Jose I.; Teixido, Jordi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">123-136</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Herein we analyze in depth the receptor-based virtual screening (VS) performance of the five recent crystd. CXCR4 structures along with a CXCR4 rhodopsin-based homol. model.  All CXCR4 Protein Data Bank (PDB) structures are co-crystd. with a small org. antagonist except structure 3OE0, which is co-crystd. with a cyclic peptide analog.  Evaluation of the CXCR4 models was done by retrospective docking-based VS using a test set of 248 known CXCR4 inhibitors from 4 different chemotype families and 4696 different presumed inactives.  The performance of the docking protocol using the five different protein structures was assessed in terms of pose prediction and hits detection using 12 different docking scoring functions and a scoring function with rescoring.  Results show that 3OE6 structure achieves the highest docking-based performance with an av. area under the curve (aAUC) of 0.84 and an av. enrichment factor (aEF) of 11.7 at 1% of decoys screened.  CXCR4 rhodopsin-like homol. model performs comparable to the crystd. structures in the 1% of database screened.  Moreover, a detailed anal. of the retrospective docking results using the CXCR4 homol. model in Discovery Studio allows us to hypothesize the existence of multiple binding sub-sites in CXCR4 binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuixBpt21UArVg90H21EOLACvtfcHk0lgM5fnJDdeggA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslaqtbrL&md5=068fb63baa9a866700b5ce0404da3a6b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2012.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2012.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DPlanesas%26aufirst%3DJ.%2BM.%26aulast%3DPerez-Nueno%26aufirst%3DV.%2BI.%26aulast%3DBorrell%26aufirst%3DJ.%2BI.%26aulast%3DTeixido%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520the%2520CXCR4%2520structure%2520on%2520docking-based%2520virtual%2520screening%2520of%2520HIV%2520entry%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2012%26volume%3D38%26spage%3D123%26epage%3D136%26doi%3D10.1016%2Fj.jmgm.2012.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Leonard, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, K.</span><span> </span><span class="NLM_article-title">The HIV entry inhibitors revisited</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">911</span><span class="NLM_x">–</span> <span class="NLM_lpage">934</span><span class="refDoi"> DOI: 10.2174/092986706776361030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.2174%2F092986706776361030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=16611075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislygsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=911-934&author=J.+T.+Leonardauthor=K.+Roy&title=The+HIV+entry+inhibitors+revisited&doi=10.2174%2F092986706776361030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV entry inhibitors revisited</span></div><div class="casAuthors">Leonard, J. Thomas; Roy, Kunal</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">911-934</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The new generation of antiviral drugs intended to counter HIV-1 entry into susceptible cells is emerging swiftly.  The antiviral agents that inhibit HIV entry to the target cells (denoted as HIV entry inhibitors) are already in different phases of clin. trials.  Operating early in the viral life cycle, they prevent viral entry, and have a novel, highly specific mechanism of action with a low toxicity profile.  Entry inhibitors have different toxicity and resistance profiles than the existing reverse transcriptase and protease inhibitors.  Some of these compds. demonstrated in vitro synergism with other classes of antivirals, thus offering the rationale for their combination in therapies for HIV-infected individuals.  It is worth focusing on recent developments in HIV entry inhibitors, as most of the current drug regimens suffer from the events of developing resistance against existing combination therapies.  Recent advances in the understanding of the cellular and mol. mechanisms of HIV-1 entry provide the basis for novel therapeutic strategies that prevent viral penetration of the target cell membrane, while reducing detrimental virus and treatment effects on cells and prolonging virion exposure to immune defenses.  A no. of potential sites for therapeutic intervention become accessible during the narrow window between virus attachment and the subsequent fusion of viral envelope with the cell membrane.  The HIV-1 coreceptors are particularly attractive from the perspective of identifying new antiviral compds., since they are seven-transmembrane motif G protein-coupled receptors (GPCRs), a family of proteins that is a well-validated target for drug development.  Among the many chemokine receptors that can mediate HIV-1 entry in vitro, only CCR5 and CXCR4 are of frontline pharmacol. importance.  In particular, CCR5 is essential for viral transmission and replication during the early and clin. latent phase of disease.  Several small-mol. antagonists of CCR5 and CXCR4 that block chemokine binding and HIV-1 entry have been identified in recent years.  Considerable advances have been made in the last years in the design of derivs. acting as inhibitors of HIV entry.  The mol. mechanism involved in viral entry and the structural and functional aspects of entry inhibitors are reviewed here.  The authors have also summarized the recent insights into how small-mol. antagonists interact with CCR5 and CXCR4, focusing on drug development programs that are well documented in the scientific literature.  An overview of the entry inhibitors that are in preclin. or early clin. development, and the Quant. Structure-Activity Relationship (QSAR) studies reported for the coreceptor antagonists, are also be presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDvFH6SyMb3LVg90H21EOLACvtfcHk0lh_X5CdB6POaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislygsb0%253D&md5=cae6cfe2914af301548e33e4e9754893</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2174%2F092986706776361030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706776361030%26sid%3Dliteratum%253Aachs%26aulast%3DLeonard%26aufirst%3DJ.%2BT.%26aulast%3DRoy%26aufirst%3DK.%26atitle%3DThe%2520HIV%2520entry%2520inhibitors%2520revisited%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D911%26epage%3D934%26doi%3D10.2174%2F092986706776361030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Cox, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span> </span><span class="NLM_article-title">Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1614</span><span class="NLM_x">–</span> <span class="NLM_lpage">1620</span><span class="refDoi"> DOI: 10.1002/cbic.201402056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1002%2Fcbic.201402056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1614-1620&author=B.+D.+Coxauthor=A.+R.+Prosserauthor=B.+M.+Katzmanauthor=A.+A.+Alcarazauthor=D.+C.+Liottaauthor=L.+J.+Wilsonauthor=J.+P.+Snyder&title=Anti-HIV+small-molecule+binding+in+the+peptide+subpocket+of+the+CXCR4%3ACVX15+crystal+structure&doi=10.1002%2Fcbic.201402056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402056%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%2BD.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26atitle%3DAnti-HIV%2520small-molecule%2520binding%2520in%2520the%2520peptide%2520subpocket%2520of%2520the%2520CXCR4%253ACVX15%2520crystal%2520structure%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26spage%3D1614%26epage%3D1620%26doi%3D10.1002%2Fcbic.201402056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, F.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wess, J.</span><span> </span><span class="NLM_article-title">Functional characterization of a series of mutant G protein αq subunits displaying promiscuous receptor coupling properties</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">17886</span><span class="NLM_x">–</span> <span class="NLM_lpage">17892</span><span class="refDoi"> DOI: 10.1074/jbc.273.28.17886</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1074%2Fjbc.273.28.17886" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=17886-17892&author=E.+Kostenisauthor=F.-Y.+Zengauthor=J.+Wess&title=Functional+characterization+of+a+series+of+mutant+G+protein+%CE%B1q+subunits+displaying+promiscuous+receptor+coupling+properties&doi=10.1074%2Fjbc.273.28.17886"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.28.17886&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.28.17886%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DZeng%26aufirst%3DF.-Y.%26aulast%3DWess%26aufirst%3DJ.%26atitle%3DFunctional%2520characterization%2520of%2520a%2520series%2520of%2520mutant%2520G%2520protein%2520%25CE%25B1q%2520subunits%2520displaying%2520promiscuous%2520receptor%2520coupling%2520properties%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D17886%26epage%3D17892%26doi%3D10.1074%2Fjbc.273.28.17886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Ho, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullen, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. R.</span><span> </span><span class="NLM_article-title">Site-directed mutagenesis by overlap extension using the polymerase chain reaction</span> <span class="citation_source-journal">Gene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span><span class="refDoi"> DOI: 10.1016/0378-1119(89)90358-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1016%2F0378-1119%2889%2990358-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=2744487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=1%3ACAS%3A528%3ADyaL1MXktVaitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1989&pages=51-59&author=S.+N.+Hoauthor=H.+D.+Huntauthor=R.+M.+Hortonauthor=J.+K.+Pullenauthor=L.+R.+Pease&title=Site-directed+mutagenesis+by+overlap+extension+using+the+polymerase+chain+reaction&doi=10.1016%2F0378-1119%2889%2990358-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed mutagenesis by overlap extension using the polymerase chain reaction</span></div><div class="casAuthors">Ho, Steffan N.; Hunt, Henry D.; Horton, Robert M.; Pullen, Jeffrey K.; Pease, Larry R.</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    </div><div class="casAbstract">Overlap extension represents a new approach to genetic engineering.  Complementary oligodeoxyribonucleotide (oligo) primers and the polymerase chain reaction are used to generate two DNA fragments having overlapping ends.  These fragments are combined in a subsequent fusion reaction in which the overlapping ends anneal, allowing the 3' overlap of each strand to serve as a primer for the 3' extension of the complementary strand.  The resulting fusion product is amplified further by PCR.  Specific alterations in the nucleotide (nt) sequence can be introduced by incorporating nucleotide changes into the overlapping oligo primers.  Using this technique of site-directed mutagenesis, 3 variants of a mouse major histocompatibility complex class-I gene have been generated, cloned and analyzed.  Screening of mutant clones revealed at least a 98% efficiency of mutagenesis.  All clones sequenced contained the desired mutations, and a low frequency of random substitution estd. to occur at approx. 1 in 400 nt was detected.  This method represents a significant improvement over std. methods of site-directed mutagenesis because it is much faster, simpler and approaches 100% efficiency in the generation of mutant product.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqebn9qfaVP9rVg90H21EOLACvtfcHk0lh_X5CdB6POaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXktVaitrk%253D&md5=a2587cbdaec79a12306c022825570e19</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2F0378-1119%2889%2990358-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-1119%252889%252990358-2%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BN.%26aulast%3DHunt%26aufirst%3DH.%2BD.%26aulast%3DHorton%26aufirst%3DR.%2BM.%26aulast%3DPullen%26aufirst%3DJ.%2BK.%26aulast%3DPease%26aufirst%3DL.%2BR.%26atitle%3DSite-directed%2520mutagenesis%2520by%2520overlap%2520extension%2520using%2520the%2520polymerase%2520chain%2520reaction%26jtitle%3DGene%26date%3D1989%26volume%3D77%26spage%3D51%26epage%3D59%26doi%3D10.1016%2F0378-1119%2889%2990358-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Kostenis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldhoer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenkilde, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norregaard, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span> </span><span class="NLM_article-title">A highly conserved glycine within linker I and the extreme C terminus of G protein α subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">78</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span><span class="refDoi"> DOI: 10.1124/jpet.104.080424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=10.1124%2Fjpet.104.080424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;key=15615862" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2004&pages=78-87&author=E.+Kostenisauthor=L.+Martiniauthor=J.+Ellisauthor=M.+Waldhoerauthor=A.+Heydornauthor=M.+M.+Rosenkildeauthor=P.+K.+Norregaardauthor=R.+Jorgensenauthor=J.+L.+Whistlerauthor=G.+Milligan&title=A+highly+conserved+glycine+within+linker+I+and+the+extreme+C+terminus+of+G+protein+%CE%B1+subunits+interact+cooperatively+in+switching+G+protein-coupled+receptor-to-effector+specificity&doi=10.1124%2Fjpet.104.080424"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.080424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.080424%26sid%3Dliteratum%253Aachs%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DMartini%26aufirst%3DL.%26aulast%3DEllis%26aufirst%3DJ.%26aulast%3DWaldhoer%26aufirst%3DM.%26aulast%3DHeydorn%26aufirst%3DA.%26aulast%3DRosenkilde%26aufirst%3DM.%2BM.%26aulast%3DNorregaard%26aufirst%3DP.%2BK.%26aulast%3DJorgensen%26aufirst%3DR.%26aulast%3DWhistler%26aufirst%3DJ.%2BL.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DA%2520highly%2520conserved%2520glycine%2520within%2520linker%2520I%2520and%2520the%2520extreme%2520C%2520terminus%2520of%2520G%2520protein%2520%25CE%25B1%2520subunits%2520interact%2520cooperatively%2520in%2520switching%2520G%2520protein-coupled%2520receptor-to-effector%2520specificity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D313%26spage%3D78%26epage%3D87%26doi%3D10.1124%2Fjpet.104.080424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Schrödinger</span><span class="NLM_x">. </span><a href="http://www.schrodinger.com/" class="extLink">http://www.schrodinger.com/</a> (accessed July 27,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger.+http%3A%2F%2Fwww.schrodinger.com%2F+%28accessed+July+27%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span>Schrödinger Suite 2012 Protein Preparation Wizard; Epik version 2.2, S., LLC, New York, NY, 2012; Impact version 5.7, Schrödinger, LLC, New York, NY, 2012; Prime version 2.3.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012+Protein+Preparation+Wizard%3B+Epik+version+2.2%2C+S.%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Impact+version+5.7%2C+Schr%C3%B6dinger%2C+LLC%2C+New+York%2C+NY%2C+2012%3B+Prime+version+2.3."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OE0','PDB','3OE0'); return false;">PDB: 3OE0</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00987">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_76664"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00987">10.1021/acs.jmedchem.5b00987</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Characterization data (<sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC/UPLC chromatograms) for <b>1</b> and <b>5</b>–<b>9</b> and additional 3D figures from computational modeling (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00987/suppl_file/jm5b00987_si_001.pdf">jm5b00987_si_001.pdf (2.18 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00987&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-20%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00987%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00987" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997f9c8faf329d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
